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The literature on the culture, epidemiology and possible
virulence factors of Clostridium difficile is reviewed
with reference to the association of the organism with
pseudomembranous colitis and other bowel disorders.
Studies were done to assess the use of enrichment broths
for increasing isolation of C. difficile from faeces.
Enrichment culture to determine the level of carriage of
the organism in healthy adults resulted in isolation of
the organism from 11% of such individuals. No correlation
was found with previous antimicrobial therapy or the sex
of individuals.
Recommendations are made for routine culture of the
organism in diagnostic laboratories. It is suggested that
about lg of faeces be mixed with 1ml of industrial
methylated spirits, left on the bench at room temperature
for one to two minutes and then plated onto CCFA medium
containing 250jag/ml cycloserine and 8pg/ml cefoxitin.
Plates should be incubated for 48h.
SDS-PAGE and immunoblotting were used to characterize
isolates from various outbreaks of C. difficile-
associated disease where cross infection was suspected.
Although cross infection was shown to be a possible
mechanism of transmission in some cases, it was not the
only factor involved in developing disease.
Cell surface components were extracted from strains of c.
difficile for immunochemical analysis. Two antigens were
extracted from crude cell membranes. The lipoteichoic
acid (LTA) moiety was shown to form a ladder pattern,
reminiscent of that seen with the lipopolysaccharide from
smooth Gram-negative organisms, when analysed by
SDS-PAGE. This was a common antigen in four strains
studied. Similar molecules were not demonstrated in C.
sordelli or C. bifermentans. The identity of the second
antigen is uncertain. It may be a deacylated form of the
LTA-type molecule. Cell wall carbohydrate antigen,
extracted from three strains, was shown to cross-react
with some, but not all, heterologous antisera.
Cell wall proteins, extracted with 6M urea, were found to
be different in each of five C. difficile strains
studied. This indicates greater diversity in such
proteins than previously described. Each strain had one
to three major proteins, with molecular masses (Mr) of
between 28.3kDa and 54kDa. These were always antigenic
when probed with homologous antiserum (by immunoblotting)
but were not detected with heterologous antisera. There
was one antigen with Mr of about 73kDa that was common to
all strains./
Most strains of the organism tested were found to be
relatively hydrophilic in nature. However it was
demonstrated that different culture techniques could
alter the results obtained.
Flagella isolated from two C. difficile strains were
shown to have an Mr of about 38kDa. They were antigenic,
showing cross-reaction with antiserum raised against
different strains of the organism.
Studies were performed to assess the ability of the
organism to adhere to mouse ileum. It appeared that
viable C. difficile cells associated with this tissue and
that the association increased with time. Bacteroides
fragilis was also shown to associate with the ileum but
not in the same manner as C. difficile.
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A note on C. difficile toxin(s):
The early literature regarding toxin production by
isolates of C. difficile has now been shown to be very
much oversimplified. Initially, it was believed that
strains of the organism produced only one toxin which was
cytotoxic and as such could easily be detected by tissue
culture assay. Thus, 'the cytotoxin' was referred to and
any organism producing a cytopathic effect was described
as 'cytotoxic'.
It has now, of course, been shown that C. difficile can
produce other toxic factors which may also be cytotoxic.
Readers of this thesis should bear in mind that
references to 'cytotoxicity' and 'cytotoxic effects' in
Chapters 1 to 4 will be made to studies where, in all
probability, the toxin preparations tested would have
been crude mixtures of several different toxic
extracellular products. Chapters 5 and 6 include
information about two of these toxic products, toxins A
and B, which have now. been studied in greater detail.
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CHAPTER 1




This organism was first isolated by Hall and O'Toole
(1935) during an investigation into colonization of the
human gut by bacterial species over the first few days of
life. Initially, due to difficulties encountered in its
isolation and subsequent study, the organism was named
Bacillus difficilis. Although culture extracts were found
to be extremely toxic to guinea-pigs and hamsters when
injected subcutaneously, the organisms' potential for
causing disease in humans was not fully recognized until
its association with pseudomembranous colitis (PMC) in
1978.
1.1.1. Morphology
The organism is a Gram-positive, obligately anaerobic rod
shaped bacterium. It produces subterminal oval shaped
spores which become terminal given the right growth
conditions. The dimensions of the organism vary (usually
1.3-1.6pm by 3.1-6.4pm) although the rod length can be
increased considerably when the organism is cultured on
media containing strong reducing sugars. It has
peritrichous flagella and characteristic oscillatory
motility in cooked meat broth (CMB).
1.1.2. Biochemistry
Studies show that biochemical reactions can vary markedly
between strains of C. difficile. Most will ferment
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glucose, fructose, xylose, salicin, mannitol and
hydrolyse aesculin but fail to attack galactose, lactose,
sucrose, raffinose, inulin and glycerol. Some produce
gelatinase and all are indole and lecithinase negative
(Hall and O'Toole, 1935; Hafiz and Oakley, 1976; Poxton,
1982).
1.1.3. Extracellular products
C. difficile is known to produce at least four toxins
which may be involved in the pathology of C.
difficile-associated disease (Mitchell et al. , 1986).
Toxin A (enterotoxin) causes fluid accumulation in animal
ileal loop assays. Toxin B (cytotoxin) is responsible for
characteristic rounding and separation of cell monolayers
in tissue culture. A further toxin (toxin C) which
increases gut motility, has been described (Justus et_
al. , 1982 ). There is also a labile toxin causing clear
fluid accumulation in rabbit ileal loops which appears
distinct from toxin A (Banno et al. , 1984). C. difficile
also produces a factor that inhibits neutrophil migration
and phagocytosis (Bolton et al., 1985).
1.1.4. Detection of C. difficile in faeces (excA^A*-^ c~olVwcd methods)
Most of the methods available for identification of C.
difficile within faeces are based on detection of the
toxins (A and/or B). Since the cytotoxic activity of the
organism was first described (Larson etal. , 1977) tissue
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culture assays (TCA) have been used to establish whether
or not the organism is present within clinical samples
(Bartlett, 1979). However, the poor availability of cell
lines and also the expertise required to maintain them
has tended to limit the diagnostic usefulness of TCA.
More recently commercial TCA kits, which require no
special expertise, have been developed which seem to
perform satisfactorily (Wu and Gersch, 1986; Nachamkin et
al. , 1986; Welch et al. , 1985). Whichever technique is
used results take up to 48h to obtain, thereby making a
rapid clinical diagnosis by these methods impossible.
Various immunological techniques have been used in trying
to detect C. difficile or its toxins within specimens.
These include immunofluorescent (IF) labelling,
counter-current Immunoelectrophoresis (CCIE), crossed
immunoelectrophoresis (CIE), enzyme-linked immunosorbent
assays (ELISA) and latex agglutination (LA) tests.
Wilson et al. ( 1982b) tried to use an IF label to detect
the organism but found extensive cross-reaction with
other clostridial species commonly found in faeces (i.e.
C. sordelli, C. bifermentans, C. chauvoei and C.
sporogenes). Attempts to absorb out the cross-reactive
antigens resulted in loss of reactivity against 18 of the
20 C. difficile strains being tested. Hubert et al.
(1981) encountered similar problems with this technique.
CCIE (in which faecal filtrates are placed in the
cathodic well and antiserum in the anodic well of a gel)
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and CIE (where the antigen(s) are electrophoresed in two
different dimensions with antiserum incorporated into the
second dimension gel) have been widely used as methods
for toxin detection (Ryan et al.f 1980; Welch et al ♦ ,
1980; Levine et al., 1982; Wu and Fung, 1983; Jarvis et
al., 1983; Rennie et al., 1984; Lyerly et al., 1985). LA
(Shahrabadi et al., 1984; Lyerly et al., 1985) and ELISA
(Yolken et al. , 1981; Lyerly et al., 1983; Laughon ejt
al. , 1984; Redmond et al., 1985; Krishnan, 1986) have
been investigated more recently.
ELISA appears to be the most sensitive technique with
detection of toxin A at levels of between 0.1 and Ing per
well (Laughon et al., 1984; Lyerly et al., 1983). This is
equivalent to detection of about 1 to 5ng of toxin per
millilitre of faecal suspension. Most laboratories have
facilities to perform ELISA and results are available in
about 4h .
The major problem with these techniques at the present
time is that highly specific, commercially produced
antisera are not available. Most published results
(obtained with CIE, CCIE or ELISA) show lack of
specificity since the antisera used have been produced
against incompletely purified toxins of either C.
difficile or C. sordelli and all contain antibodies to
many other antigens (Poxton and Byrne, 1981a; West and
Wilkins, 1982; Sands et al., 1983; Laughon et al. , 1984).
Ryan et al. (1983) have reported increased specificity of
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CCIE by use of absorbed sera and the specificity of ELISA
has been improved in the experimental situation with
monoclonal, affinity purified and monospecific antibodies
(Lyerly et al., 1985) or absorbed sera (Krishnan, 1986).
Lyerly et al. ( 1985) noted that monoclonal antibodies
could be prepared in unlimited quantities and that they
were more reproducible agents than the other
preparations. However, they did appear to have decreased
sensitivity in comparative studies.
Rautenberg et al. (1986) showed that immunoblotting of
cell culture supernates of C. difficile against
monospecific antisera could be used to detect toxin A.
They found that the denatured and reduced antigen
retained enough antigenicity for detection even after
sodium dodecyl sulphate-polyacrylamide gel electro¬
phoresis (SDS-PAGE). It has since been shown (Rautenberg
et al. (1987) that the antibodies used in this assay do
cross-react with other C. difficile proteins as well as
with proteins from C. bifermentans, C. botulinum and C.
sporogenes. However, toxin A was easily detected among
these proteins due to its unique high molecular mass (Mr)
of 230kDa. No work has yet been done to evalulate the
potential use of this technique for detection of the
toxin in faeces although the authors suggest it may be as
sensitive as other ELISA techniques. It might also turn
out to be more specific than such techniques.
Initial studies with commercial LA kits for detecting
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toxin A again appear to show lack of specificity
(Shahrabadi et al. , 1984; Kamlya et al. , 1986). Lyerly
and Wilkins (1986) and Peterson et al. (1986) found that
the antibody used in these assays reacted with antigen
also present in non-toxin-producing strains. This finding
was confirmed by Borriello et al. (1987) who also showed
that similar concentrations of this latex agglutinating-
antigen were produced by both toxigenic and non-toxigenic
strains in vivo. The antigen was shown to be totally
distinct from toxins A and B and cross-reaction with C.
sporogenes, C. botulinum types A, B and A/F as well as
Bacteroides asaccharolyticus was demonstrated. It was
concluded that the LA test was unsuitable for detection
of C. difficile toxin A but that it might be used as an
alternative to culture for detection of the actual
organism. Results such as these would lead one to
question the reliabilty of data obtained in which LA has
been used as the method of detection for toxin A
(Ushijima et al., 1985).
Gas-liquid chromatography (GLC), providing analysis of
metabolic end products, has been studied as a possible
means for rapid identification of C. difficile within
clinical specimens. Early investigations (Potvliege e_t
al. (1981) have been criticized for lack of sensitivity
(Borriello, 1981) and specificity (Brooks et al., 1984a;
Pepersack et al., 1983). Levett (1984a) found that there
was a false-negative rate of 59% when C. difficile
7
culture-positive specimens were analysed by GLC. However
recent work with frequency-pulsed electron capture
techniques (Brooks et al., 1984b) indicate that GLC may
indeed provide a useful means for direct and rapid
identification of C difficile in faeces.
1.1.5. Identification of C. difficile
Conclusive identification of C. difficile isolates is
usually done by GLC of the short chain carboxylic
acids^. ' Although some strains produce atypical profiles,
these cannot be confused with any other Clostridium
species (Poxton, 1982). There are numerous reports of the
successful use of this technique to identify the organism
after culture on or in various media (Moore et al♦, 1966;
Nunez-Montiel et al., 1983; Phillips and Rogers, 1981;
Brooks et al., 1984b; Gianfrilli et al. , 1985; Harpold et
al., 1985; Navarro-Alonso et al., 1985; Brooks, 1986;
Kudhair et al., 1986).
Use of commercial identification kits based on
biochemical reactions have produced mixed results..
Original studies with the API ZYM system (API Laboratory
Products, Basingstoke, England - Al-Jumaili and Bint,
1981; Marier et al. , 1984; Levett, 1985a) indicated that
such a method might prove useful in identification but
noted that careful standardisation of techniques was
required. Appelbaum et al. (1983) reported a high
percentage of misidentifications with the API 20A,
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Minitek (BBL Microbiology Systems, cockeysville,
Maryland, USA) and Anaerobe-Tek (Flow Laboratories,
McLean, Virginia, USA) systems. Both Levett (1985a) and
Bate (1986) reported the RaplD ANA (Innovative Diagnostic
Systems, Decatur, Georgia, USA) system to be very good
while API-AnlDENT and Minitek were less favourable.
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1.2. The association of C. difficile with bowel
disorders
Following the initial discovery of C. difficile there
were a few reports of its recovery from various clinical
specimens including abscesses, peritoneal and pleural
fluids and blood cultures (Levett, 1986; George et al. ,
1977). However the organism only became of real medical
interest once implicated in the aetiology of
antibiotic-associated PMC (AA-PMC).
1.2.1. Pseudomembranous colitis
PMC has been recognized for over 100 years as a cause of
occasional morbidity and mortality in patients already
ill from other diseases, often following surgery
(Keighley et al. , 1978a; Bolton, 1982). During the early
1950 's the condition became widely recognized as a
serious complication of broad spectrum antibiotic use
(peiner et al., 1952; Cummins, 1961; Pearce and Dineen,
1960). Initially chloramphenicol and tetracycline were
the antibiotics most frequently implicated and
Staphylococcus aureus was thought to be the pathogen
involved (Hale and Cosgriff, 1957). However overgrowth of
S. aureus in stools from patients receiving antibiotics
is not uncommon and most of these individuals have no
gastrointestinal (GI) symptoms. Furthermore, investigators
failed to produce PMC lesions in experimental animals
inoculated with S. aureus (Dearing etal., 1960). During
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of cases.
iation between cytotoxigenic
established (Larson et al. ,
is isolated from nearly 100%
1.2.1a Clinical features
The clinical features of PMC are variable. It can occur
at any age, although it is more common in adults and
affects women more frequently than men (Bolton and
Thomas, 1986). Diarrhoea is usual but not invariable, the
stool watery but rarely bloody. Onset is frequently
abrupt with vomiting in the early stages. Many patients
complain of cramping hypogastric pain and the physical
signs can simulate acute peritonitis. Other features
include pyrexia, neutrophilia, hypoalbuminaemia. The
natural history of the disease ranges from mild self
limiting illness to a rapidly fulminating fatal condition
often involving secondary complications (Mogg et al. ,
1979) .
Diagnosis rests on the demonstration of colonic
pseudomembranes either by sigmoidoscopy or tissue biopsy.
These appear as discrete yellow plaques up to 2mm in
diameter, scattered over the mucosa. In severe cases the
plaques coalesce. Histologically they consist of mucous
debris, inflammatory cells and exudate overlying groups
of partially disrupted glands.
Disease symptoms often start four to 10 days after
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beginning antimicrobial treatment although onset is
delayed for up to 10 weeks after completion of treatment
in 25 to 40% of patients (Tedesco, 1982) and can occur
after single dose antibiotic administration. Most
patients with diarrhoea starting during antimicrobial
administration will promptly improve if the antibiotic is
discontinued (Tedesco, 1982). Prolonged diarrhoea with
persistent systemic complaints is more frequent when
symptoms begin after discontinuation of antibiotics or in
patients continuing to take the implicated antibiotic
despite diarrhoea (Bartlett, 1979).
1.2.1b Antibiotic involvement
Nearly all therapeutic agents with antibacterial activity
have been implicated in the aetiology of PMC. The agents
most often associated are clindamycin and ampicillin
(Bartlett, 1981a; Toffler et al., 1978; Silva et al. ,
1984; Ambrose et al., 1985). Tedesco et al. (1974) found
10% of clindamycin recipients had PMC but other reports
gave much lower figures of between 0.01% (Ramirez-Ronda,
1974) and 2% (Gurwith et al., 1977). Changing prescribing
patterns most probably account for the decreasing number
of cases attributed to clindamycin nowadays (Tedesco,
1984). The cephalosporins, now used with increasing
frequency, have shown a corresponding rise and now
account for some 30% of PMC cases (Hutcheon et al. , 1978;
Bartlett, 1981b; Tan etal., 1979; Tedesco, 1984).
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Amoxycillin and ampicillin together account for about a
further 30% of cases. In a study of 329 patients Bartlett
(1981b) found clindamycin, ampicillin and cephalosporins
to be associated with about 80% of diarrhoeas (not
necessarily PMC cases) in which a single antibacterial
agent had been administered prior to onset of symptoms.
Ambrose et al. ( 1985) recovered C. difficile from the
faeces of 31% of volunteers who had been given a single
intravenous dose of a cephalosporin. Seven such
antibiotics were tested and the organism was recovered
from individuals receiving each of these. None of these
individuals developed PMC but 53% of them did have
diarrhoea. These effects were not repeated when the study
was performed with various penicillins.
Vancomycin has not been associated with PMC and is in
fact the first choice agent for treating the condition
(Bolton, 1982). Metronidazole, which can also be used
therapeutically, has been implicated in causing PMC
(Thomson et al. , 1981) "but this should not preclude its
use in therapy especially in cases of PMC relapse after
initial vancomycin treatment (Bolton, 1982). PMC is
extremely rare after erythromycin and parenterallly
administered aminoglycosides. Chloramphenicol and
tetracycline, originally the most frequently implicated
agents, are now rarely involved. This could be due to
declining use of chloramphenical but other factors must
also be involved since tetracyclines are still used with
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great frequency (Finkel, 1978; Bartlett, 1981b; Collee
and Amyes, 1986) .
1.2.1c C. difficile and AA-PMC
In 1977, what was believed to be a specific heat-labile
toxin with characteristic tissue culture cytotoxicity,
was detected in the faeces of a 12-year-old girl with
AA-PMC (Larson et al., 1977). Based on experiments with
hamsters it was suggested that this toxin was clostridial
in origin (Bartlett et al. , 1977). It was found that it
could be neutralized by C. sordelli antitoxin (Rifkin _et
al., 1978) although C. sordelli was never isolated from
PMC cases. C. difficile was eventually cultured from
hamsters with experimentally-induced antibiotic colitis
(typhlitis) and this was soon followed by reports of the
organism being isolated from human patients with PMC
(Bartlett et al., 1978a; George et al., 1978a; Larson et
al. , 1978; George et al., 1979b). In 1978 the cumulative
published experience of three laboratories showed C.
difficile had been recovered from 32 of 35 patients with
AA-PMC (91%) and that nearly all these strains were
cytotoxigenic (Bartlett, 1979). Nowadays C. difficile is
isolated from AA-PMC patients worldwide and the organism
is recognized as the primary pathogen in this condition.
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1.2.2. Antibiotic-associated colitis (AAC) and diarrhoea
(AAD)
Diarrhoea frequently develops following antibiotic
r
treatment (Lishman et al., 1981a), occur/ing with a wide
range of severity (Viteri et al., 1974). However the role
of C. difficile in AAC and AAD remains uncertain despite
many investigations (George et al. , 1979c; Tvede and
Willumsen, 1982; Drapkin et al., 1985; Gerding et al.,
1986). As with PMC the organism has been isolated from
individuals with colitis following only one dose of an
antibiotic (McNeely et al., 1985).
Initial studies suggested that about 6 to 15% of faeces
from patients with AAD gave TCA results indicative of the
presence of C. difficile. (Bartlett et al., 1978c;
Keighley et al. , 1978a). C. difficile was cultured from
these specimens (Bartlett et al., 1978c) and also from 16
to 20% of specimens having no detectable cytotoxic
effect. Later studies employing CCFA medium (George e_t .
al., 1979d) have shown that the organism can be isolated
from about 40 to 50% of cases of AAD (Falsen et al. ,
1980; Brettle et al., 1982) with or without the presence
of faecal cytotoxicity (Lashner et al. , 1985). Falsen e_t
al. (1980) found that C. difficile was the second
commonest enteropathogenic isolate (after Salmonella) in
a survey of unselected faecal specimens in a diagnostic
laboratory. The organism was cultured from 33% of 168
patients from whom an enteropathogen was actually
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identified.
Milder cases of AAD tend to have a lower incidence of
demonstrable cytotoxicity but both C. difficile and
positive TCA results are found to a greater extent in a
larger proportion of cases involving more severe forms of
AAC (Bolton, 1982). In such cases elimination of the
measurable cytotoxicity by vancomycin (Keighley et al. ,
1978b) or metronidazole (Pashby et al. , 1979) results in
rapid clinical and sigmoidoscopic improvement. It has
been suggested that the lower cytotoxicity levels
detected in less severe disease may be due to the
presence of fewer organisms in the gut or the presence of
organisms that are inefficient toxin producers (Bolton,
1982). It may also be that the raised serum antibody
levels to C. difficile toxin(s) that have been detected
in some patients with AAD and PMC, may play a role in
modifying the clinical syndrome seen in some individuals
(Aronsson et al. , 1983). This is discussed further in
section 5.1.5.
Oncology patients have a high incidence of GI upsets
(Malamou-Ladas et al. , 1983) which are often associated
with cytotoxigenic C. difficile (Morris et al., 1984).
Kim et al. (1981) found up to 40% of such patients
harboured C. difficile and suggested these individuals
might form a highly susceptible group due to extensive
antibiotic treatment regimes. C. difficile has also been
recovered from children receiving antibiotics for gut
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decontamination prior to bone marrow transplants and in
those receiving chemotherapy for acute leukaemia (Rogers
et al, 1981; Panichi et al. , 1985; Rampling et al. ,
1985). Renal patients are another immunocompromised group
from whom the organism has been isolated during GI upsets
(Ritchie et al. , 1982; Gokal et al. , 1982; Leung et al. ,
1985). The great majority of these isolates have been
cultured from patients receiving antibacterial agents for
a range of infections.
Patients with cystic fibrosis are an interesting group
since C. difficile is often isolated from them despite a
lack of GI symptoms (Wu et al. , 1983; Welkon et al. ,
1985; Peach et al., 1986). The organism, which may or may
not be cytotoxigenic, appears to be isolated only from
individuals receiving antibiotics at the time of
isolation.
1.2.3.
. C. difficile and chronic inflammatory bowel
disease (CIBD) .
The organism has also been implicated in exacerbation of
CIBD. Most studies show C. difficile and faecal
cytotoxicity to be present in some patients with CIBD
(Bolton et al., 1980; Keighley, 1983; Lamont and Trnka,
1980). Trnka and Lamont (1981) detected C. difficile in
19% of CIBD patients and found that cytotoxicity titres
correlated with disease severity, a finding similar to
results of studies into AAD. Other investigators
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(Greenfield et al., 1983; Meyers et al., 1981) have found
no correlation between TCA titres and disease activity.
It has been suggested that the production of £-cresol
from trypsin may be more important than any direct
necrotic effect of C. difficile or its toxins on the gut
mucosa (Editorial, Lancet, 1980). Currently no firm
conclusions have been made about the role of C. difficile
and/or its toxins in CIBD (Keighley, 1983).
1.2.4. Non-antibiotic-associated C. difficile disease.
The association of C. difficile with bowel disorders can
no longer be linked exclusively to antibiotic use. There
have been a few reports of previously healthy individuals
developing PMC without previous antimicrobial treatment
(Howard et al., 1980; Peikin et al. , 1980; Wald et al. ,
1980). C. difficile has been isolated from these cases
and cytotoxicity was detected by Wald et al. ( 1980).
These findings tend to suggest that, at least in some
patients with non-AA-PMC, the underlying pathogenesis of
the disease may be identical to that occurjing with
antibiotic use.
Ellis et al. ( 1983) reported three of 15 cases admitted
to hospital with C. difficile colitis had no recent
antimicrobial therapy. Other such cases of diarrhoea
unrelated to antibiotic administration have also been
noted (Borriello and Larson, 1981; Brettle et al., 1982;
Varki and Aquino, 1982). The organism has also been
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implicated in irritable bowel syndrome (Tvede and
Willumsen, 1982). Ellis et al. (1983) suggested that C.
difficile should be screened for in all patients with
diarrhoea regardless of whether or not they have received
antibacterial agents in order to prevent misdiagnosis
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2.2. Isolation of C. difficile
C. difficile was isolated from faeces by culture on agar
containing cycloserine, cefoxitin, fructose and egg-yolk
(CCFA - George et al., 1979d - see Appendix 1 for
composition). Colonies were sub-^ onto blood agar (BA)
containing Columbia Agar Base (Oxoid, Basingstoke,
Hampshire) with 5% (v/v) horse or human blood. Pure
isolates were stored either as Robertson's CMB cultures
(Cruickshank et al., 1975) at room temperature (RT) or
were lyophilised.
2.3. Culture of C. difficile
Lyophilised stock strains were reconstituted into 10ml of
pre-reduced (p-r) CMB and incubated for 24h at 37°C by
the standard anaerobic procedure of Collee et al. (1972)
or in an anaerobic cabinet (Forma Scientific, Marietta,
Ohio, USA). Isolates stored in CMB were sub-cultured to
fresh p-r CMB before further use. Organisms were grown up
in bulk by transferring 0.1ml of CMB culture to 100ml of
p-r proteose peptone yeast extract medium (PPY - see
Appendix 1 - Deacon et al. , 1978), supplemented with
0.075% (w/v) L-cysteine hydrochloride and 0.04% (w/v)
sodium carbonate. Actual volumes used for any particular
technique were scaled up or down as required. Cultures
were incubated anaerobically for 16 to 18h at 37°C.
22
2.4. Assessment of biochemical reactions
All fermentation patterns and biochemical characteriz¬
ation of strains was carried out as described by Brown _et
al. (in press). Tests were performed with 1ml of an
overnight culture of organisms in PPY medium.
2.5. Gas-liquid chromatography (GLC)
One colony from a BA plate was cultured in PPY containing
1% glucose (Deacon et al., 1978) for 18h. To 1ml of this
culture was added 0.2ml of 50% (v/v) H2SO4. This was
centrifuged at 4,000cj (20 min, RT) and the cell free
supernate collected. Analysis was done on a Pye Unicam
104 gas chromatograph (Philips Analytical, Pye Unicam,
Cambridge) fitted with dual flame ionization detector. A
glass column (180cm x 4mm) packed with 15% SP1220, 1%
H3PO4 on chromosorb WAW 100-120 mesh was used. Operating
conditions were 147°C isothermal, with the detector at
200°C. Gas flow rates were 35ml/min for the carrier gas
(oxygen-free nitrogen) and hydrogen; 525ml/min for air.
For volatile fatty acids (VFA) the acidified supernate
was analysed directly; for non-volatile fatty acids
(NVFA), 1ml of the acidified supernate was mixed with
0.4ml concentrated H2SO4 plus 2ml methanol and mixed by
gentle inversion (20 times) as described by Holdeman et
al. , 1977). After overnight incubation at RT and after
gentle mixing, 0.5ml of chloroform was added. This was
vortex mixed. Following separation of the layers the
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chloroform layer was sampled from beneath the aqueous
layer. The sample volume for both VFA and NVFA was ljil.
Identification of the metabolic end products was done by
comparing peak retention times in the samples with those
of standard solutions (see Appendix 1).
2.6. Cytotoxicity assay
The level of faecal cytotoxicity was assayed by observing
a cytopathic effect on monolayers of either human
embryonic fibroblast cells or epithelial cells in
Microtitre plates (Sterilin Ltd, Teddington, Middlesex)
as described by Poxton (1982). Each well was seeded with
about 1 x lO^ cells in 100>il of Eagles's (modified)
Minimum Essential Medium (Flow Laboratories, Irvine,
Ayrshire) containing 10% Tryptose phosphate broth, 7%
calf serum, 2mM L-glutamine, penicillin (200 units/ml),
streptomycin (200jig/ml) and sodium bicarbonate. The
cytotoxicity of faecal supernates was assessed after
emulsifying the specimen in an equal volume of phosphate
buffered saline (PBS: 50mM phosphate buffer, pH 7.4,
containing 0.15M NaCl) and centrifuging this at 10,000g
(2 min, RT). The cytotoxicity of fresh isolates of C.
difficile was estimated by assaying the supernate from
five-day cultures in 3.5% (w/v) Brain Heart Infusion
(BHI) medium (Oxoid). Positive titres were recorded as
the highest dilution that produced 50% rounding of the
cells after 24h. Incubation was at 37°C in a 5% CO2
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incubator. Neutralization was performed with IOjjI of c.
sordelli antitoxin (obtained from Wellcome, Temple Hill,
Dartford). This was diluted 1 in 25 and added to two
wells containing the first two dilutions being tested. A
positive control sample was included in all tests.
2.7. Hydrophobicity assay
The procedure used was an adaptation from that described
by Jessop (1986). Cultures of C. difficile grown up in
PPY overnight were washed twice in PUM buffer, pH 7.1
(22.2g K2HPO4.3H2O, 7.26g KH2PO4, 1. 8g urea, 0.2g
MgSC>4.7H20 in 1000ml distilled water). Cells were
resuspended in PUM buffer to give an optical density (OD)
at 470nm of about 0.3 with buffer as standard. Each
suspension (3.6ml) was placed in a Wassermann Tube to
which was added 300>il of octane (Sigma, Poole, Dorset).
Tubes were placed in a 25°C water bath for 10 min before
vortex mixing for 60 sec. Tubes were left to settle for
about 30 min after which the lower aqueous phase was
removed with a syringe and needle and the OD470 recorded
again.
2.8. Preparation of antiserum
Antisera were raised against ultra-violet (u-v) - killed
bacteria as described by Poxton (1979). For NCTC 11223,
RIE 11831 and MPRL 161 this was in New Zealand White
rabbits; for MPRL 604, MPRL 683, MPRL 1123 and MPRL 1128
25
I
Dutch rabbits were used. Bacteria were grown in 100ml
volumes of PPY and washed twice in filter-sterilized PBS.
The organisms were resuspended in PBS to give about 1 x
10^ organisms per millilitre. These suspensions were
irradiated as a thin film in a glass petri dish with a
Bactericidal u-v unit (Hanovia Lamps, Slough, England)
positioned 20cm from the cells. The irradiated cells were
stored frozen (-70°C) in aliquots of 1.2ml.
When required the suspensions were thawed and 1ml given
intravenously to the rabbits according to the following
schedule: weeks one and two, three successive daily
injections; week three, no injection; week four only one
injection; week five, test bleed (5ml). All sera were
tested against EDTA-extracts of the homologous strain in
an ELISA to check the titres obtained. The rabbits were
bled out by cardiac puncture and their sera collected.
2.9. Absorption of antiserum
This was done as described by Poxton et al. ( 1982).
Bacteria, harvested from 50ml of an 18h culture - and
washed twice in PBS, were mixed concurrently with 1ml of
each absorbing antiserum. The suspension was shaken
during the absorption period of 30 min at 37°C on a
blood-cell suspension mixer. Cells were removed by
centrifugation at 5,000^ for 30 min at RT. This procedure
was repeated once.
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2.10. Formalin treatment of cells
A 20% inoculum of a 17h PPY culture was sub-cultured into
10ml p-r PPY and incubated for 4.5h. Formaldehyde
solution was added to the culture to give a final
concentration of 0.2% and was incubated aerobically at
37°C for 2h. The cultures were stored at 4°C until
required.
2.11. Slide agglutination - Widal test
A loopful of undiluted antiserum was placed on a clean
glass slide. A loopful of the formalinized cells being
tested was added to the antiserum and the two solutions
mixed by gently rocking the slide backwards and forwards.
A negative control was provided by mixing saline with the
formalinized cells.
2.12. Enzyme-linked immunosorbent assay (ELISA)
This was adapted from Poxton (1979). Fifty microlitres of
antigen diluted in 50mM carbonate buffer (pH 9.6,
containing 0.02% sodium azide) to give a final protein
concentration of 60;ag/ml, were added to each well of a
Microtitre plate (Sterilin Ltd). These were incubated at
37°C for 4h, then held at 4°C overnight. Plates were
washed three times with 0.15M NaCl containing 0.05% Tween
20. Antiserum, as doubling dilutions (beginning at 1 in
400) in PBS containing 0.05% Tween and 0.02% sodium azide
(antibody buffer), was added to each well (50jli1) and
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incubated at RT for 4h. The plates were washed as before
and anti-rabbit IgG-conjugated alkaline phosphatase (ICN
Biomedicals, High Wycombe, Buckinghamshire), diluted 1 in
600 in antibody buffer, was added to each well (50>il) and
incubated overnight at RT. After washing the plates
again, 50>al volumes of the enzyme substrate (a lmg/ml
solution of p-nitrophenylphosphate (Sigma) in 50mM
carbonate buffer, pH 9.8, containing ImM MgCl2) were
added to each well. After lh incubation at RT the colour
change was read on a Titertek Multiscan Spectrophotometer
(Organon Teknika, St. Neots, Cambridgeshire) at a
wavelength of 405nm.
2.13. Protein assay
Protein concentations were determined by the method of
Lowry et al. (1951) with bovine serum albumin as
standard.
2.14. Carbohydrate assay
Carbohydrates, as glucose equivalents, were assayed by
the phenol sulphuric acid method of Dubois et al. (1956).
2.15. Phosphate assay
Organic and inorganic phosphate was estimated by the
method of Chen et al. (1956).
28
2.16. Sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE)
A modified version of the method of Laemmli (1970) was
used, as described by Poxton and Brown (1979). Details
of the buffers are included in Appendix 2. Vertical slab
gels (170mm x 140mm x 1mm) consisting of a 10mm 4%
stacking gel above a 10% acrylamide separating gel were
used to run up to 20 samples in a Raven Slab Gel
Apparatus (Haverhill, Suffolk, England). Samples, after
boiling for 3 min, were added to wells in the stacking
gel and electrophoresed at 70V until they had moved
through this layer (1 to 2h); voltage was subsequently
increased to 150V until the sample buffer front
(indicated by bromophenol blue) had travelled 7.5cm from
the top of the separating gel (2 to 3h).
2.17. Staining of polyacrylamide gels
Gels containing protein extracts were stained with
Coomassie blue (Poxton and Sutherland, 1976); those with
carbohydrate were silver stained by a method adapted from
that of Tsai and Frasch ( 1982). Gels were fixed in 40%
ethanol (v/v) and 5% acetic acid (v/v) overnight.
Oxidation was with freshly prepared 0.7% (w/v) periodic
acid in 40% ethanol and 5% acetic acid for 45 to 60 min.
This was followed by washing for 3 x 30 min in distilled
water. Fresh ammoniacal silver nitrate solution was added
(1.4ml ammmonia solution plus 21ml 0.36% NaOH with 20g
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AgNC>3 in 100ml distilled water) for 15 min after which
gels were washed in distilled water (2 x 10 min). Gels
were transferred to fresh 0.005% (w/v) citric acid in
0.19% (v/v) formaldehyde and left to develop. When the
required staining intensity was reached the gels were
washed repeatedly in large volumes of distilled water.
2.18. Immunoblot transfer
The method of Towbin et al. (1979) as described by Poxton
et al. (1984) was followed. Extracts, separated by
SDS-PAGE, were transferred to nitrocellulose membrane by
use of a Biorad ImmunBlot Assay kit (Biorad, Watford,
Hertfordshire). Electrophoresis was at 12V (40mA, 4°C)
for 18h. The membrane was washed in Tris-buffered saline
(TBS: 20mM Tris, 500mM NaCl, pH 7.5) and the unbound
sites were blocked with a solution of 3% gelatin in TBS
for 45 min. The membrane was transferred to C. difficile
antiserum (1st antibody) diluted in 1% gelatin in TBS
(antibody buffer) and incubated at RT for 3h. Following
two 10 min washes in 0.025% Tween 20 in TBS, the membrane
was placed into goat-anti-rabbit IgG Horseradish
peroxidase (HRP) conjugate (2nd antibody - Biorad or ICN
Biomedicals) diluted 1 in 3000 in antibody buffer. After
lh the membrane was washed as before and placed into a
solution consisting of 60mg HRP colour development
reagent (BioRad), 20ml ice cold methanol, 60>al H2O2 and
100ml of TBS. Colour development took 5 to 20 min.
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Several changes of distilled water were used to stop the
reaction. All steps were performed with gentle shaking.
2.19. Extraction of whole bacterial cells with
ethylenediaminetetraacetic acid (EDTA) (Standard
method)
This method was as described by Poxton et al. (1984).
After culture in 50ml p-r PPY, cells were harvested by
centrifugation (20,000cj, 5 min, 4°C) and washed twice in
50ml of PBS. The pellet was resuspended in 1ml of lOmM
EDTA (BDH Chemicals, Thornliebank, Glasgow) in PBS,
vortex mixed for 2 sec and placed in a 45°C water bath
for 30 min. The bacterial suspensions were re-vortexed
and the supernate collected after two cycles of
centr ifugation at 10,000£ (2.5 min, RT) . This was used
undialysed as antigen.
2.20. Isolation of flagella
This method was adapted from Parton (1975). One litre of
p-r PPY culture was harvested (13,000£, 10 min, 4°C) and
washed once in an equal volume of PBS. The cells were
resuspended in 20ml PBS and homogenized at full speed in
a Waring blender for 2 min. The resulting suspension was
centrifuged (12,000g, 10 min, 4°C), the supernate
collected and re-centrifuged. This process was repeated
until the supernate appeared free from any whole
bacterial cells when viewed microscopically. The cleared
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supernate was centrifuged at 100,000£ (90 min, 4°C) .
Pellets obtained were resuspended in 4ml of a 0.425g/ml
caesium chloride suspension in PBS. The refractive index
(RI) of this was checked and adjusted with more PBS or
more CsCl2 to give a value of 1.3630. This is equivalent
to a density of 1.3g/cm3 (Chandler and Gulasekharam,
1974). These solutions were centifuged at 145,000£ (21h,
20°C). The tubes were subsequently viewed with an
inverted microscope to locate the position of any bands
present. Such bands were carefully harvested from the
tubes with a P1000 Gilson pipette (Anachem Ltd, Luton,
Bedfordshire) after removal of overlying CsCl2 solution.
Each fraction collected was diluted in 10ml of distilled
water and centrifuged at 100,000£ (lh, 4°C) . The
supernate was discarded and the resulting pellet
resuspended in 0.5ml of distilled water with a syringe
fitted with a 19G needle.
2.21. Electron microscopy (EM) and gold-palladium
shadowing
Formvar-coated copper grids were floated onto 2^1 of
sample. After 2 min excess moisture was removed with
filter paper. The grids were placed in a desiccator to
dry for at least 30 min before shadowing in an Edwards
vacuum coater model 306 (Edwards, Manor Royal, Crawley,
Sussex). Grids were viewed with an HU 12A Hitachi
electron microscope.
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2.22 isolation of cell surface carbohydrate antigens of
C. difficile
This was essentially as described by Poxton and cartmill
(1982). Bacteria from 61 of PPY culture were harvested
and washed twice in PBS, pH 7.4 (10,000£, lOmin, 4°C) .
The cells were resuspended to about 30% (w/v) in PBS and
were disrupted in a pre-cooled French Pressure Cell
(Aminco, Silver Springs, Maryland, USA) at a pressure of
38 to 48 MPa. DNase 1 and RNase A (Sigma) were added to
the disrupted cells for 30 min before centrifuging
(45, 000cj, 20min, 4°C) to separate membranes from walls.
The supernate (containing the membranes) was frozen and
lyophilised. The pellet was gently resuspended in about
15ml of distilled water and heated to 80°C for 5 min. An
equal volume of boiling 5% (w/v) SDS was added and left
stirring overnight at RT. The walls were washed and
centrifuged at 35,000£ (10 min, 20°C) with five changes
of distilled water. Material was lyophilised and stored
at rt'.
2.23. Sodium hydroxide extraction of cell walls
The method was adapted from that of Archibald et al.
(1969). The SDS-treated lyophilized cell walls were
extracted with 0. 5M NaOH at an approximate concentration
of 0.3% (w/v) by stirring for 4h at RT. The suspension
was centrifuged twice at 35,000^ (30 min, 4°C) to
sediment the walls. The supernate was retained and
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neutralised with 1M HCl and dialysed against running
water overnight, and for a further 2h against distilled
water. The extract was lyophilised and stored at RT.
2.24. Phenol extraction of membranes
The lyophilised supernate was finely divided and defatted
with two successive extractions (for 8h and 12h) in 200ml
of chloroform/methanol (2:1 v/v). Following filtration
through Whatman No.l filter paper the residue was dried
in a 37°C incubator overnight, ground to a fine powder,
weighed and extracted with phenol. This was adapted from
the method of Coley et al. ( 1975). The membranes were
mixed with distilled water to give a 10% (w/v)
suspension. An equal volume of 80% (w/v) aqueous phenol
was added and the mixture stirred for 30 min at RT. This
was centrifuged at 2,500^ (20 min, 4°C) in a swing out
rotor. The top layer was removed and centrifuged at
10,000g (10 min, 4°C) in a fixed angle rotor. The
supernate was dialysed against running water overnight,
after which an equal volume of 0. 2M acetic acid/acetate
buffer, pH 5.0, containing 0.02M magnesium chloride, was
added. DNase 1 and RNase A (Sigma) were mixed with the
extract, a drop of toluene placed on the surface of the
fluid and the flask covered with a foil lid and incubated
overnight at 37°C. The extracts were subsequently
re-extracted with phenol as above. After overnight
dialysis they were lyophilised and stored in a sealed
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container at RT. This crude carbohydrate extract was
further purified by gel filtration through a Sepharose 6B
column (30cm x 9mm - Pharmacia, Uppsala, Sweden) with
0.2M ammonium acetate buffer, pH 6.9, containing 0.01%
sodium azide. Forty fractions of about 1ml were
collected. Desalting of required fractions was done on a
10ml Sephadex G25 column with distilled water.
2.25. Rocket immunoelectrophoresis (RIE), Fused-rocket
immunoelectrophoresis (FRIE) and Crossed-immuno-
electrophoresis (CIE)
RIE (Weeke,1973a), FRIE (Svendson, 1973) and CIE (Weeke,
1973b) were done with Shandon Southern apparatus
(Camberley, Surrey). The agarose gel and buffers used are
described in Appendix 2. Buffer was used undiluted in the
electrode reservoirs and electrophoresis was at 60V
overnight.
rie: Antiserum (250jj1), along with an equivalent volume
of cie buffer diluted 1 in 2 with distilled water and
containing 2% Triton-XlOO (v/v) was mixed with 3ml of
agarose solution (at 52°c) and cast onto 50mm x 50mm
GelBond (icn Biomedicals - see Fig. 2.1a). Wells punched
in the gel were loaded with lOjil of sample.
FRIE: 4ml agarose solution (plus 333>il CIE buffer diluted
1 in 4 with 1% (v/v) Triton X-100) was cast lengthwise
onto half of a piece of GelBond measuring 100mm x 50mm.








Fig. 2.1. Diagram of gels used for (a) rocket and (b)
fused-rocket Immunoelectrophoresis. Electro¬
phoresis was in the direction indicated.
gel was held at 4°C for 30 min in a moist box after which
4ml agarose, containing 333/al rabbit antiserum, was cast
onto the other half of the GelBond (Fig. 2.1b).
CIE: 1st dimension: Agarose (15ml) was cast onto a glass
plate (80mm x 80mm). Wells punched in the gel were loaded
with 12jul of sample (see Fig. 2.2a). These were
electrophoresed at 60V for 1.25h at 4°C.
2nd dimension: Strips were cut from the first dimension
gel in the direction of electrophoresis as shown in Fig.
2.2a. These were placed along one side of a piece of
GelBond (50mm x 50mm). Agarose (3ml) containing 250/11 of
antiserum and 250ul of 1:2 CIE buffer, with 2% Triton
X-100 (v/v), was cast onto the remainder of the GelBond.
The gel was electrophoresed (60V overnight) in a
direction 90° to that of the first dimension (Fig. 2.2b).
2.26. Staining of agarose gels
Following electrophoresis, gels were covered with Whatman
No. 1 filter paper cut to the same size, and were pressed
under 2 to 3cm of weighted blotting paper for 15 min. The
paper was removed and the gels washed twice for 15 min in
0.1M NaCl, then once in distilled water. Gels were
pressed once again and after removal of the filter paper
were dried with a hairdryer. Staining was for at least 30
min in a solution containing 5% (w/v) Coomassie Brilliant
Blue R-250; 45% (v/v) ethanol; 10% (v/v) glacial acetic










0 1st dimensi on
+
Fig. 2.2. Template used to prepare (a) first dimension
gels and (b) second dimension gels for crossed
Immunoelectrophoresis.
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solution consisted of 45% (v/v) ethanol, 45% (v/v)
distilled water and 10% (v/v) glacial acetic acid.
2.27. Isolation of crude cell walls for protein
extraction
Cells were cultured in 101 PPY (containing only Na2CC>3,
no cysteine hydrochloride), harvested and washed once
(10,000^, 10 min, 4°C) . The wash buffer consisted of
0.05M Tris/HCl, 0.025M MgCl2 and 0.85% NaCl, pH 7.4. All
steps were done on ice. Cells were resuspended in 40ml of
buffer, DNase and RNase (Sigma - both proteinase free)
were added and the cells disrupted by French pressing
once, as previously described for carbohydrate
extraction. After centrifugation at 20,000£ (30 min, 4°C)
the resulting pellet was washed four times in ice-cold
distilled water (centrifuging 30,000g, 15 min). The
pellet was resuspended in 10ml of distilled water and
stored as 1ml fractions at -20°C.
2.28. Urea extraction of cell wall proteins
The crude cell wall material (1ml) was separated into
pellet and supernate by centrifugation (50,000g, lOmin,
4°C). The pellet was resuspended in 1ml of 2% Triton-XlOO
in distilled water (v/v) and left at RT for 30 min.
Following two washes in distilled water it was
resuspended in 1ml of 6M urea and again kept at RT for 30
min. Following separation into pellet and supernate
(50,000g,
stored at
10 min, 4°C) the supernate was retained and
-20 C.
2.29. lodine-125 radiolabelling of cell surfaces
This was essentially as Lambert and Booth (1982). A 20%
inoculum of a 16h PPY culture of C. difficile NCTC 11223
was put into 100ml p-r PPY and incubated for 3h. A total
count was done with a counting chamber (Thoma, Hawksley,
England) and the cells harvested and washed in PBS.
Following resuspension of the cells in 1ml PBS to give
about 5 x lO^ cells/ml, 0.5ml lactoperoxidase (O.lmg/ml
in PBS) was added along with lOjul of Na^^i with an
activity of 100>iCi. Four lOOjul portions of H2O2 (lOmM in
H2O) were added at 2.5 min intervals. The iodination was
stopped by addition of 8ml cysteine (lOmM in H2O) 10 min
after the first addition of H2O2. The labelled cells were
harvested (5,000g, 5 min), washed four times in PBS and
resuspended in 0.5ml of distilled water. Extracts were
stored at 4°C overnight.
2.30. Autoradiography
lodine-125 radiolabelled sample was mixed with an equal
volume of double strength sample buffer and boiled for 10
min. Samples (75^1) were applied to an SDS-PAGE gel. The
separated material was transferred to nitrocellulose by
immunoblotting. After washing in TBS, this was dried in a
37°C incubator and wrapped in Clingfilm. This was placed
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in a Kodak X-Omatic Cl cassette (Eastman Kodak Company,
Rochester, New York, USA) between two pieces of film and
kept at -70°C. One was developed after 72h, the other
after two weeks.
2.31. Incorporation of sulphur-35-labelled methionine
into cell proteins
This was essentially as Tabaqchali et al. (1984a). About
eight C. difficile colonies were sub-cultured from a 48h
BA plate to 50jJl of p-r PPY. 35g-methionine (l^il), with
about lO^Ci radioactivity, was added and the suspensions
incubated at 37°C for either 2h or 5h in an anaerobic jar
containing GasPak (BBL Microbiology Systems,
Cockeysvilie, Maryland, USA). When removed from the jar
an equal volume of double strength sample buffer was
added to each bacterial suspension. This was heated for 2
min at 100°C, cooled to RT, and the bacterial proteins
subsequently separated by SDS-PAGE (4(^ul sample volume).
The gel was sealed in a plastic bag (Pifco Vacuum
Sealer), frozen to -20°C and placed in a Kodak X-Omatic
Cl cassette for one week at -70°C.
2.32. Isoelectric focussing
s
This was as outlined in 'isoelectric Focussing principles
and Methods' (Pharmacia). Urea extracted protein samples
(lO^ul) were applied directly to the agarose gel and were
electrophoresed at 5W, 150mA and 1500V for 2h. The
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volthour integrator was set at 2000. Gels were dried and




This was done as described in 'Chromatofocus)ing - with
Polybuffer and PBE' (Pharmacia). A 30mm x 9mm column was
packed with Polybuffer exchanger PBE 94 after it had been
washed in 0.025M imidazole-HCl solution (Sigma, pH
adjusted to 7.4 with 1M HCl after degassing). Polybuffer
74 was made up as indicated in the instructions i.e. the
pH was adjusted to 4.0 with 0. 5M HCl and the solution
made up to 200ml with distilled water. This was not
degassed. After 5ml of this buffer had flowed into the
column the sample (in imidazole buffer) was applied.
Fractions of about 1ml were collected. Before collection,
these passed through a flow cell fitted in an SP6-550
UV/V1S spectrophotometer (Pye Unicam) set at a wavelength
of 280nm. Absorbance was recorded by a Servoscribe IS
pen-recorder (Belmont Instruments," Glasgow), set at an
amplitude of lOmV and a chart speed of 30mm/h.
2.34. Embedding and sectioning of mouse ileum
The tissue was placed into 10% formalinized-saline
overnight. Dehydration was done by passing the tissue
through a series of progressively more concentrated
ethanol baths, each for 2h. The first contained 70%
ethanol, the next 80%, then 90% and finally there were
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three successive changes of absolute ethanol. The tissue
was cleared in two changes of chloroform. Paraffin
embedding was performed with three changes of 58°C
melting point paraffin wax, with the third change being
done in a vacuum embedder. The tissue was finally blocked
out in the same wax. Sections (3 to 5jum thick) were cut
with a Leitz rotary mictotome (E. Leitz Instruments,
Luton) and were transferred to glass slides.
2.35. Staining of tissue sections
Sections were deparaffinized and taken to water before
staining. Two techniques were used for staining, (a) the
Periodic acid-Schiff (PAS) reaction and (b) Alcian Blue.
Both were done as described by Cook (1972).
CHAPTER 3
CULTURE OF CLOSTRIDIUM DIFFICILE AND ISOLATION OF THE
ORGANISM FROM HEALTHY INDIVIDUALS
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3.1. Introduction
Clostridium difficile was first isolated from the faeces
of four of 10 infants involved in an investigation of
bacterial colonization in neonates. The organism grew
following faecal inoculation into constricted tubes
containing dextrose broth (Hall and o'Toole, 1935).
During subsequent investigations, it was noted that the
organism had a slow growth rate and that it was difficult
to isolate in pure culture for further studies; hence its
original name Bacillus difficilis.
The next report of the organism being isolated was by
Snyder (1940). He used deep brain medium that had been
freshly boiled and then cooled to isolate the organism
from 10 of 22 babies on 28 different occasions.
3.1.1. Isolation of C. difficile from cases of AA-PMC
The first reported isolations of C. difficile from cases
of AA-PMC were made with a variety of media commonly used
for growth of anaerobes. During a study of patients
suffering from PMC and post-operative diarrhoea George et
al. (1978a) isolated Clostridia on lysed BA containing
either kanamycin sulphate (7O^g/ml) or nalidixic acid
(10^g/ml). C. difficile was isolated from each of eight
patients with colitis and six of 20 patients with
post-operative diarrhoea. Bartlett et al. (1978a)
isolated the organism from four patients (three with
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AA-PMC; one with AAD) . All strains grew well on
Brucella-based BA (BBA) containing menadione (10,ug/ml)
and clindamycin (lO^g/ml). Larson et al. (1978) used
'selective or enrichment media' to isolate C. difficile
but the selective agents were not specified.
3.1.2. Development of selective media for isolation of
C. difficile
A selective medium is one which contains one or more
substances that will inhibit growth of all but a few
types of bacteria. It will facilitate isolation of
particular species from a mixed inoculum. If a selective
medium is agar based, quantitative analysis can be done
on the level of a particular organism initially
inoculated onto it.
If a liquid medium favours the multiplication of a
particular species, either by containing enrichments that
selectively "favour it or inhibitory substances that
suppress competitors, cultures from mixed inocula are
termed enrichment cultures. Such cultures fail to
indicate the proportion of the species present in the
original inoculum.
Initial isolations of C. difficile from faeces were not
made with selective media specific for the organism.
Consequently, many other anaerobic bacteria grew during
culture making isolation of C. difficile difficult and
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time consuming. Hafiz and Oakley (1976) were the first to
try and develop a selective medium specifically for
growth of this organism. It was known that C. difficile
could deaminate phenylalanine, first to £-hydroxy-
phenylacetic acid (as do most Clostridia that attack this
substrate) and then decarboxylate this to £-cresol
(Elsden et al., 1976). Assuming an organism that produces
£-cresol must by necessity be resistant to it this
appeared a useful ingredient to include in a selective
medium. It was further noted that none of the other 22
clostridial species examined did this.
Hafiz and Oakley (1976) found that all the 30 C.
difficile isolates used in their studies grew in
Reinforced Clostridial Medium (RCM) containing 0.4%
£-cresol while other clostridial species failed to grow
in medium containing even 0.1% £-cresol. From their
studies they concluded that RCM plus 0.2% £-cresol would
provide a potentially useful selective medium.
However subsequent investigations indicated that such a
medium may not always be satisfactory for isolation of C.
difficile. George et al. (1979d) tried to isolate the
organism on an agar containing 0.2% £-cresol but without
success while Larson (1978) obtained no growth of C.
difficile in RCM containing 0.2% £-cresol despite growth
of the organism in plain RCM. Willey and Bartlett (1979)
plated £-cresol broth cultures onto medium containing
cycloserine ( 250/pg/ml) and cefoxitin (lO^g/ml) expecting
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this to be highly selective for the organism but it was
found that only three of 18 cultures yielded C. difficile
in pure culture.
3.1.3. Use of CCFA medium for isolation of C. difficile
The major breakthrough in isolation of C. difficile from
faeces came with the development of CCFA medium by George
et al. ( 1979d - see Appendix 1 for composition). This
medium exploited the resistance of C. difficile to
D-cycloserine and cefoxitin and its ability to ferment
fructose. The concentrations of the two selective agents
were chosen based on the level of resistance of 16
isolates whose minimum inhibitory concentration (MIC) for
cefoxitin was 32^ig/ml and for cycloserine was 1024pg/ml.
With this agar (containing SOO^g/ml cycloserine and
16,ug/ml cefoxitin) it was noted that the viable counts
obtained were not appreciably different from those on BA.
Colony description: After 48h anaerobic incubation at
37°C colonies tend to be about 7.5mm in diameter
(compared to 4.5mm on BA). They are yellow, with a ground
glass appearance, circular with a slightly filamentous
edge, flat to low umbonate in profile and are lipase and
lecithinase negative. They also produce golden yellow
fluorescence when viewed under long wave u-v light.
During growth the initial orange colour of the medium
often changes to yellow for 2 to 3mm around the colony.
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Cells growing on CCFA have an altered morphology, usually
being elongated (up to 8>im in length) by the presence of
the antimicrobial agents. However, after only one
subculture onto BA they revert to typical morphology.
The selectivity of CCFA is such that only after 24 or 48h
incubation do other colony types appear. These are
usually small white or pink colonies which are circular
and raised and can in no way be confused with C.
difficile.
Since the initial development of this agar further
studies have indicated that the concentrations of the
antimicrobial agents employed can be inhibitory for some
isolates of C. difficile (George et al., 1979a; Dzink and
Bartlett, 1980). Levett (1985b) compared the rate and
level of isolation of C. difficile from 33 faecal
samples. Initial culture on CCFA containing half the
usual concentration of antimicrobial agents (i.e.
250yug/ml cycloserine and 8>ig/ml cefoxitin - 1/2 CCFA)
resulted in recovery of C. difficile from all of these
specimens. However, when re-examined by culture on full
strength CCFA only 75% of the samples yielded the
organism. Moreover, the degree of growth on the 1/2 CCFA
plates was invariably greater. Willey and Bartlett (1979)
developed an agar containing cycloserine and cefoxitin
independently of George et al. ( 1979d). With this medium
(which contained 250/ig/ml cycloserine and lOjug/ml
4S
cefoxitin) the organism was isolated from 71 of 73 stools
in which C. difficile-associated cytotoxicity had
previously been detected. A 67% increase in isolation of
the organism was obtained when 18 stools, positive for C.
difficile cytotoxicity, were examined by use of this
medium compared to BBA. Phillips and Rogers (1981) used
1/2 CCFA also containing 0.1% (w/v) £-hydroxyphenylacetic
acid to isolate C. difficile as they again found that
full strength CCFA reduced quantitatively and
qualitatively the growth of stock strains of the
organism.
3.1.3a Use of further selective procedures in conjunction
with CCFA
Buggy et al. ( 1985) compared plating of faecal specimens
onto CCFA with use of such plates containing 0.1% sodium
taurocholate (TCCFA) . This is a primary bile salt that
encourages germination of spores and has been used
successfully to increase isolation of Clostridia from
humans. They reported that both crude and pure sodium
taurocholate significantly increased recovery of C.
difficile. This was in contrast to Wilson (1983) who
reported that crude extracts of sodium taurocholate could
inhibit growth whereas pure synthetic taurocholate or
cholate enhanced growth. Buggy et al. ( 1983) had
previously indicated that TCCFA would allow recovery of
spores 20 to 25 times as great as on CCFA. Wilson et al.
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(1982a) found' that TCCFA quantitatively recovered
vegetative forms of C. difficile in the same numbers as
CCFA while recovery of spores was a mean 1.7 log^o higher
on TCCFA than on CCFA.
Alcohol shock has been used to kill selectively
vegetative forms of the bacterium, as well as other
non-sporing faecal organisms, before isolation of
resistant spores (Borriello and Honour, 1981; Levett,
1984b). Borriello and Honour (1981) did a comparison of
direct plating onto CCFA (containing 250>ig/ml cycloserine
and 10>ig/ml cefoxitin) with plating following treatment
with ethanol at a final concentration of 50%. This study
indicated that such treatment of samples could aid
isolation of the organism. It was suggested that it might
be especially useful in laboratories lacking the
selective CCFA medium. Willey and Bartlett (1979) however
found that 50% (v/v) alcohol could decrease isolation of
the organism.
Heat shock is another method that has been used to
selectively isolate sporing forms of the organism (Wilson
et al., 1982a; Stark and Lee, 1982). Spores of C.
difficile are resistant to heating at 80°C for 10 min and
70°C for 20 min (George et al., 1979d). In their study
Wilson et al. (1982a) found that after such treatment the
best recovery of the organism was achieved with TCCFA.
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3.1.4. Use of broth cultures to recover C. difficile
Both CCFA and 1/2 CCFA plates are now used extensively
for routine isolation of C. difficile. However, due to
the restrictions on the size of faecal sample applied to
such plates approximately 10^ organisms per gramme of
faeces must be present before the organism can be
detected (Wilson et al., 1982a). In many cases the
organism may be be present in lower numbers as for
example, following vancomycin therapy (Onderdonk et al. ,
1980). Similarly low numbers may be present in specimens
examined in epidemiological studies. Consequently,
several groups have investigated methods for increasing
recovery of low levels of the organism that might exist
within samples.
3.1.4a Use of Cooked Meat Broth
Pre-reduced CMB will support growth of any anaerobes
inoculated into it. since it contains no selective or
inhibitory ingredients. Consequently, it may not be all
that useful for recovery of any organism that is present
at very low levels or that does not grow as rapidly as
other organisms also inoculated. Levett (1984b) used CMB
to try and increase isolation of C. difficile compared
with direct plating onto 1/2 CCFA. Direct plating
resulted in recovery of the organism from 15 of 143
stools (10.5%) from individuals suspected of having C_;_
difficile-associated diarrhoea. Inoculation of the
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samples into CMB increased this to 33 of the specimens
(23%). Both Brettle et al. (1982) and Stark et al. (1982)
used CMBs during epidemiological investigations but there
is no indication given as to whether the organisms
isolated during the studies were obtained from direct
culture or by use of these enrichments.
3.1.4b Enrichment Broths
There have been a variety of CMBs containing various
antibiotics used to enrich for C. difficile. Hoist et al.
(1981) compared the use of direct plating onto CCFA with
use of chopped meat glucose broth containing cycloserine
( 500,ug/ml) and either kanamycin (lOOjig/ml) or cefoxitin
(10;ag/ml). No difference in the level of recovery of the
organism from 117 children was found with the three
different media. Buchanan (1984) devised a CMB containing
increased levels of carbohydrates and also the
antimicrobials cycloserine and cefoxitin at 500jjg/ml and
16)iq/ml respectively. It was found that there was a 16%
increase in recovery of the organism after the enrichment
compared to direct culture on CCFA (as detected by GLC
and subculture onto BA).
It is difficult to assess which enrichment method is
best, since other factors in the isolation procedure
(e.g. the age of the specimens, methods of transport and
storage, anaerobic techniques used etc.) also influence
results. Levet " itis-Bassoulis (1985) compared
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three enrichment media (CMB alone or with cycloserine
( 250jjg/ml) and cefoxitin (8;ig/ml), or 0.1% sodium
taurocholate). All faecal samples were subcultured onto
1/2 CCFA after five days. All three enrichment media gave
higher isolation rates than direct culture. The isolation
rate was marginally higher with taurocholate-containing
broth than with the unselective CMB. Surprisingly,
isolation rates in the antimicrobial-containing CMB were
lower than in the other two broths. Chang and Gorbach
(1982) used antimicrobial-containing CMB to facilitate
the rapid detection of C. difficile by TCA but did not
report use of the broth in isolating the organism per se.
A few other studies involving non-CMB based enrichment
media have been done. Carroll et al. (1983) used a BHI
broth supplemented with 5jag/ml gentamicin, 250;ig/ml
cycloserine and 8/ig/ml cefoxitin to try and isolate c.
difficile. An additional seven isolations of the organism
were made with this broth compared to direct plating onto
1/2 CCFA (with which 12 C. difficile had been isolated).
O'Farrell et al. ( 1984) used a cycloserine cefoxitin
fructose broth (500pg/ml and 16|ig/ml respectively)
containing 0.1% sodium taurocholate (CCFT) for the
isolation of C. difficile from vaginal and faecal
specimens. They concluded that the use of such a broth
culture was a useful addition to direct plating when only
low levels of the organism were likely to be present in a
specimen.
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It seems clear that a significant increase in the
isolation rate of C. difficile may be expected when
enrichment culture is performed in addition to direct
culture on a selective medium. The sensitivity of a
particular technique may vary widely between one study
and another. This may in part be due to other factors
involved in different isolation procedures as well as
potential differences in the samples studied. The
potential for use of enrichment techniques in
epidemiological studies (especially in investigations of
low level reservoirs of the organism) is an important
area for further studies.
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3.1.5. Isolation of C. difficile from healthy
individuals
Within the healthy adult population C. difficile has been
isolated from both the GI and the genital tracts.
3.1.5a Gastrointestinal carriage in adults
The majority of investigations performed in the United
States and in Europe have indicated that faecal carriage
of C. difficile is uncommon in healthy adults who have
not received antimicrobial therapy (see Table 3.1). In
these studies, C. difficile has been isolated from only
3% or less of the individuals examined. Faecal cyto¬
toxicity has not been detected in any of them.
There are a few reports of the organism being isolated
from a higher proportion of healthy individuals. Wilson
et al. (1982b) cultured C. difficile from 5 of 39 (15%)
normal adults with CCFA. Bender et al. (1986) found 22%
of 40 elderly individuals carried the organism. Nakamura
et al. (1981a) recovered the organism from 23 of 149
(15.4%) healthy young Japanese adults examined and 15 of
213 (7.0%) healthy elderly adults. The faecal count of C.
difficile in these individuals was found to range from
102 to 10? organisms per gramme faeces. A cytotoxic
effect (assessed by TCA of crude faecal supernates) was
not detected even among those adults carrying more than
105 C. difficile (shown to be cytotoxigenic in vitro) per
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TABLE 3.1
Some reported detections of C. difficile from healthy
adults
Reference No. of No. of C.d. Toxin Selective
subjects specimens +ve +ve Medium
George et al. 137
(1978b)


































a: selective medium not used
b: information not given
c: agar containing cycloserine 250/ug/ml; cefoxitin
10^ig/ml
d: results based on tissue culture assay only
e: CCFA (George et al., 1979d)
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gramme of faeces.
Faecal specimens from adults that produce positive TCA
results are almost always associated with diarrhoea
although Lishman et al. (1981b) did report cytotoxic
titres of up to 10^ cytopathic units (cu) in asymptomatic
adults receiving antibiotics. Titres were more usually in
the range 10-'- to 102 cu. In patients with PMC,
cytotoxicity has been detected when the number of C.
difficile has been as low as 102 organisms per gramme of
faeces (Bartlett et al., 1978c).
In spite of the absence of C. difficile-associated
cytotoxicity in the faeces of healthy Japanese adults,
antibody against crude toxin preparations was
demonstrated among young adults. This was at a rate of
90% among those actually carrying isolates of the
organism in their faeces that were TCA-positive in vitro.
Even the sera from 19% of young adults from whom C.
difficile was not isolated contained such antibody. In
contrast, antibody was not demonstrated among elderly
adults, no matter how abundant the cytotoxigenic
organisms.
Because of the variety of methods used to cultivate the
organism (Nakamura et al. (1981a) used 1/2 CCFA in their
studies), it is not possible to say whether the reported
disparities in levels of isolation of C. difficile arise
due to variations in culture techniques or genuine
differences in the prevalence of GI carriage of the
57
organism among distinct populations. There is one report
(Finegold et al. , 1974) comparing the faecal flora of
individuals eating either a western diet or a Japanese
diet. C. difficile was isolated from one of 15
individuals on the Japanese diet; the organism was not
recovered from any of the 18 persons on a western diet.
However these results were obtained with too small a
group of subjects to be particularly significant.
There are several other reports of attempted isolations
of C. difficile from various 'healthy' populations.
However many of the individuals involved in these studies
are patients in hospital for some other reason apart from
diarrhoea (Varki and Aquino, 1982; Brettle and Wallace,
1984) or in fact do have diarrhoea that is not
associated with antimicrobial usage (Falsen et al. , 1980;
Borriello and Larson, 1981). Other individuals often
included as 'normals' are patients receiving
antimicrobials who have no GI symptoms (Viscidi et al. ,
1981). Since the individuals in these groups cannot be
regarded as entirely healthy discussion about them is not
included here. However it should be noted that C.
difficile is isolated from such groups only at the very




The available evidence about genital carriage in men and
women has been accumulated from studies of patients
attending antenatal and postnatal clinics and departments
of genitourinary medicine. O'Farrell et al. (1984),
Tabaqchali et al. ( 1984b), and Thirkell et al. (1984)
found carriage rates of 18 to 24% in antenatal patients.
They reported that few specimens/swabs grew C. difficile
when plated directly onto CCFA compared with enrichment
culture in CCFT broth. In the study of Thirkell et al.
(1984) 0.2% £-cresol broth also gave only low isolation
rates. Carriage was not detected in any antenatal
patients by Al-Jumaili et al. ( 1984) or Bolton et al.
(1984) by direct culture of swabs onto CCFA or into 0.2%
£-cresol broth (in the latter study). Hoist et al. (1981)
were also unsuccessful in recovering the organism from
the vagina.
Reports relating to genitourinary clinics are also
conflicting. With the use of 0.2% £-cresol broth Hafiz et
al. (1975) reported carriage of the organism in 72% of
108 women. O'Farrell et al. (1984) isolated the organism
from nine of 82 patients (11%) using CCFT but were unable
to demonstrate the carrier state with 0.1% £-cresol
broth. Thirkell et al. (1984) recovered C. difficile from
six of 50 women, again with CCFT. However other workers
(Moss, 1983; Levett, 1984c) have not identified any
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carriers. Masfari et al. (1983) recovered no C. difficile
from 28 asymptomatic controls.
Similar differences have been observed in men attending
genitourinary medicine departments. Hafiz et al. ( 1975)
isolated the organism from all of 42 men with
non-specific urethritis whilst only two patients out of
150, both with balanoposthitis, were detected in studies
by Masfari et al. ( 1983). All twenty patients
investigated by Levett (1984c) were culture negative.
The major concern regarding recovery of C. difficile from
healthy adults is whether or not the culture media and
methods used have been sensitive enough to detect small
numbers of the organism. As discussed previously many
studies have been done confirming that alterations in
culture methods can markedly affect the ability to detect
C. difficile (George, 1986). It is clear that the use of
selective broth media increases the ability to detect the
organism in both faecal (Mulligan et al. , 1982) and"
genital (Tabaqchali et al., 1984b) specimens. Also media
enhancing recovery of spores can markedly increase
recovery of the organism.
These findings would indicate that previous studies done
to detect carriage of C. difficile that have not employed
a broth medium or a selective medium designed to increase
detection of spores may have underestimated the actual
prevalence of C. difficile as normal flora. Thus it would
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appear that the significance of endogenous carriage of C.
difficile in adults is still uncertain and warrants
further investigation.
3.1.5c C. difficile in healthy infants
Despite the fact that C. difficile is rarely detected in
the healthy adult population and while there may be a
transient rise in asymptomatic faecal carriage following
antibiotic therapy (Ambrose et al. , 1985), occasionally
with positive cytotoxic effects, the finding of C.
difficile in the faeces of an adult is usually associated
with symptoms. This however is not the case with
children. Faecal colonization by C. difficile, often
associated with high cytotoxicity titres, has been
reported on numerous occasions in normal healthy children
(Collignon et al., 1986).
Chang et al. (1979) reported detection of C.difficile
cytotoxicity in 2% of neonatal specimens studied. Hoist
et al. (1981), in a detailed study found C. difficile in
only 4% of infants under one month of age. All isolates
were cytotoxigenic in vitro. A more recent report (Merida
et al., 1986) did not find the organism in any full term
neonates but did culture it from five of 32 (16%)
premature neonates. None of these strains produced a
positive TCA result. These reports contrast with the
majority of investigations of neonatal colonization where
levels of 30 to 40% are not uncommon (Hall and O'Toole,
fcl
1935; Stark and Lee, 1982; Bolton et al. , 1984; Viscidi
et al., 1981). Donta and Myers ( 1982) suggested that
there was rapid colonization of the infant gut over the
first few days of life with concomitant or subsequent
cytotoxicity. Despite obvious discrepancies in these
reports as to the precise age of colonization with the
organism there is general agreement that a high
proportion of infants do carry the organism from a very
early age. counts of between 103 and 10^ organisms per
gramme of faeces are common (Stark et al. , 1982).
Hoist et al. (1981) reported colonization in 64% of
infants aged one to eight months with up to 79% of those
between three and five months being C. difficile-culture
positive. All isolates were cytotoxigenic in vitro. Stark
et al. ( 1982) reported 90% colonization of infants during
the first year of life. Other reports suggest rates of 30
to 50% (Cooperstock et al., 1983; Richardson et al. ,
1983; Viscidi and Bartlett, 1981; Merida et al., 1986).
Following the high rates of isolation of the organism
reported during the first year of life a dramatic
decrease in recovery of the organism occurs after 12
months of age with reported isolation rates approaching
the low levels found in the adult population. (Hoist et:
al., 1981; Nash etal., 1982; Stark etal., 1982).
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3.1.6. Association of C. difficile with disease in
children
In any investigations concerning the involvement of C.
difficile in GI disease in children results are difficult
to interpret due to the occurrence of the organism
(apparently without causing symptoms) in many such
healthy individuals. However, below is a brief summary of
conditions the organism has been associated with.
3.1.6a PMC: PMC is very rare in neonates and infants
although cases have been described both with (Donta et
al., 1981; Richardson et al., 1981; Mandal et al., 1982)
and without (Hyams et al. , 1981) previous antibiotic
exposure. Amoxycillin and ampicillin seem to be the most
commonly implicated agents. Viscidi and Bartlett (1981)
documented 10 cases of cytotoxicity positive AA-PMC in
children (aged between four and 17 years) and identified
in the literature a further 25 cases with 28% mortality.
As in adults AA-PMC can occur in previously healthy
patients receiving a short course of antibiotics for
trivial infections. C. difficile does not appear to be
related to AAD in children in the absence of
pseudomembranes (Don and Davis, 1981; Elstner et al. ,
1983) .
3.1.6b Infantile diarrhoea: A role for C. difficile has
been proposed in some cases of infantile gastroenteritis
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(Ellis et al., 1984), failure to thrive (Liston, 1983;
Thompson et al. , 1983), sudden infant death syndrome
(Cooperstock et al., 1982) and chronic diarrhoea (Sutphen
et al. , 1983). However the role of C. difficile in the
aetiology of any of these conditions is obscure and
difficult to evaluate (Luzzi et al., 1986).
3.1.6c Necrotising enterocolitis (NEC): C. difficile has
been suggested to be involved in this potentially lethal
disease of sick and premature newborn infants. Although
faecal cytotoxicity may be detected in some patients
(Lishman et al. , 1984; Cashore et al., 1981) the weight
of published evidence does not support a major pathogenic
role for C. difficile in NEC (Chang and Areson, 1978;
Stoll et al., 1980; Sherertz and Sarubbi, 1982; Thomas et
al., 1984).
3.1.6d Enterocolitis in Hirschsprung"s.disease: In 1982
C. difficile was incriminated in the aetiology of .the.
enterocolitis associated with this condition (Thomas et_
al., 1982; Cooperstock et al♦, 1982) and confirmed in a
subsequent prospective controlled study (Thomas et al. ,
1985). The major pathogenic role of C. difficile in this
disease appears confined to children under three years of
age.
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3.1.7. Aims of this study:
1. to assess the effectiveness of enrichment broth for
detecting low levels of C. difficile in faeces.
2. to try and discover if the previously low levels of
isolation of C. difficile from normal healthy adults
could be boosted by means of enrichment culture.
3. to provide an easy, quick and reliable method for





All enrichment studies were done within an anaerobic
cabinet (Forma Scientific) with p-r broths and agar
plates.
3.2.1a Use of enrichment cultures
It is likely that C. difficile could exist in the GI
tract of normal healthy adults at levels too low to be
detected by direct plating onto CCFA medium. The use of a
broth containing the same selective agents as this agar
medium seemed potentially useful as a means of enriching
any low levels of the organism that might exist within
faeces.
Assessment of CCFB and 1/2 CCFB for recovery of
vegetative cells and spores in the presence of normal
faecal flora
a) From vegetative cells: A 17h PPY culture of MPRL 558
(0.5ml) was inoculated into 10ml of PPY and incubated for
2.5h. A total count was made with a counting chamber
(Thoma) and the culture diluted with nutrient broth (NB)
to give 500 organisms/ml. Samples (20>il) were inoculated
into 10 x 10ml CCFB (essentially CCFA containing 500>ig/ml
cycloserine and 16^g/ml cefoxitin but lacking the
egg-yolk and the agar). Also, 20pl were inoculated into
10 x 10ml 1/2 CCFB (250jag/ml cycloserine and 8pg/ml
cefoxitin). A 0.4ml sample of a 1 in 4 dilution of pooled
C. difficile-negative faeces (as determined by previous
enrichment culture in CCFB) was also added to each broth.
After inoculation of each broth a further 20jj1 of the C.
difficile suspension was put onto BA to give an
indication as to the actual number of organisms each
culture was receiving.
b) From spores: A loopful of CMB culture of MPRL 558 was
spread onto a BA plate and incubated at 37°C for 4 days.
Colonies from this plate were suspended in PBS, pH 7.4,
and washed twice before heating to 70°C for 20 min to
kill any vegetative cells. The spores were counted in a
chamber and resuspended to give about 500/ml. These were
inoculated into CCFB and 1/2 CCFB as described above. The
spore suspension was also added to CCFB and 1/2 CCFB
containing 0.1% sodium taurocholate (Sigma).
All broths and plates were incubated at 37°C for 48h. A
loopful of broth from each was spread onto CCFA after 24,
48 and 72h to check for growth of C. difficile.
When the vegetative cells were inoculated the organism
was recovered from all of the CCFB and 1/2 CCFBs after
24h incubation, each broth having received between 2 and
12 organisms. These had survived incubation with normal
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faecal flora equivalent to that found in O.lg of faeces,
the usual inoculum used in enrichment work in this
laboratory. When the experiment was repeated with the
sporing culture C. difficile was not recovered from
either of the broths until after 48h incubation. The
addition of sodium taurocholate did not result in quicker
recovery of the organism. It was noted in all the studies
that there were many more plate contaminants when broths
were plated onto 1/2 CCFA compared to CCFA. However these
could in no way be confused with C. difficile being
mostly small, pink colonies. Both the CCFA and 1/2 CCFA
plates required 48h incubation before the C. difficile
colonies were clearly identifiable.
3.2.1b Isolation of C. difficile from healthy adults
Three groups of volunteers were used in these studies
(see Table 3.2). Faecal samples were used unfrozen and
unrefrigerated (unless otherwise indicated) and all
attempts were made to culture them less than 12h after
collection.
Groups 1 and 2: About 2g of each sample was emulsified in
10ml of NB; 0.2ml of this was spread directly onto a CCFA
plate as a control and 4.8ml inoculated directly into
100ml of CCFB.
Group 1; The remaining 5ml of homogenate was placed in a
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TABLE 3.2
Groups of healthy volunteers providing faecal samples
for study
Group Males No. on
antibiotics
Ages Females No. on
antibiotics
Ages
1 7 0 25-55 10 2 20-45
2 14 3 20-21 17 5 20-21
3 11 2 20-21 13 1 21
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screw cap bottle and heated in a 70° C waterbath for 20
min; 0.2ml was spread onto CCFA and the remainder
inoculated into 100ml CCFB.
Group 2: The 5ml of remaining homogenate was inoculated
into 100ml of CCFB containing 0.1% sodium taurocholate
(Sigma). For a later study 10 samples from this group
which had been stored at -20°C were taken, 2g emulsified
in 10ml NB and 5ml put directly into 100ml 1/2 CCFB. The
remaining 5ml was added to an equal volume of ethanol and
left for lh before inoculation into a further 100ml of
1/2 CCFB.
These broths were incubated at 37°C and after 24, 48 and
72h a loopful from each was streaked onto a CCFA plate.
This was also repeated after 7 days incubation of the
broths. Samples inoculated into 1/2 CCFB were streaked
onto 1/2 CCFA.
Group 3: Here the faecal samples were weighed and a
loopful was spread onto 1/2 CCFA as a control. The entire
sample was homogenised in 1/2 CCFB which was subsequently
made up to 100ml with more 1/2 CCFB. Loopfuls from the
broths were spread onto 1/2 CCFA plates after 24, 48 and
72h and assessed for growth of C. difficile after 24 and
48h incubation.
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The first attempts to recover C. difficile from normal
healthy adults were made with faecal samples (one sample
per individual) from groups 1 and 2 cultured as described
previously. The results obtained from these studies are
summarised in Table 3.3.
C. difficile was not recovered from any specimen by
direct inoculation onto CCFA. After enrichment the
organism was cultured from three individuals none of whom
were receiving, or had received antibiotics in the six
months prior to sample collection. One of the males was
22, the other in his forties. The female was 23 years of
age. The addition of the sodium taurocholate made no
difference to the results. It took at least 48h
enrichment in the CCFB to yield the organism. After seven
days incubation, samples from the broths grew no C.
difficile regardless of whether the organism had been
isolated previously.
Heating was not found to increase recovery of the
organism and in two of the three positive samples
actually appeared to inhibit growth. The one heated
culture yielding the organism also grew C. difficile from
the untreated broth. Both these cultures required 72h
incubation before the organism was isolated.
All broths inoculated with unheated samples grew many
streptococci and showed signs of bacterial growth and
fermentation within a few hours of inoculation. The
broths inoculated with the heated samples did not show
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TABLE 3.3
Recovery of C. difficile from healthy adults by culture
in CCFB
Number of C. difficile positive samples
Untreated With heat With Na+ taurocholate
broth
Group Male Female Male Female Male Female
1 2 1 0 1
2 0 0 i i i i o o
— experiment not performed
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such signs until 48 or 72h after the start of the
experiment.
Ten samples found to be C. difficile-negative in this
study were added to 1/2 CCFB with and without prior
alcohol treatment. After 48h incubation of these broths
the organism was isolated from another three samples. Two
of these were from females (21 years of age and 34 years
of age) who were receiving short term antibiotic therapy
(tetracycline and amoxycillin respectively); the other
from a female with no recent history of antimicrobial
treatment (20 years of age). One of these strains was
recovered only after alcohol treatment. The other two
strains were from broths inoculated directly; the
organism was not recovered after these two samples had
been treated with alcohol. Plate contaminants were
virtually eliminated after treatment with alcohol.
On the 1/2 CCFA plates several colonies .grew that looked
fairly similar to C. difficile. However after subculture
to BA and CMB they were found to have different colonial
morphologies and motility. Positive identification of C.
difficile isolates was made by use of GLC and sugar
fermentation tests.
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3.2.1c The role of inoculum size in recovery of C.
difficile from faeces
The work described previously was done with inocula of
about lg faeces into 100ml of enrichment broth. In order
to assess further the role of inoculum size in recovery
of the organism the following experiment was done. Two
faecal specimens (1.5g each) from different healthy
individuals, not receiving antimicrobials, were
emulsified in 6ml of NB and 200^1 of this suspension was
inoculated into 30 x 10ml enrichment broths. Ten of these
were CMBs, 10 were CCFBs and the remaining 10 were broths
containing cycloserine, cefoxitin and mannitol (CCMB).
All were incubated at 37°C. A loopful from each was
spread onto CCFA after 24, 48 and 72h and the plates
incubated for 72h before being discarded. One sample
yielded no C. difficile in any of the broths; the other
resulted in recovery of the organism from only four of
the 30 broths. Three of these were from CCFB; the other
from CCMB. All of the tubes grew quite high levels of
streptococci.
From this result it appears that C. difficile must have
been present at extremely low levels within this
particular specimen. Clearly, there is a very real chance
that the organism would not be recovered if any less than
a gramme of faeces were used in trying to culture it from
this sample.
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Faecal samples obtained from individuals in group 3 (see
pages 67 to 69) were weighed after collection and the
entire sample (except a loopful that was spread directly
onto 1/2 CCFA) inoculated into 1/2 CCFB. There were 24
samples weighing between 0.4g and 9.9g (see Table 3.4).
C. difficile was not recovered from any of the samples
when plated directly onto 1/2 CCFA. Only two of the 24
samples yielded C. difficile when the broths were
cultured onto 1/2 CCFA after 48h incubation. One of these
was from group ii, the other from group iv. Both the
specimens were from 20-year-old males, one of whom had
been receiving continuous antibiotic therapy (mostly
tetracycline derivatives) for a year. The other had not
been exposed to any antimicrobials. It would appear from
these results that recovery of the organism is not
increased by use of larger inocula sizes. Neither is
there a gradation in levels of recovery with the
different quantities of material cultured.
3.2.Id Summary of C. difficile isolations from healthy
adults
As a result of all these studies C. difficile was
recovered from eight of 72 (11%) individuals (one
specimen per individual). Table 3.5 summarises how each
of these isolates was obtained.
EDTA extracts were made from isolates 6 to 8 which had
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TABLE 3.4
Samples used to investigate the role of inoculum size in
recovery of C. difficile from faeces
Group Weight of sample No. of samples
i less than l.Og 3
ii l.lg - 3.0g 8
iii 3.1g - 6.0g 7
iv 6.1g - 9.9g 6
It
TABLE 3.5
Method of isolation of C. difficile isolates from healthy
individuals
Method of culture









+: growth of C. difficile.
no growth of C. difficile,
a: isolate obtained only after alcohol treatment and
culture in 1/2 CCFB.
...: method not tried for this isolate.
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been isolated during the same investigation. All were
shown to have different protein profiles when separated
by SDS-PAGE (25/ug). Isolate 1 and another isolate
obtained from the same faecal sample during a subsequent
study were examined in the same manner and found to be
different, indicating this individual had been carrying
two strains of the organism at the same time.
Cytotoxicity assays done on these eight isolates were all
negative. All faecal samples from groups 1 and 2 were
also tested for cytotoxic activity and all gave negative
results.
Sera from seven individuals in Group 1 were tested for
IgG antibodies against an EDTA extract of C. difficile
NCTC 11223 by use of. SDS-PAGE and immunoblotting.
Extracts (25jjg of protein in 50>il of double strength
sample buffer) were immunoblotted with sera diluted 1 in
10 in antibody buffer (see section 2.18)♦ Rabbit
anti-human HRP conjugate (ICN Biomedicals - diluted 1 in
500) was used as the second antibody.' None of the sera
gave positive results despite isolation of C. difficile
from two of these individuals.
3.2.1e Comparison of CCFA and 1/2 CCFA for routine
direct isolation of C. difficile
It has been shown that the only disadvantage arising from
use of 1/2 CCFA for isolation of C. difficile is the
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greater number of contaminants that grow on it compared
to on CCFA. However since other research groups have
shown increased recovery of C. difficile with 1/2 CCFA
the diagnostic laboratories here wanted to adopt this
medium as the means for routine culture of the organism.
An alcohol shock step was included in the isolation
procedure to decrease contaminant growth.
One hundred unselected faecal specimens arriving in the
diagnostic laboratories from general practice or hospital
wards were examined. The samples were held at 4°C and
cultured over the following few days. A loopful of each
sample was inoculated directly onto both CCFA and 1/2
CCFA plates. The remaining specimen was homogenized in an
equal volume of 50% ethanol (v/v) in NB with a vortex
mixer and left on the bench for 60 min prior to
inoculating a CCFA and a 1/2 CCFA plate with two loopfuls
of this suspension. All four plates were subsequently
incubated in the same anaerobic jar and examined after 48
to 72h.
Of these 100 specimens 16 yielded C. difficile. Five of
the 16 organisms were obtained only on 1/2 CCFA. The rest
were isolated on both. The use of alcohol did not
increase recovery of the organism on CCFA but on 1/2 CCFA
it increased isolation from 15 to 16 organisms. It did
noticeably decrease the growth of plate contaminants.
A further comparison was done between the use of 1/2 CCFA
with alcohol and the standard laboratory procedure for
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isolation of C. difficile (direct plating onto CCFA).
Consecutive specimens (265) were examined. Samples were
held on the bench and cultured as a batch at the end of
each day. Samples arriving during the weekend were held
at 4°C until Monday. A loopful of each specimen was
plated onto CCFA (standard isolation procedure). The
remaining specimen was mixed with 50% ethanol (v/v) as
previously described but for only 10 min. All other
procedures were as in the previous experiment.
Of the 265 specimens 26 (10%) yielded C. difficile. All
these isolates were cultured by the 1/2 CCFA/alcohol
technique whereas only 19 grew on CCFA. A decrease in the
period of alcohol shock from lh to 10 min was found to be
satisfactory for decreasing levels of contaminants.
In order to obtain a more quantitative idea of recovery
on 1/2 CCFA compared to CCFA and also to determine the
potential usefulness of alcohol treatment in the
isolation procedure the following experiment was done.
Two faecal samples (A and B) from which C. difficile had
been previously isolated on CCFA were diluted 1 in 4 with
NB. One half of each diluted sample was mixed with an
equal volume of p-r NB and the remainder with an equal
volume of absolute ethanol (final concentration therefore
50%). Samples were left at' RT for lh. Serial 10 fold
dilutions were made of each sample and 50jil of each
dilution spread in triplicate onto CCFA and 1/2 CCFA
plates which were incubated for 48h before determining
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the viable counts.
From the results (Table 3.6) it can be seen that there is
a significant increase in isolation of C. difficile when
the mean viable counts obtained by culture of alcohol
treated and non-alcohol treated samples are compared
(0.01 >P> 0.001). This would indicate that recovery of
the organism from both faecal samples has been influenced
by treatment with the alcohol.
The difference between the mean viable counts of
organisms recovered by culture on CCFA and 1/2 CCFA does
not appear to be so significant. For sample A
(non-alcohol treated) and sample B (alcohol treated)
there is no evidence to suggest any difference between
the mean viable counts obtained (0.5 >P> 0.1). There is
more likelihood of the 1/2 CCFA having increased recovery
of C. difficile from the other two samples. However, the
significance of the difference between these results is
not as great as the effects observed during the




Comparison of recovery of C. difficile on CCFA and 1/2 CCFA
with and without alcohol treatment
Mean Viable Count ona




A 2.9 x 106 2.7 x 106 0.93 0.5 >P> 0.17
Ab
(ale)
5.2 x 106 6.3 x 106 2.44 0.1 >P> 0 .05
_t testc 7.44 9.18
P value 0.01 >P> 0.001 P> 0.001
B 2.7 x 107 2.9 x 107 3.00 0.05 >P> 0.02
Bb
(ale)
3.4 x 107 .. 3.6 x 107 1.39 0.5 >P> 0.1
t testc 6.54 7.42
P value 0.01 >P> 0.001 0.01 >P> 0.001
see over/
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a: mean of counts from three plates expressed as colony
forming units per gramme of faeces. Appendix 3
records the counts from each individual plate.
b: figures obtained for alcohol treated samples.
c: _t test comparing the significance of the difference
between the mean values calculated for alcohol and
non-alcohol treated samples.
d: _t test comparing the significance of the difference
between the mean values calculated for recovery of
C. difficile on CCFA and 1/2 CCFA.
_t test values were calculated
with the following formula: t_ = xj - X2
SD = standard deviation
n = number of samples
P was calculated for the _t values obtained by use of




where SD2 = £(x - x)2i + £( x - x)22
(n - l)i + (n - 1)2
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3.3. Discussion
This work has confirmed that enrichment culture will
increase the level of recovery of C. difficile from
faecal specimens of normal, healthy individuals. During
these studies the organism was not isolated from any
individual when samples were plated directly onto CCFA or
1/2 CCFA but was recovered from 11% of samples after
enrichment. Initial work indicated that about 10
vegetative C. difficile cells could be recovered from
broths within 24h of inoculation while sporing cultures
required 48h before recovery. With faecal samples all
broths required at least 48h incubation before the
organism was isolated. This was probably due to the
organism being in the sporing form by the time it was
cultured in the laboratory.
During these studies I used only samples that had not
been refrigerated or frozen. George et al♦ (1982) have
shown that freezing substantially reduces counts of C.
difficile. Bowman and Riley (1986) found that C.
difficile can remain viable in samples held at 5°C for up
to 10 days. However, in an attempt to achieve maximum
recovery I tried to use fresh samples that had been
collected within 12h. I also asked all volunteers to
provide as large a sample as possible to give any C.
difficile present theifin as much protection as possible
from atmospheric oxygen. Bowman and Riley (1986) showed
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that the larger a sample obtained, the better was the
potential for survival of any C. difficile present.
There was no clear correlation between isolation of C.
difficile and antibiotic therapy. Of the eight
individuals from whom the organism was isolated (four
males, 4 females) only three were receiving such agents
(two on tetracyclines, one on amoxycillin). Although
these antibiotics are associated with emergence of C.
difficile (Bartlett, 1979) it should be borne in mind
that a further 10 volunteers in these studies (all of
whom were in their twenties) were also receiving such
agents and the organism was not isolated from them. Also,
any organisms isolated were present at low levels, all
requiring enrichment before detection. Due to the fact
that the volunteer population in these studies consisted
mainly of individuals in their early twenties it is not
possible to draw conclusions about any effect age might
have on colonization with C. difficile.
Three isolates obtained during the same experiment were
analysed by SDS-PAGE of their surface proteins and all
were shown to be different. This would indicate that a
variety of strains can exist within the normal healthy
population and it also proved that the isolates had not
arisen from a common contaminant within the anaerobic
cabinet. It was also shown that one individual could
harbour more than one strain of the organism at any one
time.
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All isolates obtained were non-cytotoxigenic. It would
have been interesting to test for toxin A but at the time
of this work pure anti-toxin was unavailable commercially
for such an investigation. It is worth remembering that
results obtained by toxin assay in vitro will greatly
depend on cultural conditions employed during growth of
the organisms. Haslam et al. ( 1986 ) clearly demonstrated
that the precise environment of the gut at the time of
isolation of the organism would require to be mimicked in
vitro to get a true idea of the in vivo toxigenicity of
an isolate. Clearly, such an ideal situation is
impossible to obtain at present.
Of seven individuals tested for serum igG antibodies
against surface proteins of C. difficile all were
negative, even two individuals from whom the organism had
been isolated. It thus appears that these proteins are
non-antigenic in these individuals when tested by this
method. Use of an ELISA technique would perhaps have
provided a more sensitive assay. I did not test for
anti-toxins since a) no cytotoxic effect was detected and
b) we did not have anti-toxin A.
What became increasingly apparent during this work was
the potential role that inoculum size might be playing in
recovery of the organism from samples. Enrichment studies
in this laboratory had previously been done with O.lg of
faeces in 10ml of CMB. My original aims were to increase
both the size of inoculum and the volume of culture
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medium (to lg in 100ml) and to provide a more selective
broth to see if this would improve recovery of the
organism from normal individuals. The study done in which
0.05g of a faecal sample was inoculated into each of 30
broths produced interesting results as the organism was
recovered from only four of these. It had been thought
that the composition of the broths might be important in
determining the results obtained. As well as CCFBs and
CMBs a broth containing mannitol (CCMB) was included.
This could potentially have been more selective for C.
difficile compared to CCFB as mannitol is fermented by
fewer species than fructose. It was found however that
only one of the four isolates was obtained from this
CCMB; the other isolates were from the CCFB. From these
results it seems that if only O.lg of this sample were
inoculated into a broth there would only be a 4/15 chance
of recovering the organism (27%). It is clearly not
feasible to try and culture C. difficile from any less
than lg of such a sample.
Considering these results I decided on a further' study
where much larger faecal inocula would be used. Based on
the previous results it could be expected that larger
inocula would result in increased recovery of the
organism or even give a gradation in recovery with
increasing inoculum size. However when this was done no
such effect was encountered.
It was found that the addition of 0.1% sodium
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taurocholate to broths or heat treatment of samples did
not aid in recovery of the organism. In fact, heating
samples appeared to inhibit growth of the organism.
However, such results could be explained by the fact that
the broths might not actually have received an inoculum
of the organism if it were present at only low levels.
Again with the alcohol treatment there appeared to be
some contrary results. When this was used to try and aid
recovery of the organism from frozen samples it appeared
that the treatment had again inhibited recovery of the
organism. However, as previously, this may have been an
inoculum effect. This is borne out by the fact that in
both the routine isolation of the organism and culture of
specimens known to contain high levels of C. difficile,
alcohol treatment did noticably increase isolation of the
organism. Such findings agree with other groups who have
found the use of alcohol beneficial in recovery of C.
difficile from faeces /Borriello and Honour, 1981;
Levett, 1984b). Results from the quantitative study
indicate that the alcohol treatment can increase the
recovery of strains even when they are not inhibited by
full strength CCFA. This could well be important if the
organisms are present at quite low levels. The use of 1/2
CCFA will of course, be important in recovery of strains
sensitive to higher antibiotic concentrations.
The original trials reported here, done in the diagnostic
laboratories, used alcohol at a final concentration of
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25%. Further studies showed that even one to two minutes
treatment with 50% ethanol would give equally good
results. Since then the following method, employing
industrial methylated spirits instead of alcohol, has
been fixed upon as being satisfactory for routine
isolation of C. difficile from clinical specimens.
3.3.1. Recommended method for routine isolation of C.
difficile from clinical specimens
1. Emulsify a pea-sized piece of faecal sample (about
lg) in 1ml of industrial methylated spirits and leave on
the bench for one to two minutes.
2. Plate a loopful of this suspension onto 1/2 CCFA.
3. Incubate plates in an anaerobic cabinet where they
can be easily checked for growth of C. difficile after
24h and/or 48h incubation. Plates incubated in an
anaerobic jar are best left for 48h.
CHAPTER 4
EPIDEMIOLOGICAL STUDIES OF CLOSTRIDIUM DIFFICILE-




The epidemiology of C. difficile-associated disease is an
intriguing subject about which there are many questions
but as yet very few clear answers. The organism appears
pathogenic within the large bowel, almost always
following some alteration of intestinal microecology.
Although a few cases are reported with no apparent
predisposing conditions or whose underlying disease is
poorly understood, most patients have received
antibacterial agents or some other treatment such as
cancer chemotherapy. However, the risks associated with
most of these therapeutic agents are not clearly defined.
4.1.1. Effects of antibacterial agents on normal gut
flora
Agents capable of suppressing other gut anaerobes and of
achieving high concentrations in the gut are the most
likely to facilitate the acquistion and/or overgrowth of
C. difficile (Larson et al. , 1978; Wilson et al., 1981).
Studies with antibacterial agent-treated animals confirm
that the normal flora does play some protective role
(Wilson et al. , 1981). Rolfe et al. (1981) found that
Lactobacillus, Streptococcus and Bifidobacterium species
all suppressed growth of C. difficile in vitro. S.
faecium was particularly inhibitory (Malamou-Ladas and
Tabaqchali, 1982). Consequently it has been suggested
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that removal of some of these normal bowel organisms by
antibacterial agents could allow overgrowth of C.
difficile. However it is clear that any ensuing disease
cannot simply be due to drug-induced suppression of other
gut flora since strains involved in disease are often
susceptible in vitro to the agent being administered. In
fact, isolates of C. difficile are always susceptible in
vitro to ampicillin and frequently susceptible to
clindamycin - even strains obtained from patients treated
with these agents (Dzink and Bartlett, 1980). It is also
unclear why some patients receiving antibacterial agents
develop disease while others having the same treatment
remain well. This may be partly due to differences in C.
difficile strains as well as host or environmental
factors (see Chapter 5). To date there is no evidence to
suggest that the gut flora of patients who develop
disease is any different or has an altered response to
the predisposing agents administered compared to those
individuals who remain healthy. The presumed role of the
normal gut flora in protection is still poorly understood
as are variations in the flora of normal persons and the
specific effects of many therapeutic agents.
4.1.2. Potential reservoirs of C. difficile
There are two potential ecological niches for C ♦
difficile. Either it exists somewhere within the
environment or it is present as a commensal within human
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beings and/or other animals. There are several reports of
recovery of the organism from environmental sources
(Mulligan et al ♦ , 1979; Malamou-Ladas et al. , 1983); as
already discussed the level of endogenous carriage of the
organism within the human population is uncertain. It is
of course, also conceivable that both endogenous and
exogenous sources of the organism exist. If so, the
relative importance of the two sources in the development
of disease requires determination.
4.1.2a Environmental sources of C. difficile
Prolonged contamination of surfaces occurs readily in
hospital environments (presumably due to the survival of
highly resistant spores) especially if there is
incontinence (Mulligan et al., 1980). Kim et al. ( 1980)
recovered the organism in 15% of cultures from
environmental sites 'potentially subject to faecal
contamination' in the vicinity of three patients with ,C.
difficile-associated diarrhoea. Only 3% of cultures in
control sites were positive. Fekety et al. (1981) found
the organism on hospital floors, buckets, toilets,
bedding, mops, scales and furniture in the environment of
patients with C. difficile-associated colitis. The
organism was also present on these items, but less
frequently, in areas where there were no known carriers.
Carriage of C. difficile on the hands of hospital
personnel has been documented (Mulligan etal. , 1979; Kim
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et al., 1981) and the organism has also been isolated
from the faeces of asymptomatic staff (Fekety et al.,
1981). Airborne transmission has not been conclusively
demonstrated although Larson et al. (1980) suggested such
spread of the organism might be possible when they found
that animals housed in single cages, given clindamycin,
developed disease symptoms before they had been handled
or given food. Few studies have been done to investigate
the possible distribution of the organism in environments
other than those associated with hospitals and patients.
The few reports which are available chiefly involve
isolation of the organism from soil or peat (Martin et_
al. , 1982).
4.1.2b Other potential reservoirs for C. difficile
Animals such as household pets have been reported as
another potential reservoir for C. difficile (Borriello
et al., 1982). Cytotoxic and non-cytotoxic strains of the
organism were recovered from 21% of dogs, 30% of cats, as
well as ducks and geese. The possibility of food-borne
contamination has also been suggested (Gurian et al. ,
1982). However the organism has not as yet been detected
in food products (Oishi et al. , 1983) and it has been
shown that at normal gastric pH levels C. difficile cells
are rapidly killed and the cytotoxic activity is
abolished. No mention was made of the proportions of
vegetative cells to spores in this work (Gurian etal. ,
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1982). C. difficile has not been isolated from hospital
foods or from unopened animal feed (Fekety et_al., 1981;
Kim et al., 1981).
4.1.3. Reported outbreaks of C. difficile-associated
disease
C. difficile-associated PMC, AAC, AAD etc. could result
from infection by another individual or from the
environment. The most significant evidence for the
infectious nature of these conditions is provided by the
apparent clustering of cases in some instances which tend
to suggest exogenous acquisition of C. difficile was an
important step prior to development of symptoms.
Available evidence does indicate that PMC occurs as a
sporadic infection. Swartzberg et al. ( 1977) saw 14
patients with PMC over a brief period then prospectively
evaluated diarrhoea in 1000 patients given clindamycin
and did not identify any more cases. The prospective
study by Tedesco et al. ( 1974) identifying PMC in 20 of
200 (10%) consecutive patients receiving clindamycin is
an experience confirmed by some (Kabins and Spira, 1975)
but not by others (Ramirez-Ronda, 1974; Gurwith et al. ,
1977). Bennett et al. (1984) reported cross infection
within a geriatric population where there was no
isolation of the organism from the environment or from
staff. The discovery of C. difficile as a specific
aetiological factor in PMC and other bowel conditions has
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permitted cases which occur under disparate circumstances
to be associated. Consequently medical and surgical
cases, antibiotic-associated outbreaks and clinically
mild or severe cases can all be investigated and assessed
together. When all the reports of C. difficile-
associated disease are looked at what arises is a
persistent flow of reports with grouped or clustered
incidence. Greenfield et al. (1981) described eight cases
in 11 days. This report has been followed by many similar
accounts from centres worldwide, including London (Rogers
et al. , 1981; Haji et al., 1981), the USA (Pierce et al.,
1982) and New Zealand (Ritchie et al., 1982).
What is lacking in all early epidemiological
investigations is a reliable method for typing the
isolated organisms to determine whether or not they are
in fact the same strain. Clearly, if they were found to
be different the case for cross infection would be
substantially reduced. Burdon (1982) recovered a strain
of the organism with distinctive antibiotic resistance
from the majority of patients developing C.
difficile-associated disease while in hospital. This
resistance pattern was uncommon among isolates from other
patients. Another early study (discussed later) involving
typing of isolated organisms was done by Wust et at.
(1982).
Both of these studies pointed to cross infection as the
major method for acquisition of the organism. Now several
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groups have been investigating a variety of methods for
typing of C. difficile which will be discussed in greater
detail in section 4.1.5.
4.1.4. Epidemiological studies of C. difficile in infants
One enigma when considering the epidemiology of C.
difficile-associated disease is the fact that the
organism is a common faecal isolate from healthy infants
yet is rare in healthy adults, is the latter a result of
insensitive culture or is the former a consequence of
exposure of an unusually susceptible population to a
common environmental contaminant?
Some investigators have suggested that diet may influence
the colonization of infants. One group (Cooperstock e_t
al. , 1982; Cooperstock et al., 1983) found that about 70%
of formula-fed infants carried the organism compared to
less than 20% of breast-fed individuals. Of these
strains, about 50% were cytotoxigenic. Stark et al.
(1982) reported earlier colonization of formula-fed
infants and also that such infants carried higher levels
of the organism. However, other reports have shown no
such relationship (Hoist et al., 1981; Brettle and
Wallace, 1982; Richardson et al. , 1983) or even that
breast-fed infants have higher colonization rates (Donta
and Myers, 1982).
It has also been suggested that the organism could be
acquired from the mothers' vagina and/or cervix during
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delivery (Gorbach et al. , 1973; Hafiz et al., 1975).
However, there is general scepticism about this as a
method of acquisiton of C. difficile especially since
many children acquire detectable numbers of the organism
only days or months after birth. The organism is often
isolated from infants while the mother is C. difficile
culture-negative (Hoist et al. , 1981; Larson et al ♦ ,
1982) and although vaginal delivery has been associated
with increased faecal cytotoxicity in infants, the
organism is also isolated from babies delivered by
Caesarian section (Larson et al., 1982).
The available data on the levels of infant colonization
by C. difficile shows considerable variability (Donta and
Myers, 1982; Larson et al. , 1982; Sherertz and Sarubbi,
1982}„ There is now increasing evidence indicating that
the high levels of isolation reported by some groups may
in fact arise as a consequence of person-to-person spread
within hospitals. Given such a situation young children
could subsequently acquire the organism as a result of
their decreased resistance to infection.
Larson et al. (1982) undertook a prospective study in
which 451 newborn infants were screened for the organism.
This group thought that the previously reported high
incidence of the organism in infants might in fact be the
result of cross infection. Two studies at that time
(Hoist et al., 1981; Chang et al♦, 1979) had indicated
that neonatal colonization could be less than 5%. Three
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wards were studied by Larson et al. ( 1982) and
colonization rates were found to range from 2 to 52%
within these wards. Many colonizations were sporadic, but
on two wards there was evidence of clustering. On one of
these occasions prospective environmental sampling
yielded C. difficile from a potential common source.
Among the organisms tested there were cytotoxicity
positive and negative isolates.
Sherertz and Sarubbi (1982) attributed the differing
colonization rates reported in children to nosocomial
spread of C. difficile and suggested that the organism
could serve as a general marker for cross infection in
neonatal intensive care units. It is worth noting that
the variability observed in neonatal carriage of C.
difficile is similar to the apparently sporadic
development of hospital acquired AA-PMC, which again may
point to a role for cross infection in the developement
of disease.
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4.1.5. Typing schemes for C. difficile
As mentioned previously most of the early work undertaken
on the epidemiology of C. difficile-associated disease
has relied on empirically obtained general impressions,
lacking proper scientific evidence, as to the similarity
or otherwise of the strains involved. Epidemiological
studies would be greatly aided if a recognized system
were available to 'type' any organisms isolated. Several
groups have tried different approaches for developing a
suitable, quick and reliable scheme and these are
outlined below.
4.1.5a Antibiotic resistance patterns (antibiograms) and
biochemical typing
A few groups (Rogers et al., 1981; Burdon, 1982) have
attempted to trace the epidemiology of C ♦
difficile-associated infections by determining the
antibiotic sensitivities of the strains isolated.
However, such studies are of limited usefulness since
antibiotic resistance within an organism tends to be
widespread. Bolton et al. (1984) used antibiogram typing
during a study of neonatal colonization but admitted it
was of limited usefulness.
Poxton (1982) arranged 43 C. difficile isolates into
seven different biotypes based on their reactions in six
biochemical tests. Some of these results took a long time
to obtain and some sugars were fermented only weakly.
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Since this work other techniques have been developed
which provide much quicker and clearer definition between
strains.
4.1.5b Use of bacteriophage and bacteriocins
Sell et al. (1983) were able to isolate 10 bacteriophages
and 20 bacteriocins active on C. difficile. Of 254
organisms studied, 132 were found to be susceptible to
phage or bacteriocin. Within the phage sensitive isolates
at least nine distinct groups could be discerned. With
these phages and bacteriocins various isolates cultured
from patients at different times were investigated and
found to be similar while isolates from different
geographic locations were found to vary. It would seem
that this technique has potential as a reliable method
for typing strains.
Wust et al. (1982) compared 16 isolates obtained during a
hospital outbreak of C.difficile-associated colitis by
CIE, TCA, and analysis of plasmid and SDS-PAGE profiles.
Of these isolates 13 resembled each other so closely when
compared they were classed as the same strain although
there were minor differences between some of them. It was
concluded that this strain had been spread by cross
infection during the outbreak. Hachler and Wust (1984)
analysed these same 16 organisms by use of bacteriophage
typing. Ten of the 16 were found to be susceptible to one
particular phage but not to any of the others available.
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The other three isolates originally thought to be the
same strain, were found to be resistant to all of the
available phages and it was concluded that they were
unlikely to have been involved in the outbreak. The other
three strains were also shown to be resistant to all the
phages.
4.1.5c Serum agglutination
Nakamura et al. (1981b) showed that formalin treated
strains of C. difficile could be agglutinated with rabbit
antisera. Delmee et al. (1985) took this approach further
and produced six different agglutinating antisera (in
rabbits) which they used to define six serogroups of C.
difficile. An excellent correlation was found between the
serogroup and sorbitol fermentation by strains. It was
found that certain of these serogroups were isolated from
outbreak cases of AAD involving both adults and children
(A, C and D).. Different serotypes were shown to be
carried by asymptomatic neonates (B, F and G) . Other
epidemiological studies have now been done with this
method (Delmee et al. , 1986; Delmee and Michaux, 1986;
Mulligan et al., 1986). Serogrouping has the potential
for development into a very quick and simple typing
method which would be useful in the diagnostic situation.
However, for such a system to be fully comprehensive, a
wide variety of strains need to be investigated and an
adequate array of antisera produced.
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4.1.5d Use of electrophoresis
i) CIE: Poxton and Byrne (1981b) showed that four
different precipitin lines could be visualised when EDTA
extracted surface antigens of C. difficile were separated
by CIE. It was shown that these lines occurred with
differing intensities in different isolates and it was
thought use of CIE in conjunction with biotyping might
prove useful for studying C. difficile outbreaks. However
this has now been abandoned in favour of other techniques
giving more objective results.
ii) SDS-PAGE: the earlier investigations using this
technique relied upon simple comparison of complex
protein profiles produced by whole cell extracts of
isolates (Cato et al., 1982; Kim et al., 1983). Wexler et
al. ( 1984) examined EDTA extracts of isolates, placing
emphasis on the presence or absence of particular protein
bands within an extract. This approach was also adopted
by Mulligan et al. (1986).
Tabaqchali et al. (1984a) used sulphur-35-labelled
methionine to radiolabel isolates and help differentiate
between strains. This procedure gives rise to patterns of
radiolabelled proteins which can be visualised by
autoradiography. Based on analysis of such gels nine
distinct profiles (labelled A, B, C, D, E, W, X, Y and Z)
were obtained among isolates from an outbreak of C.
102
difficile-associated disease. Like Delmee et al. ( 1985)
certain strains were isolated from asymptomatic neonates
(A to D) while strains isolated from clinical outbreaks
of AAC among adults belonged to groups X and E. Only
five strains out of 250 studied were non-groupable. This
group have continued to use this technique to demonstrate
cross infection and nosocomial acquistion of the organism
(Heard et al., 1986a).
Poxton et al. ( 1984) examined EDTA extracts of C.
difficile isolates separated by SDS-PAGE. Coomassie blue
stained gels were looked at in conjunction with
immunochemical analysis by electroblot transfer
(immunoblotting). In this way it was possible to identify
one strain of C. difficile involved in a hospital
outbreak of C. difficile-associated disease in Sweden and
to differentiate this from several other isolates.
Mulligan et al. (1986) did a comparison of results
obtained by SDS-PAGE of EDTA extracts and bacterial
agglutination of cells to distinguish isolates of C.
difficile. Excellent correlation was found between the
two methods when geographically distinct isolates were
typed without knowledge of their clinical origin.
4.1.5e Whole cell DNA restriction endonuclease profiles
Kuijper et al. (1987) obtained
from C. difficile, free from
subsequently digested with Hind
unsheared chromosomal DNA
plasmid DNA, which was
III. Repeat preparations
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from the same isolates gave reproducible results. The
technique has been used to show that six isolates of C.
difficile (two from patients with PMC; four from
environmental sampling) were identical.
4.1.6. Conclusions from studies done with typing
techniques
It would seem that the introduction of various typing
schemes has further emphasized the possibility that C♦
difficile can be spread from one individual to another in
an epidemic fashion (Heard et al., 1986a; Hawkins et al.,
1984). However, various teams have also found that the
typing of isolates indicates that cross infection (in
their particular studies) has not been important
(Rampling et al. , 1985; Hall et al., 1985). It should be
remembered that any epidemiological investigation
requires confirmation that increases in recovery of the
organism are truJiy the result of an outbreak and not
spurious causes such as better identification schemes or
sudden laboratory interest in the organism (Hall et al.,
1985). For this reason prospective studies are
particularly useful.
Unfortunately, few of these have been reported to date.
Heard et al. (1986a) have published results of one
prospective study involving a large-scale clinical
outbreak of C. difficile-associated diarrhoea. Following
35s-methionine labelling of cells and subsequent
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autoradiography it was shown that this outbreak was most
likely due to cross infection by one particular strain of
C. difficile (type X). This was cultured from 35 of 49
(71%) oncology patients from whom C. difficile was
isolated. In addition 29 patients who were C.
difficile-negative on entry into hospital acquired this
strain during their stay.
In conclusion, it can be said that there is still much
confusion over the relative roles of cross infection
and/or "endogenous infection by C. difficile. Perhaps now
that laboratories are, in general, more aware of the
organism and typing schemes are becoming available more
information will become available on which to try and
base conclusions.
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4.1.7. Aims of this study:
l.a) to assess the antigenic stability of C. difficile
during different growth conditions and EDTA
extraction of surface proteins. As a consequence of
these studies it would be possible to assess the
reliability of immunoblotting for use in differ¬
entiating isolates,
l.b) to produce a set of guidelines for the successful
use of immunoblotting in epidemiological
investigations.
2. to study any 'outbreaks' of C. difficile-associated
disease to assess the importance of cross
infect ion.
It was also hoped to determine whether an
individual could harbour more than one strain of
the organism at any one time.
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4.2. Results
The following studies were done to investigate the
antigenic stability of C. difficile/ both during culture
and subsequent antigen extraction of isolates. The
organisms used in these investigations were isolated from
renal patients involved in an epidemiological
investigation occurring at that time (see section 4.2.5a)
or from other medical patients in the Royal Infirmary of
Edinburgh (RIE). In all studies 25jjg of protein in 50,ul
of double strength sample buffer was applied to each
track of the SDS-PAGE gels. Immunoblots were all probed
with antisera raised against whole cells of NCTC 11223.
<4-
4.2.1. jVariation in phase of growth at harvesting on the
immunoblot patterns produced
With the standard technique organisms are harvested and
antigens extracted with EDTA buffer after 16 to 18h
cultivation (see section 2.19) . For_ this study a 5%
inoculum of MPRL 558 was cultured in PPY and 100ml
amounts were harvested after 2, 4, and 8h. Similarly a 1%
inoculum was harvested after 16, 18, 20, 24 and 40h. All
other conditions remained the same as in the standard
technique during subsequent EDTA extraction.
These extracts were all compared by SDS-PAGE and
immunoblotting. From the subsequent immunoblot patterns
produced (Fig. 4.1a) it can be seen that there was a
107
Fig. 4.1. (a) Imrnunoblot patterns produced by EDTA
extracts of C. difficile MPRL 558
prepared 2 to 40h after inoculation of PPY medium. Tracks
1 to 8 (25;ig of protein per track) contain extracts
obtained after 2, 4, 8, 16, 18, 20, 24 and 40h
respectively. Extracts were probed with antiserum raised
to NCTC 11223 diluted 1 in 250 with antibody buffer,
(b) Corresponding SDS-PAGE profile stained for protein
with Coomassie blue.
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great degree of similarity in the banding patterns. There
were minor variations, especially in the polypeptides
with higher Mrs, but these may in part be due to slight
variations in the amount of protein loaded onto the gel
as seen in the corresponding Coomassie blue stain (Fig.
4.lb) .
4.2.2. Variations in antigen extraction
Another likely source of variation between extracts could
be differences in the actual method of antigen
preparation. Three C. difficile isolates (MPRL 558, MPRL
559 and MPRL 589) were used to investigate the effects of
altering one or other of the parameters usually held to
be constant during preparation of EDTA extracts.
Cultures were harvested, washed and resuspended in EDTA
buffer. These suspensions were then divided into four
aliquots and each was subjected to one of the following
treatments prior to harvesting: (a) 'normal' antigen
extraction at 45°C for 30 min, (b) extraction at 50°C for
30 min, (c) extraction at 45°C for 2.5h, (d)
freeze-thawing (-20°C to 37°C) three times over a period
of 3h and then 45°C for 30 min.
When these extracts were analysed it was found that MPRL
558 and MPRL 559 produced very similar banding patterns
when stained with Coomassie blue. However there were
consistent differences between the isolates in the
immunoblot patterns produced (Figs 4.2a and 4.2b). There
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Fig. 4.2. SDS-PAGE and immunoblot patterns produced by
(a) MPRL 558, (b) MPRL 559 and (c) MPRL 589
after various treatments during EDTA extraction. Track 1:
extraction at 45°C for 30 min, track 2: 50°C for 30 min,
track 3: 45°C for 2.5h, track 4: freeze-thawed extract.
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was a much ' stronger reaction involving the high Mr
proteins in MPRL 559 than occurred with MPRL 558 and this
remained consistent despite the differing treatments
during extraction. MPRL 589 behaved differently. Here the
extract which had been heated for 2.5h produced a blot
pattern which was different from the others in the
mid-region of the track (Fig. 4.2c). Why this occurred is
not clear. With all three isolates the EDTA/freeze-thawed
extracts had more protein bands apparent on the Coomassie
stained gel. However, the immunoblot did not show up
these additional bands indicating that they were probably
intracellular proteins with which the antisera raised
against whole u-v killed bacteria would not react.
4.2.3. Effect of differing periods of development on the
immunoblot patterns produced
Four immunoblots of EDTA extracts of MPRL 832, MPRL 835
and MPRL 840 were prepared and placed into developing
solution. One was removed after 1.5 min, another after
3.5 min, one after 10 min and the final one after 16 min.
It was found that the longer the immunoblot was left to
develop, the stronger the colour of the bands became
(Fig. 4.3). Some bands, not apparent after 1.5 min,
appeared after longer periods of development. Also, the
amount of background staining increased the longer the
blot was left. A Coomassie stain of these same isolates
suggested that tracks 2 and 3 were identical but the
Ill
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Fiq. 4.3. Immunoblot patterns resulting from differing
periods of time in HRP colour development
solution, (a) was left for 1.5 min, (b) for 3.5 min, (c)
for 10 min and (d) for 16 min before stopping
reaction. Tracks 1 to 3 contain EDTA extracts of MPRL 832,
MPRL 825 and MPRL 840 respectively.
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immunoblot shows up subtle differences between the two
isolates. This is not really apparent until after 10 to
16 min development of the blot.
4.2.4. Variations on subculture of the organisms
Having found no major variations in immunoblot pattern
could be accounted for by differences in culture or
antigen preparation, further studies to determine the
stability of an individual isolate both in vitro and in
vivo were undertaken.
in vitro: a CMB culture of MPRL 558 was passaged weekly
into fresh p-r CMB over seven weeks. EDTA extracts were
prepared from each of these by the standard method after
incubation for 24h.
in vivo: a spore suspension of MPRL 558 (100^1 of saline
containing 10 C. difficile colonies from a 72h BA plate)
was administered orally to a female Balb/c mouse known to
be C. difficile-negative after faecal enrichment in CCFB.
Faecal pellets were collected weekly for seven weeks.
Each was inoculated into 10ml p-r CCFB which was
incubated for up to 72h. EDTA extracts were prepared of
the organisms isolated on CCFA.
When the resulting sets of extracts were analysed the
patterns produced were shown to be identical over the
entire period of study(e.g. Fig. 4.4 - patterns from in
vivo isolates).
The only other potential source of variation during this
work was in the composition of the PPY medium used to
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Fig. 4.4. SDS-PAGE and immunoblot patterns produced
by EDTA extracts of MPRL 558 obtained from
faecal pellets of a Balb/c mouse. Tracks 1 and 2 contain
extracts of isolates cultured after 24h and 4 days.
Tracks 3 to 8 are from weeks 2 to 7 respectively.
114
culture the organisms. However, these* studies were done
over a period of four months during which several
different batches of media were used and no variation in
antigenic patterns was observed.
4.2.5. Epidemiological investigations undertaken using
SDS-PAGE and immunoblotting
a) Renal Unit Investigation: C. difficile was isolated
from 18 individuals who were in-patients in the Medical
Renal Unit (MRU) at the r!1e between August 1983 and April
©
1984. Details of these individuals are given in Table
4.1. Two were undergoing haemodialysis (HD) because of
acute renal failure. The other patients had end-stage
chronic renal failure and were receiving maintenance
dialysis either by HD or continuous ambulatory peritoneal
dialysis (CAPD). Diarrhoea was graded severe, moderate or
minimal according to patient interview or observation by
medical staff. Stool specimens from all these patients
were submitted to the laboratory for routine culture of
bacterial enteric pathogens. C. difficile was isolated
and EDTA extracts of surface proteins prepared as
described in section 2.19.
Fig. 4.5 shows the results of Coomassie blue staining and
immunoblotting of SDS-PAGE gels. It can be seen that
there are a variety of protein profiles produced on
staining and that some isolates appear very similar. Use
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TABLE 4.1 Details of patients from whom C. difficile was cultured
Patient Isolate Age Sex Type of Severity of Type of Antibiotics Month of Outcome
(MPRL) (yrs) dialysis diarrhoea infection administered isolation
1 559 61 F CAPD + Peritonitis None July 1983 Resolved
2 558 60 F CAPD +++ Peritonitis Crd,Flu,Tob n n Died
3 560 48 F HD - None None ti n Remained
Well
4 589 15 F CAPD ++ Peritonitis Crd,Tob Aug " Died
5 595 56 F HD +++ Wound Cfx,Met ti n Diarrhoea
Continue*
6 597 59 F HD ++ AV-fistula Flu,Pen n n Resolved
7 604 61 M CAPD + Peritonitis Flu,Met,Tic it n Resolved
8 616 69 F CAPD + Peritonitis Crd Sep n Resolved
9 629 59 M HD + Mastoid Flu,Pen Oct Resolved
10 681 50 M HD + Pericolic
abscess
Crd,Cfx ,Met n n Resolved
11 678 68 F CAPD ++ Peritonitis Tob NOV " Resolved
12 659 71 F CRF + None None Jan 1984 Resolved






14 816 33 F HD ++ Urinary
tract
Cot Feb Resolved




Cfx,Met,Tob it n Died
16 696 64 F CAPD ++ Peritonitis Flu n n Resolved
17 712 60 M CAPD + Peritonitis Flu Mar " Resolved
18 718 66 F HD +++ AV fistula Crd,Cfx,Tob n n Died
Type of dialysis:
CAPD: continuous ambulatory peritoneal dialysis
HD:haemodialysis
CRF: chronic renal failure not yet on dialysis
Symptoms: +++ severe diarrhoea; ++ moderate
diarrhoea; + minimal diarrhoea; - no diarrhoea
Antibiotics administered:
Amp: ampicillin Gen: gentamicin
Cfx: cefuroxime Met: metronidazole
Cot: co-trimoxazole Pen: benzylpenicillin
Crd: cephradine Tic: ticarcillin
Ery: erythromycin Tob: tobramycin
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Fig. 4.5. SDS-PAGE of EDTA extracts from the 18 strains
of C. difficile isolated from the MRU patients
listed in Table 4.1. (a) stained with Coomassie blue and
(b) corresponding immunoblot probed with antiserum to
NCTC 11223.
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of the immunoblotting technique (Fig. 4.5b) confirmed
that at least 13 distinct profiles were produced. The
same pattern was produced by isolates from five
individuals (Nos 12, 13, 14, 15 and 18). The first four
of these patients had been in the MRU at the same time;
patients 15 and 18 subsequently died although they were
both severely debilitated because of pre-existing medical
conditions (ischaemic bowel and polyarteritis nodosa
respectively).
Another strain was isolated from two patients (Nos 7 and
11); the strains isolated from patients 1 and 2 were also
very similar on the Coomassie stain but there were
consistent differences in the immunoblot patterns
produced especially with the high Mr proteins.
Having established that a variety of strains was involved
in this outbreak of C. difficile-associated disease in
these patients a further study was set up to find whether
two or more different strains might co-exist in the gut
at any one time. Two faecal samples were used (X and Y),
both from MRU patients who had not been included in the
original study. C. difficile (MPRL 720 and MPRL 808) had
been isolated from these specimens previously. The
patients had also had the organism isolated from them on
two other occasions.
Ten separate colonies were picked from a primary CCFA
isolation plate and EDTA extracts prepared from each of
these. Eight of the extracts produced from C. difficile
lib
colonies isolated from sample X gave two distinct
profiles (Fig. 4.6). One of these profiles (in tracks 1,
2, 3, 6 and 7) corresponded to that produced in a
previous gel by MPRL 720. All 10 extracts from sample y
were run and one of those was shown to be different from
the others. Both patterns produced were different from
two other strains also isolated from this patient on
other occasions.
4.2.5b Investigation of Dutch Isolates: Six isolates of
C. difficile were sent to the laboratory from Amsterdam
where they had been isolated from a suspected 1-caoo of
cross infection between two patients (Table 4.2).
Both of these patients had received metronidazole,
tobramycin and ampicillin although we were informed that
the isolated organisms were sensitive to the last of
these. Patient A had PMC (as diagnosed by colonoscopy);
patient B had fever, abdominal p.ain and watery diarrhoea
but no sign of pseudomembranes. When examined by
immunoblotting it was apparent that all these isolates
were the same. It is therefore entirely possible that
they could have been transmitted between the patients. It
was noted at the time of isolation of these organisms
that there was no increase in rate of isolation of C.





of EDTA extracts prepared from 8
colonies picked from a CCFA primary
plate, (a) SDS-PAGE, (b) immunoblot.
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TABLE 4.2
C. difficile isolates from Amsterdam
Isolate Source Date of Isolation
MPRL 1169 Patient A 2nd April 1985
MPRL 1170 Patient B 4th It ft
MPRL 1171 floor 8th It It
MPRL 1172 telephone 8th it If
MPRL 1173 floor 17th n It
MPRL 1174 floor/corridor 24th it tt
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4.2.5c Investigation of Irish isolates: We were sent 11
organisms which had been isolated from patients suffering
from PMC in three Dublin hospitals (see section 2.1. -
list of bacterial strains). The isolates were obtained
over a period of 12 to 13 months. Cross infection between
patients was a possibility since there were frequent
transfers between the hospitals.
When analysed four of these isolates were found to be
identical (tracks 1 to 4, Fig. 4.7, containing MPRL 1244,
MPRL 1245, MPRL 1246 and MPRL 1247). The two strains in
tracks 7 and 8 (MPRL 1250 and MPRL 1251) were also shown
to be the same. The isolate in track 11 looked very
different from the others on the Coomassie stained gel
and there was no reaction apparent on the immunoblot. The
extremely high contrast film used for the photography
actually gives a false impression of the reaction. When
its biochemical and fermentation patterns were checked it
was found that this isolate was in fact a Clostridium
butyricum.
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Fig. 4.7. SDS-PAGE of EDTA extracts from 11 Irish
isolates (a) stained with Coomassie blue and
(b) the corresponding immunoblot.
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4.3. Discussion
The immunochemical fingerprinting of C. difficile
isolates described here has been used in this laboratory
over the past three years to study various outbreaks of
disease with which the organism has been associated. The
first investigation involved a study of 28 isolates of C.
difficile sent from Sweden (Poxton et_al. , 1984). Some of
these were from an outbreak of AAD in a hospital; others
from random cases of AAD throughout the country. By use
of SDS-PAGE and immunoblotting it was possible to
demonstrate the existence of a common strain within the
hospital where the outbreak had occurred. The results of
this study (in which the isolates had been examined
without prior knowledge of their origins) indicated this
technique might prove useful in tracing the epidemiology
of C. difficile-associated disease.
Since this study questions regarding the level of
reproducibilty of the immunoblot patterns produced from
one study to the next have arisen. It was noticed that
minor variations could occur between blotting patterns
produced by different clinical isolates. The assessment
of whether these differences were due to real variations
between strains or if they arose due to differences in
growth conditions or in antigen extraction methods
required investigation.
It is apparent from the work done here that the antigenic
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nature of any particular isolate of C. difficile will
remain constant when analysed by this technique. The only
major difference observed with an isolate was when MPRL
589 was left to incubate for an extended period during
antigen extraction. It might be that the protein involved
was altered by the prolonged exposure to EDTA.
Variations in the amount of protein loaded onto gels (as
detected by Coomassie blue staining) can lead to
difficulties in interpretation of immunoblot patterns;
faintly staining bands often fail to show up properly on
immunoblotting. However, provided care is taken, these
minor problems do not detract from the usefulness of the
technique. Below is a set of guidelines for the
successful use of immunoblotting in epidemiological
investigations .
4.3.1. Recommendations for successful use of
immunoblotting in epidemiological studies
1) Pick several colonies - at least 10 - from the primary
isolation plate in case the patient is carrying more than
one strain of the organism.
2) A standardised technique should be used for culture
and preparation of the EDTA antigen extracts. In this
laboratory cells are incubated for 30 min at a
temperature of 45°C although minor variations in this do
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not appear to matter. Since different strains may vary in
their sensitivity to changes during antigen extraction it
is best to keep to a well-defined regimen. Freezing and
thawing during the EDTA extraction procedure releases
more protein: this complicates the Coomassie blue
pattern, adds nothing to the immunoblot and should be
avoided.
3) Only compare EDTA antigens run on the same gel. It is
difficult to compare one gel with another as it is
impossible to reproduce running conditions accurately.
4) When analysing SDS-PAGE and immunoblot patterns minor
variations should be overlooked if the general picture
arising is of similarity between strains.
5) Conclusions should be drawn with information provided
by both the Coomassie blue-stained gel and the immunoblot
since some patterns that appear similar on the blot can
appear quite different on the gel and vice-versa. The
advantage of doing an immunoblot as well as a Coomassie
blue-stained gel is that the blot is simpler and easier
to read.
The Coomassie stain and the immunoblot patterns do vary
considerably from one isolate to another although one or
two major bands (as well as several minor ones) are
1 I, fc>
common to all. Some of the major bands staining in
Coomassie blue gels are stained by the test antiserum
whilst others are not; this is also true for the minor
bands. In these studies the variations in staining of the
bands can be seen by comparing the patterns produced in
Fig. 4.1 and in Fig. 4.6. In Fig. 4.1 the major Coomassie
blue-stained bands are also immunogenic, while in Fig.
4.6 only one of the major Coomassie blue-staining bands
reacts strongly on the immunoblot and most of the
staining on this is due to minor bands. A more detailed
study of surface proteins and antigenicity is discussed
in Chapter 5.
It would have been interesting to compare the results
obtained by use of immunoblotting with other typing
techniques. I did attempt to radiolabel all the strains
involved in the renal unit investigation with
35s-methionine as described by Tabaqchali et al. ( 1984).
However, although this was repeated several times
(including leaving the cells in contact with the
radioisotope for 2.5 times the suggested period) there
was no incorporation of the radiolabel into the cells. On
developing the autoradiography only the sample buffer
front was visible. This must be attributed to variations
in our methodology which did depart from the details in
the original manuscript.
Of the methods currently available for typing of C.
difficile the most applicable to the diagnostic situation
must be either serum agglutination or phage typing.
However for both of these to be successful (either
diagnostically or in research) a defined battery of sera
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would be required or phages isolated. For research
purposes, where more time is usually available,
immunoblotting appears useful for providing a comparison
between isolates. It does not require the use of special
facilities (as does radiolabelling) and most laboratories
will possess PAGE equipment and blot tanks can be easily
constructed in the laboratory. Also, only one antiserum
is required for all studies. However, it must be borne in
mind that as a consequence of immunoblotting with only a
limited selection of antisera, it is not possible to
fully 'type' isolates. Immunoblotting used in this manner
will only provide a guide to the similarity or otherwise
of isolates. It cannot completely characterize them.
The three epidemiological studies described here (as well
as several others that I have also been involved in) have
provided no definite answer to the question of whether or
not C. difficile is an endogenous pathogen or has an
environmental source. Unfortunately, no environmental
swabs were taken in the'MRU during the period of their C.
difficile-associated problems. This was a retrospective
study and by the time it was undertaken the actual
problem had disappeared. The results of the Amsterdam
study could point to cross infection between the patients
although it is also possible that they both carried this
strain normally and both were ■ shedding it into the
environment.
The MRU outbreak of C. difficile-associated diarrhoea
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appears to have been a true phenomenon as the organism
had previously been isolated only very infrequently from
this unit. Cross infection was thought to be the likely
mode of infection as isolation of patients was limited by
lack of space and the specialised nursing that dialysis
requires. There were two previous reports of C. difficile
being isolated from cases of AAD in renal patients
undergoing treatment by either HD or CAPD (Ritchie e_t
al. , 1982; Gokal et al. , 1982). In both of these cross
infection was considered to be very likely although no
typing of isolated organisms was undertaken. The five
patients from whom the same strain was isolated in our
study were probably cross infected; all were nursed in
one of two adjacent cubicles, the first four within one
month. The isolation of 13 different strains of C.
difficile would, however, tend to exclude cross infection
as the major mechanism by which C. difficile was acquired
during this outbreak.
Fifteen of the 18 MRU patients had received or were
receiving antibiotics at the time of C. difficile
isolation. Of these, eight had been given cephalosporins.
CAPD patients, in particular, tend to be given these
broad-spectrum agents since many organisms can cause CAPD
peritonitis and treatment often has to be instituted
before dialysate culture results are known (Vas, 1983).
Renal patients, in general, are prone to infections often
requiring treatment with antibiotics. Contributing
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factors include relative defects in cellular (Collart _et
al., 1983) and humoral (Bommer et al., 1983) immunity in
uraemia, abnormal nutritional status (Kopple and Jones,
1979), regular cannulation of arterial fistulas and the
the presence of foreign bodies (external arteriovenous
shunts, peritoneal catheters). On the basis of experience
it was recommended to the MRU physicians that it would be
best to maintain as narrow a spectrum of antibiotic
therapy as possible and to avoid the use of oral
antibiotics which could have a more disruptive effect on
gut flora than those given by other routes. The use of
oral cephalosporins has now been discontinued for
peritonitis in the MRU and since April 1984 the rate of
isolation of C. difficile from patients has remained low
and AAD has not been a major problem.
These findings suggest that cross infection with C.
difficile may occur in patients receiving dialysis,
although it is not always the major mechanism of
acquisition of this organism. It would be unwise to
abandon standard measures against cross contamination,
and it should be appreciated that patients undergoing
dialysis may be particularly prone to infection with C.
difficile.
The isolates received from Amsterdam were all found to be
similar. This finding was confirmed by both Tabaqchali
(with 35g-methionine labelling) and Kuijper (restriction
endonuclease analysis of DNA - Kuijper et al., 1987). We
were not given many details about the precise origin of
the isolates sent from the Dublin hospitals but in the
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subsequent correspondence received (from Dr. H.
Humphries, St. James's Hospital, Dublin) it seemed that
some of the strains may well have been acquired by cross
infection.
CHAPTER 5
VIRULENCE FACTORS OF CLOSTRIDIUM DIFFICILE: THE ROLE OF
THE BACTERIAL CELL SURFACE
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5.1. Introduction
Since C. difficile may be present in the GI tract of
persons remaining healthy despite receiving antibacterial
therapy, or even in patients who have not received such
agents, it seems clear that some additional factor or
factors must be necessary for disease to occur. Some of
the most obvious candidates for having a potential role
in the development of disease symptoms are discussed
below.
5.1.1. Levels of C. difficile in the GI tract
Although evidence is conflicting, the severity of disease
developing does not appear to correlate purely with the
number of organisms present in the gut. Viscidi et al.
(1981) found isolation rates of C. difficile from
patients with AAD (104-® per gramme faeces where TCA
results were negative and 105-6 where TCA was positive)
were comparable to isolation rates in antibiotic
recipients without diarrhoea (10^*^). Nakamura et al.
(1981a) found some healthy individuals harboured C.
difficile at concentrations about the same or even higher
than the mean level of 10^*8 per gramme faeces reported
in patients with PMC (Willey and Bartlett, 1979). The
organism can also be isolated from healthy infants at
levels between 10^ and 10? per gramme faeces (Stark e_t
al., 1982).
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5.1.2. Toxins of C. difficile
Initially, investigators studying the role of toxin in C.
difficile-associated disease attempted to correlate
cytotoxic activity (as determined by TCA) of what was
believed to be a single cytotoxin, with disease severity
(Bartlett, 1979; Bolton, 1982). However it is now
apparent that all studies published prior to 1981, as
well as some since then, were most probably performed
with crude extracellular preparations containing a
mixture of toxins.
At the present time, four toxins which may be of
potential relevance in the pathogenesis of C.
difficile-associated disease are known (see section
1.1.3.). Most recent work however, has concentrated on
studying two of these toxins, toxins A and B.
5.1.2a Toxin B
This is a potent cytopathic toxin with a cytotoxic
activity 1,000 to 10,000 times greater than toxin A
(measured on a weight basis with highly purified
preparations - Taylor et al. , 1981; Sullivan et al. ,
1982; Banno et al. , 1984). Since it is so much more
cytotoxic than any of the other toxins and as a
consequence of investigators assuming that any strain
producing toxin A would always produce B (in the same
ratio - Libby and Wilkins, 1982), it has generally been
considered that any TCA would detect only toxin B, the
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cytopathic effect of A being masked by B.
Haslam et al. (1986) have now shown that the toxins can
be produced independently. The relative proportion of
toxins A and B produced by any particular strain is very
much influenced by the composition of the medium used to
culture the organisms. Autoclaving in particular was
shown to drastically alter the ability of media to
support toxin production. As discussed in section 3.3
this makes the correlation of toxicity values obtained in
vitro, with the situation in vivo, practically
impossible.
Various investigators did show large differences in the
incidence of and cytotoxigenic potential of C. difficile
isolates associated with disease (Burdon et al. , 1981a;
Bartlett and Laughon, 1984; Riley et al. , 1986). Bartlett
(1981b) found 100% of specimens from 329 patients with
AAD or AA-PMC contained cytotoxic activity in TCA and
that there were considerable strain variations in the
toxic effect produced (yiscidi et al., 1981). Analysis of
isolates from cytotoxicity-positive specimens showed a
crude correlation between the TCA titres in the stools
and those produced in vitro by the strain recovered, an
observation not borne out in a similar study by Borriello
and Larson (1981). Neither the cytotoxigenic potential of
a strain nor the cytotoxic titre in the stool was found
to correlate well with severity of clinical disease
(Brettle etal., 1982, Burdon etal. , 1981b; Trnka and
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LaMont, 1984).
A study by Onderdonk et al. (1979) showed 100 to 1000
fold increases in TCA titres obtained when chemostat
cultures of C. difficile were subjected to a variety of
adverse conditions including an increased Eh (-360mV to
+100mV), increased temperature (37°C to 45°C) or the
addition of sub-MICs of vancomycin and penicillin. It was
speculated that similar alterations in the gut, induced
by antibiotics, might prove important in the development
of disease.
5.1.2b Toxin A
It has been suggested that toxins A and B are one and the
same thing. However, by use of specific antisera to each
of the toxins, it has been demonstrated that they are
separate entities (Lyerly and Wilkins, 1984; Taylor et
al. , 1981; Libby and Wilkins, 1982). Since the weak
cytotoxic activity of A cannot be neutralized by
antiserum specific for B, this effect is considered not
to arise due to contamination with B. Also,-Lyerly et al.
(1986) have examined peptide digest maps of both toxins
and no significant homology has been found.
Toxin A may be separated from B by ion-exchange
chromatography and further purified by acetic acid
precipitation (Sullivan et al., 1982) or PAGE (Taylor et
^—al. , 1981). Highly purified preparations (as indic/ted by
a single band on PAGE) have been achieved. This is in
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contrast to B where PAGE of the best preparations usually
shows multiple bands, each containing cytopathic
activity. It may be of course that these are merely
different forms of the same toxin (Lyerly et al., 1986).
5.1.2c The potential role of C. difficile toxins in
disease
Following discovery of toxin A, investigations to assess
the possible role of this in the pathology of disease
have been undertaken by many groups. In contrast with
Vibrio cholerae and Escherichia coli labile enterotoxins
which induce fluid accumulation with no tissue damage
(Elliot et al. f 1970; Moon et al. , 1971), toxin A of C.
difficile causes fluid accumulation with mucosal damage
in several animal species. These include Syrian hamsters
(Bartlett et al. , 1978b; Chang et al., 1978; Ebright et
al., 1981; Libby et al., 1982), guinea pigs (Rothman,
1981), rabbits (Regh and Pakes, 1982; Banno et al., 1984)
and mice (Banno et al., 1981; Taylor et al., 1981; Lyerly
et al., 1982). Recently, it has- also been reported that
treating prairie dogs with cefoxitin resulted in
isolation of C. difficile and production of
pseudomembranes (Muller et al., 1987). Upon sacrifice,
all these animals are invariably found to have
haemorrhagic ileocaecitis. The toxin also causes
increased vascular permeability in guinea pig skin
(Taylor etal., 1981).
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A detailed study by Mitchell et al. (1986) provided
results that may prove useful in interpreting the
clinical syndrome seen in the majority of patients with
C. difficile-associated disease. When rabbit ileal and
colonic loops were treated with purified toxin A it was
found that fluid accumulating in colonic loops contained
less protein and was less bloody compared to that in
ileal loops. As most patients with C. difficile disease
excrete mainly watery stools (few contain blood) this
would indicate major colonic involvememt in the disease
process. Other patients (with no immediate previous
history of diarrhoea) can show evidence of damage to the
colonic mucosa. From Mitchell's work (1986) it was shown
that tissue damage could occur prior to induction of
fluid secretion. This might indicate that patients from
whom C. difficile is isolated, who do not have diarrhoea,
might still have sub-clinical bowel damage.
This group also found that purified toxin B had no effect
on ileal or caecal tissue. Lonnroth and Lange (1983)
reported that toxin A on its own caused a clear and
watery hypersecretion in mouse intestinal loops but that
both A and B were required to produce haemorrhagic
hypersecretion in rabbit ileum and hamster caecum. These
results are in contrast to the data of other workers
(Taylor et al. , 1981; Lyerly et al. , 1982; Mitchell et.
al. , 1986) who report homogenous toxin A to cause
haemorrhagic secretory responses. It might be that these
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differences arise due to the use of differing animal
models .
It does appear that the continuing belief that toxin B is
the major factor involved in C. difficile-associated
disease is becoming rather tenuous. Libby et al. ( 1982)
did report that effective protection against
clindamycin-induced caecitis was only achieved after
immunization against both toxins A and B. Toxin B has
been shown to be lethal when given parenterally in
several animal species (Arnon et al. , 1984; Libby et al.,
1982). However the work by Mitchell et al. ( 1986) and
others (Taylor et al. , 1981; Lyerly et al. , 1982) would
indicate protection against A to be sufficient. The need
sV>ov»iru
for co-protect ion I by Libby et al. (1982) may have arisen
since only partially purified toxin B was used. This
being the case, the pathogenic effects observed might
have been due to very small quantities of toxin A still
present in the preparation.
Honda et al. (1983) tested the effects of clindamycin,
cephaloridine and tetracycline on the production of toxin
A by one C. difficile strain. It was found that
clindamycin and cephaloridine stimulated toxin A
production by 8 and 16 fold respectively - a very
interesting finding considering the established
involvement of these agents in disease.
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5.1.2d Isolation of cytotoxic C. difficile from healthy
infants
About 50% of the C. difficile strains isolated from
healthy infants are cytotoxigenic in vitro and crude
faecal filtrates give positive TCA results (Chang et al.,
1979; Hoist et__al., 1981; Bolton et al. , 1984). Some
studies indicate that the cytotoxigenic potential of
those isolates is low compared with isolates from
symptomatic adults (Bolton et al., 1984) suggesting
reduced pathogenicity. However others (Viscidi et al. ,
1981) have reported no differences between such isolates.
It has been suggested that maternal antibody (igA)
secreted in colostrum may provide a protective effect
against toxin (George and Hartley, 1983; Kim et al. ,
1984). George and Hartley (1983) reported that serum
antibody titres against cytotoxigenic culture filtrates
of C. difficile were high in 8 of 57 (14%) pregnant women
compared to non-pregnant individuals. However this is
rather a low percentage on which to base any conclusions.
Increased faecal cytotoxicity levels have been detected
in breast fed infants (Donta and Myers, 1982). It could
be that colonisation in infancy is desirable, perhaps
inducing subsequent protection via some local immunity.
This might explain the low incidence of childhood disease
and the variable course of the disease in adults.
It may be that infant gut lacks receptors for
difficile). Cooperstock et al. (1985) suggested that the
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organism might cause subtle mucosal pathological changes
that were not clinically apparent. A recent report by
Chang et al. ( 1986) suggested that the apparent
resistance of infantile intestine to C. difficile toxins
might be related to the nature of intestinal cells rather
than intraluminal factors. It was shown that both human
amnion (epithelial) and chorion (fibroblasts) cells were
relatively insensitive to both toxins A and B during the
first week of culture in vitro. As the cell cultures grew
older, both types of cells gradually gained
susceptibility to the toxins./ It was also found that
foetal intestinal mucosal tissue did not absorb toxin A
or B when exposed, while adult mucosa did so readily.
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5.1.3. The bacterial cell surface
To initiate an infection, any potential pathogen requires
the ability to associate with particular target cells
within the host animal. Having established itself, it
will then have to be able to defend against any immune
response generated as a result. In fulfilling these
requirements, particular components of the bacterial cell
surface will be involved to a greater or lesser extent.
Very little work has actually been done on the cell
surface of C. difficile (or indeed any other
Gram-positive anaerobic rod). The basic components that
make up the Gram-positive cell envelope are shown
schematically in Fig. 5.1. What is known about some of
these components in C. difficile is discussed below.
5.1.3a capsule: when observed by phase contrast
microscopy in wet india ink C. difficile is seen to
possess a small capsule. This contains both carbohydrate
and protein in a ratio of 1.0 : 1.8 (Byrne, 1982).
5.1.3b protein layer: Kawata et al. ( 1984) demonstrated
that the cell wall of C. difficile was composed of an
inner and an outer wall layer (OWL). This OWL was
composed of a regular array of protein subunits, the
centre-to-centre spacing between individual subunits
being about 8.2nm. This layer projected inwards from the









(Courtesy of Dr. I.R. Poxton)
r
^ cross-li-nking peptide chain
phospholipid
membrane-associated proteins
Fig. 5.1. Schematic representation of the Gram-positive
cell envelope.
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proteins. Of 11 isolates studied, nine had regular arrays
made up of proteins with Mrs of 45 to 47kDa and 32kDa.
The other two contained proteins with Mrs of 42kDa and
38kDa.
Similar protein layers have been observed on the walls of
other clostridial species where they may be linear (C.
novyi, C. tetani, C. botulinum - types A and E),
tetragonal (C_. sporogenes ) or hexagonal ( C .
thermohydrosulfuricum) in arrangement (Wecke et al.,
1974; Takagi et al. , 1965; Takumi and Kawata, 1974; Betz
and Zeikus, 1968; Sleytr, 1975). Very little is known
about the functions of this layer although various
suggestions have been made. It could be there as a
protective layer against external influences or as a
diffusion barrier. It has also been suggested that the
layer helps retain toxins within cells (Wecke et al.,
1974) .
5.1.3c cell wall: the basic polymer of the cell wall is
peptidoglycan. This consists of parallel polysaccharide
chains made up of repeating units of N-acetyl glucosamine
and N-acetyl muramic acid which are covalently linked by
peptide side chains to form a continuous covalently bound
structure around the cytoplasmic membrane and accounts
for between 50 to 80% of the Gram-positive cell wall.
The secondary wall polymers, such as teichoic acids and
teichoic acid-like polymers have been isolated from the
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cell walls of some Gram-positive genera. In many
instances these polymers are antigenic and are the
species-specific antigens (e.g. in streptococci). They
can account for up to 50% of the weight of the cell wall
(Baddiley, 1972). There are many variations on the basic
structural pattern of these polymers although they were
originally defined as polymerised polyol phosphates,
often with side chains of mono- or oligo-saccharide units
and also ester-linked D-alanine residues (Rogers et al. ,
1980). Poxton and Cartmill (1982) isolated a
carbohydrate-based antigen from C. difficile that
appeared to be an analogue of teichoic acid. This
consisted of glucose, mannose, galactosamine and
phosphate in the approximate molar proportions of 2.0 :
0.65 : 1.0 : 0.63.
Proteins are also present as part of the cell wall but
few have been purified and identified. This is because
the routinely used methods for purifying cell walls (e.g.
boiling 2% SDS, aqueous 80% (w/v) phenol at 0°C) destroy
proteins. Milder extraction methods will release only
non-covalently bound peptides. Proteases and nucleases
can be used to extract covalently bound proteins without
denaturation although non-covalently bound material is
also likely to be removed.
5.1.3d cytoplasmic membrane: a major membrane polymer of
many Gram-positive bacteria is the membrane teichoic
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acid, also known as lipoteichoic acid (LTA). This polymer
can contribute significantly as a surface antigen. Poxton
and Cartmill (1982) extracted such a polymer from
disrupted cells of C. difficile by use of phenol. This
was found to contain glucose, glucosamine, phosphate and
fatty acid in the approximate molar proportions of 2.0 :
1.0 : 1.6 : 0.04. Both this antigen and the teichoic acid
analogue showed partial immunological identity and both
cross-reacted with C. sordelli antiserum.
5.1.4. The potential role of cell surface components in
virulence
a) Motility
Motility has been associated with the virulence of
certain bacterial pathogens e.g. V. cholerae(Guentzel and
Berry, 1975); Pseudomonas aeruginosa (Holder et al.,
1982). From these studies it was found when the motility
of these organisms was impaired genetically or
immunologically their virulence was reduced. Bacteria
that become non-motile or non-chemotactic may have a
reduced ability to locate near, adhere to, or penetrate
into host tissues; early steps in many disease processes
(Savage, 1980; Freter et al ♦ , 1978).
When viewed microscopically C. difficile has
characteristic motility, especially when grown in CMB.
With EM, numerous flagella can be seen covering the
surface of the organism; these appendages may well be
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important in facilitating association of the bacterial
cell with the gut mucosa.
5.1.4b Adhesion
Adherence of microorganisms to surfaces has gained
increasing attention as an important initial event in the
pathogenesis of bacterial infection; it has been shown to
be a crucial step in the production of disease for most
of the well-studied enteropathogens (Ofek and Beachey,
1980). This association is essential for at least three
reasons: (1) to resist the cleansing action of solutes of
the mucosal surfaces, such as mucus in the gut (Attridge
and Rowley, 1983); (2) to promote the attachment to
target tissues within the host that are distant from the
point of entry (e.g. in shigellosis - Labrec et al. ,
1964) and (3) to deliver toxins in higher concentration
to receptors in cell membranes. Attachment has been shown
to enhance the virulence of Gram-negative toxigenic
enteropathogens such as V. cholerae(Schrank _and Verway,
1976), Campylobacter jejuni (Lee et al. , 1986) and E.
coli (Jones and Rutter, 1972). Most adhesion studies with
Gram-positive organisms have been done with staphylococci
and streptococci (Shibl, 1985) and have concentrated on
the role of teichoic acid and/or LTA (Ofek et al., 1975;
Aly et al., 1980; Carruthers and Kabat, 1983).
When discussing bacterial adherence it is vital to
differentiate between actual attachment to specific
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receptors on cell surfaces and 'association' with, for
example, the mucus covering these cells. In the gut this
layer can act both as a promotor of attachment or as an
inhibitor (Freter, 1982). Borriello and Barclay (1985)
claimed to have demonstrated adhesion of C. difficile
following recovery of about 10^ organisms per gramme
colonic mucosa (hamster) after extensive washing.
However, this study failed to differentiate between true
attachment and simple association with mucus. Barer
(1984) investigated various methods for studying
attachment of C. difficile to various types of cells in
aerobic conditions. No evidence for association could be
demonstrated when the organism was put in contact with
resected human colon or buccal epithelial cells. However,
preliminary results with intestinal cell monolayers
suggested that some sort of attachment was occurring. It
took at least 90 min for significant increases in the
number of bacteria associating with cells to occur;
thereafter levels continued to rise. It was also
suggested that it was important for the cell substrate to
-to Via—
be viable but perhaps not so important for bacteria/
viable.
Studies with other Gram-positive bacteria (Streptococcus
cc os
pyogenes, Sj. aureus) have indicated that LTA may be
implicated in the adhesion of these organisms to cell
surfaces (Ofek et al. , 1975; Carruthers and Kabat, 1983).
Ofek etal. (1975) examined various surface components of
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S. pyogenes and found that only LTA was able to inhibit
competitively the adhering properties of the organism to
any significant degree. Treatment of the organism with
diluted antiserum to LTA blocked its binding to
epithelial cells. LTA is also thought to contribute to
cell surface hydrophobicity (Miorner et al. , 1983) It was
suggested that LTA molecules on the bacterial surface
could allow bacteria to approach the negatively charged
epithelial cells, thereby enabling special binding
molecules on each of the cell surfaces to interact with
each other to form specific bonds of high affinity.
Carruthers and Kabat (1983) showed that inhibition by LTA
was lost after deacylation of the preparation, perhaps
indicating that fatty acid molecules are essential to
binding.
A recent study by Wood-Helie et al. (1986) indicated that
the surface of C. difficile (at least the nine strains
studied) may be hydrophobic. All these strains showed
pronounced adhesion to human embryonic intestinal cells
and adult colon cells, with no significant difference in
the percentage adhesion. It was found that viable
bacteria were required for adhesion to both cell lines.
Sub-MIC concentrations of antibiotics can affect the
adherence properties of microorgansims in various ways
(Shibl, 1985). They can inhibit the expression of
fimbriae and the synthesis of other surface components;
they may also cause the release of cell constituents. The
14b
ability of antibiotics to affect the properties of
microbial adherence to cell surfaces may be an important
criterion in selecting an antibiotic for therapy; the
adherence of some bacteria appears to increase after
exposure to antibiotics (Vosbeck et al., 1982). Since the
pathogenicity of C. difficile is usually associated with
antibacterial therapy this might be a useful area for
further studies.
5.1.5. Host defence mechanisms
Variation in immune response to C. difficile infection is
another factor that might explain differences in host
susceptibilty to disease. Early reports on antibody
levels in patients are limited to two case reports where
neutralizing serum antibodies to the cytotoxic effects of
C. difficile were demonstrated in TCA (Fairweather et_
al., 1980; Lishman et al., 1981b). Lishman et al. (1981b)
reported formation of neutralising antibody in serum from
one patient with AAD and also from a healthy control
subject. They suggested that the ability of patients to
produce neutralising antibodies could affect the severity
of disease and might also give protection against further
exposure to C. difficile. Nakamura et al. (1981a) found
cytotoxicity-neutralising activity in the sera of many
young adults and, less commonly, in that of elderly
persons. The fact that c. difficile appears to be more
common in healthy Japanese adults than in Western
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populations (Larson et al., 1978) might account for these
differences in antibody formation.
Viscidi et al. ( 1983) detected toxin A antibody (by
ELISA) in 64% of healthy individuals over two years of
age and in 19% of those under 2 years. Antibody to toxin
B was detected in 66% of those older than six months and
in 33% of those less than 6 months. A strongly positive
ELISA value for antibody to either toxin correlated
closely with the presence of cytotoxicity-neutralizing
antibody to the particular toxin being tested (either A
or B). Strongly positive ELISA values were obtained more
commonly in convalescent sera from 16 patients with C.
difficile-induced colitis than in sera from control
populations. Testing of paired sera revealed significant
increases in the titre of igG antibody to toxin A or B.
There was, however, no evidence for a protective effect
in view of the fact that relapse was not uncommon,
s
Aronjfison et al. (1983) did a similar study, investigating
antibody levels in AAD and AA-PMC patients. nineteen of
33 (57%) serum samples from patients with AA-PMC
contained antibodies (IgG) to toxin B; one contained only
igA. Twelve of 28 (43%) samples from patients with AAD
also contained IgG against toxin B. In neither group was
there a response to toxin A. The pronounced difference in
antibody levels to toxin A in these two studies is in
s
part due to the fact that Aronj/son et al. (1983)
determined a base line titre (A405 x dilution factor)
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equal to 200 for EL ISA responses in the control
population against which all the other titres were
calculated. Thus, their control population showed only 7%
of individuals with serum antibody against toxin B and
no-one with anti-toxin A even although there had been a
response (less than 200) in the ELISA test.
£
A further study by this group (Aroniison et al. , 1985a)
has indicated a correlation between clinical recovery
without relapse of C. difficile-associated diarrhoea and
high igG titres to toxin B in ELISA and/or neutralising
antibodies: 44% of patients had antibody to toxin B and
11% to toxin A. The strong effect of toxin A on the gut
as demonstrated by ELISA or neutralising assay
determinations during animal experiments (Libby et al.,
1982), indicates that it may have a major role in
disease. The reported lack of antibody response in serum
could reflect low toxin production in the gut, or that
there is insufficient absorption from the gut. It may
also be that the toxin is only weakly immunogenic in
humans. Lack of an IgM response might reflect earlier
exposure to the antigen (e.g. in childhood) resulting in
a secondary type of response without IgM antibody
format ion.
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5.1.6. Aims of this study;
1. to isolate and study by immunochemical methods-
a) the carbohydrate molecules associated with both
the cell membrane and cell wall of C. difficile
b) the cell wall proteins
c) the flagella
2. to assess the potential role of any of these
molecules in virulence.
3-. to determine the ability of C. difficile to
adhere to gut mucosa.
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5.2. Results
5.2.1. Immunochemical characterization of the cell
surface of C. difficile
a. Studies of the cell membrane carbohydrate antigen
Crude aqueous-phenol-extracted membrane carbohydrate
antigen was prepared from four C. difficile strains -
NCTC 11223, MPRL 161, RIE 11831 and MPRL 597. Similar
extracts were also prepared from C. sordelli NCTC 8780,
C. bifermentans NCTC 506 and C. irregularis NCTC 11830.
The yield of this material from 61 of culture is shown in
Table 5.1.
The C. irregularis had not grown very well when harvested
and the carbohydrate extracted from it was found to have
a different consistency from all the other preparations
which were white and fluffy. The C. irregularis extract
was cream in colour and much more powdery.
These crude extracts were separated by SDS-PAGE and
stained with silver. The results (Fig. 5.2) show that the
patterns produced by the C. difficile strains all appear
as regularly spaced ladder patterns. The patterns
produced by the other three species were indistinct, and
even when twice as much material was applied to the gel
no ladder pattern was demonstrated. Immunoblots of the C♦
difficile extracts probed with antiserum to NCTC 11223
revealed faint patterns of antigenic bands similar to
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TABLE 5.1
Yield of membrane carbohydrate obtained from Clostridium
species following phenol extraction
Strain Yield (mg)
from 61 of culture
C. difficile NCTC 11223 34
n MPRL 161 33
n RIE 11831 63
n MPRL 597 55
C. bifermentans NCTC 506 33
C. sordelli NCTC. 878 0 47
C. irregularis NCTC 11830 6
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Fig. 5.2. Silver-stained SDS-PAGE of crude aqueous-
phenol extracts of C. difficile. Lane 1, NCTC
11223; lane 2 MPRL 161; lane 3 RIE 11831; lane 4 MPRL
597. Samples (50^1) containing 250ug crude antigen were
applied to each track.
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those of the silver stain. These were too faint to
photograph well.
One of these crude extracts (from MPRL 161) was further
purified on a Sepharose 6B column. Two antigens were
isolated (as detected by FRIE). The first of these eluted
in the void volume. This is the volume of fluid required
for elution of molecules only distributed in the mobile
phase because they are larger than the largest pores in
the Sepharose gel. The second antigen eluted with a Kav
of 0.71. This Kav value represents the fraction of the
stationary gel volume which is available for diffusion of




Ve = elution volume of peak
V0 = void volume of column
Vt = total volume of column bed
For the column used here Ve was equal to 20ml; VQ to 8ml
and Vt to 9mm x 280mm of Sepharose 6B, i.e. 25ml, thereby
giving for the second peak:
20-8
Kay — = 0.71
25-8
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The fractions corresponding to the two peaks were pooled,
desalted, lyophilized and resuspended in 0.5ml of
distilled water before further analysis by SDS-PAGE and
immunoblotting. Initial attempts to obtain good
photographs of immunoblots were hampered by the apparent
lack of sensitivity of the procedure. Subsequently, SDS
was omitted from the gels but retained in the sample and
electrode buffers. This resulted in greater sensitivity
of detection by immunoblotting. The silver-stained gel
was very similar to the SDS-containing gel except that
the bands ran slower when SDS was omitted. The results
obtained by PAGE and immunoblotting of the crude antigen
and the two fractions obtained after Sepharose 6B
fractionation are shown in Fig. 5.3. The material in
fraction 1 gave an identical banding pattern to that seen
with the crude material. In the silver stain there was
nothing apparent in the sample corresponding to fraction
2. However in the immunoblot an antigenic band was
detected in this track just behind the gel front.
Immunoblotting of the C. bifermentans and C. sordelli
extracts with antiserum raised against whole cells of C.
difficile NCTC 11223 gave a strong cross-react ion in the
mid region of the gels. This corresponded to a series of
fine lines, appearing as a smear in the silver stain.
11)7
12 3 12 3
Fig. 5.3. (a) Silver-stained PAGE (without SDS) of
crude aqueous-phenol extract of MPRL 161
(lane 1) and the two antigenic fractions detected by FRIE
from the Sepharose 6B column (lane 2 is the first antigen
and lane 3 the second). Lane 1 contained 25<Dpg crude
antigen, lanes 2 and 3 25jig purified antigen,
(b) Corresponding immunoblot with antiserum raised
against NCTC 11223 diluted 1 in 250.
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5.2.1b Extraction of cell wall carbohydrate
Cell wall carbohydrate was extracted from three strains
of C. difficile (NCTC 11223, RIE 11831 and MPRL 161) as
detailed in Sections 2.22 and 2.23. Crossed
immunoelectrophoresis indicated that there was only one
antigen present in each of these preparations (Fig. 5.4).
The extracts were electrophoresed (by use of RIE) against
both homologous and heterologous antisera raised against
whole cells of C. difficile. All three extracts showed
antigenic reactions with their homologous antiserum. It
was noted that the MPRL 161 extract required twice as
much antiserum to focus it compared to the other two
extracts (i.e 500^1 instead of 250pl). Each of the
extracts cross-reacted with antisera raised against RIE
11831, MPRL 11223, MPRL 604 and MPRL 1128. However, no
cross-reaction was demonstrated when the extracts were
electrophoresed with antisera against MPRL 161, MPRL 683
or MPRL 1123.
Nothing was detected when the three extracts were
analysed by SDS-PAGE or were immunoblotted with
homologous or heterologous antiserum.
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Fig. 5.4. Crossed Immunoelectrophoresis of NaOH-soluble
cell wall antigen of NCTC 11223 against
homologous antiserum (10^1 of 5mg/ml solution). Similar
pictures were obtained for RIE 11831 and MPRL 161 against
their homologous antiserum.
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5.2.1c Extraction of cell wall proteins from C.
difficile
Crude cell walls from C. difficile NCTC 11223 were
prepared as described in section 2.27. This material
contained protein and carbohydrate in a 3 : 1 ratio i.e.
about 90mg/ml protein to 30mg/ml carbohydrate. Organic
phosphate was present at a concentration of about
300>pg/rnl. After storage (at -20°C) a 1ml sample of the
preparation was divided into supernate and pellet by
centrifugation and the pellet resuspended in 1ml of
distilled water.
_ Protein assays performed on both this
and the supernate indicated that up to 48% of the total
protein in the preparation was removed in the supernate
following repeated freezing and thawing of the extract.
Studies done (each with 1ml of crude sample) to find a
standard method for extraction of the proteins prior to
freezing produced the results noted in Table 5.2.
The heat treated sample was separated into pellet and
supernate only after the heating process; all the other
methods involved prior centrifugation to obtain the
pellet which was then resuspended in 1ml of the test
solution. This was subsequently centrifuged to obtain
both the supernate and pellet referred to in Table 5.2.
Maximum extraction of protein from the pellet was
obtained by treatment with 5% SDS, heat or 6M urea. The
6M urea treatment was taken as the method of choice for
any further extractions as this was relatively quick
TABLE5.2































compared to the SDS treatment and did not involve use of
special equipment for heating. Prior treatment with 2%
Triton X-100 was also included to remove any cell
membrane proteins that might still be present (section
2.28) .
When the urea extract prepared from NCTC 11223 was run on
SDS-PAGE it was shown to contain three major proteins as
well as several minor ones (Fig. 5.5a). The major
proteins were calculated to have Mrs of about 46kDa,
32kDa and 28.3kDa. There was also a fairly prominent band
at 73kDa. Probing with antiserum raised against whole
cells of the homologous strain showed that these four
proteins were antigenic (Fig. 5.5b). The three major
bands were also apparent on an autoradiograph
produced after 125j _ surface-radiolabelling of whole
cells (Fig. 5.5c). The 73kDa antigen did not show up on
this .
Urea extracts were prepared from a further four strains
"of C. difficile (MPRL 604, MPRL 683, MPRL 1123 and MPRL
1128), all of which had been shown to be different by
prior SDS-PAGE and immunoblotting of EDTA extracts. When
run on SDS-PAGE these extracts were all found to contain
between one and three major protein bands, all having
different Mr values (Fig. 5.6 and Table 5.3). In some
instances it was difficult to assess whether the bands in
the different isolates represented similar or different
proteins as they were very thick. Molecular mass
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Fig. 5.5. SDS-PAGE (a) and immunoblot (b) of urea
extracted proteins from NCTC 11223; (c) is an
autoradiograph of whole cells radiolabelled with il2^.
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Fig. 5.6. SDS-PAGE of cell wall proteins extracted from
C. difficile with 6M urea. Track 1, NCTC
11223; track 2, MPRL 604; track 3, MPRL 683; track 4,
MPRL 1123; track 5, MPRL 1128.
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TABLE 5.3
Protein bands separated from strains of C. difficile





NCTC MPRL MPRL MPRL MPRL





















































* : molecular mass was determined by measuring the
distance travelled by a protein band in Fig. 5.5 and
converting this by use of the standard curve of log Mr
against percentage mobility in SDS-PAGE in Appendix 4.
** : intensity of the bands
strongly staining band, ++
+ : faintly staining band,
was recorded as +++ :
moderately staining band,
: no band of this Mr.
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measurements were in fact made from the centre of all the
bands. I did suspect that the proteins with Mrs measured
to be 32.5kDa and 32kDa (in the extracts from MPRL 604
and NCTC 11223 respectively) might in fact be the same
protein. However, there was no cross-reaction when either
extract was probed with antiserum raised against whole
cells of the other strain.
There were two protein bands on Coomassie staining that
were common to all the strains (Fig. 5.6); one with an Mr
of 73kDa and the other with Mr of 30kDa. Although the
73kDa band was faint in the Coomassie stains of some of
the extracts it always gave a very strong antigenic
response when each strain was probed both with homologous
antiserum and with antiserum raised against the other
four strains. Also, when probed with homologous antiserum
that had been absorbed with whole cells of the other
strains, the staining of the band decreased. This would
indicate that this particular protein was a common
antigen. The other band (30kDa) was only antigenic (when
tested with homologous antiserum) in MPRL- 604, MPRL 1128
and possibly in NCTC 11223. The immunoblot of this latter
strain was too complex to be certain about whether one
very fine band was giving a response. There was no
cross-reaction of these proteins when immunoblots were
probed with heterologous antiserum. Therefore it would
appear that these are different proteins even although
they all have the same Mr value.
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All of the major proteins (+++ in Table 5.3) were shown
to be antigenic when probed with homologous antiserum
(Figs 5.5 and 5.7i to iv). Most of these proteins
appeared to be unique to particular strains but minor
bands having the same Mr values were present in some of
the other strains. The 46kDa antigen demonstrated with
homologous antiserum present in MPRL 1123 appeared to be
the same antigen as the major protein in NCTC 11223.
There was apparent cross-reaction when probed with
antiserum against NCTC 11223 but the reaction did not
diminish with use of absorbed homologous antiserum. The
converse reaction i.e. reacting the NCTC 11223 extract
against antiserum to MPRL 683 did not occur. This shows
that although these proteins had the same Mr they were
different antigens.
Protein bands of 28.3kDa were present in MPRL 683/ MPRL
1123 and NCTC 11223. In NCTC 11223 this was a major
antigen but in MPRL 1123 and MPRL 683 the protein was not
antigenic when probed with homologous antisera. However
the MPRL 683 extract cross-reacted with antiserum against
NCTC 11223. This reaction was not abolished when absorbed
NCTC 11223 antiserum was used. The converse reaction
produced no response. It may be that this protein occurs
in MPRL 683 at levels too low to elicit a strong antibody
response in the rabbits. However/ when probed with
heterologous antiserum containing high levels of
antibodies to the protein a reaction could occur.
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Fig. 5.7. (i) SDS-PAGE (a) and immunoblot (b) of urea















Fig. 5.7. (ii) SDS-PAGE (a) and immunoblot (b) of urea
extracted proteins from MPRL 683.
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Fig. 5.7. (iii) SDS-PAGE (a) and immunoblot (b) of urea












Fig. 5.7. (iv) SDS-PAGE (a) and immunoblot (b) of urea
extracted proteins from MPRL 1128.
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Iso-electric focussing of the urea extract of NCTC 11223
indicated that all the proteins had pi values of between
five and three. The extract was subsequently applied to a
Chromatofocussing column with a pH gradient between four
and seven. The 200ml of Polybuffer 74 made up originally
(see section 2.33) was not enough to remove all the
proteins from the column. Three hundred fractions (about
lml each) were actually collected and a continuous
pen-recording of A28O against time obtained (Fig. 5.8).
Proteins were eluted in fractions 70 to 210. This
represented a pH interval of about 5.5 to 4.1 (see Fig.
5.9). Two main peaks appeared between fractions 98 and
112 (pH about 5.1 to 5.2) and 181 to 189 (pH about 4.3 to
4.4). The fractions from the column were pooled into 12
groups (Table 5.4) and dialysed, lyophilised and
resuspended in 250ul of distilled water. After mixing
with an equal volume of double strength sample buffer
50ul of each of the 12 fractions was applied to a gel. It
was apparent from this gel that the proteins had not been
very well separated on the column. The protein with Mr of
73kDa was not apparent on the gel while the proteins with
Mrs of 46kDa, 32kDa and 28.3kDa were spread over pooled
fractions 8 to 12 which were at pHs ranging from 4.1 to
4.6.
It is clear that the surface proteins of this particular
strain of C. difficile are highly charged. In order to
assess the nature of the charges occurring on the cell
surface of the organism as a whole, hydrophobicity assays
Fig.5.8Pen-recordingofA28Op oducedbyChr mato- focussingcolumel e tpassingthroughfl w cellinaPyeUnicamSP6spe trophotometer.Colu nwas composedfPolybufferexchangerPBE94.
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fraction no.
Fig. 5.9. pH levels measured in fractions collected from
the Chromatofocusing column. Column was equi¬
librated between pH 7.0 and pH 4.0.
TABLE 5.4
Fractions pooled following Chromatofocussing of urea
extracted cell wall proteins from C. difficile NCTC 11223
Fractions Tube Nos.* Pooled fraction
off column number
68 - 76 69 - 77 1
77 - 92 78 - 93 2
93 - 97 94 - 98 3
98 - 112 99 - 113 4
128 - 130 129 - 131 5
144 - 151 145 - 152 6
154 - 156 155 - 157 7
163 - 172 164 - 173 8
175 - 180 176 - 181 9
181 - 189 182 - 190 10
190 - 198 191 - 199 11
199 - 209 200 - 210 12
*: there was a time lag of 2 min 45 sec between a sample
passing through the spectrophotometer and its eventual
collection by the fraction collector. As the collector
was set to move once every three minutes this meant it
was operating about one fraction behind the
spectrophotometer.
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were performed on NCTC 11223 as well as several other
isolates. The particular assay system used (see section
2.7) measured the partition of strains into octane
compared to buffer solution. Hydrophobic strains would be
expected to partition into the hydrocarbon (resulting in
a large decrease in OD of the aqueous phase) while
hydrophilic strains would remain in the aqueous buffer
phase. The results of these assays (following culture of
the organisms in PPY medium) are in Table 5.5. All were
done in triplicate (at least). A S.aureus strain was
included in the assay as this species is known to be
hydrophobic (Rosenberg et al., 1980). It can be seen from
the results that nearly all the strains tested appear to
be fairly hydrophilic by comparison. Only two isolates
(MPRL 604 and MPRL 678) had a decrease in OD greater than
60%. Both these isolates were in fact shown to be the
same strain by SDS-PAGE and immunoblotting of EDTA
extracts.
This assay was repeated with the five strains from which
urea extracts had been prepared. The technique employed
for the assay was identical except that the organisms
were cultured for 24h on BA instead of in PPY medium
prior to testing. There was no change in the percentage
decrease values obtained for MPRL 683, MPRL 1128 and NCTC
11223. The decrease with MPRL 604 was reduced to about
50% while the results for MPRL 1123 were more consistent




Results of hydrophobicity assays on C. difficile after
culture in PPY medium
Isolate Percentage decrease Average
in optical density
MPRL 1122 9 11 13 11
MPRL 1124 15 13 13 14
MPRL 1121 15 12 15 14
NCTC 11223 15 20 10 15
MPRL 1128 17 18 17 17
MPRL 715 22 22 16 20
MPRL 683 22 22 22 22
MPRL 161 21 28 37 29
MPRL 718 29 38 28 32
RIE 11831 33 32 32 32
MPRL 678 73 70 69 71
MPRL 604 71 69 75 72
MPRL 1123 48 56 100 *
Staphylococcus 87 85 83 85
aureus PRl
* : results produced by this strain were not reproducible
ranging from 100 to 48%
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5.2.Id Isolation of flagella from C. difficile
When viewed microscopically, especially following culture
in CMB, nearly all strains of C. difficile are motile.
There are, however, clear differences in the intensity of
the movements observed between strains. Slide
agglutination of three formalinised strains of the
organism, done with homologous antiserum (see sections
2.10 and 2.11 - Widal test), gave positive results and
cross-reaction was also demonstrated (Table 5.6). In many
species such reactions involve the flagella present on
the bacterial cell surface. Consequently, it was decided
to investigate these appendages more thoroughly.
Attempts were made to prepare flagella from four strains
of C. difficile; RIE 11831 and MPRL 161 which demonstrate
very active motility, NCTC 11223 which is only sluggishly
motile and MPRL 558 which grows mainly as elongated cells
showing little movement. After final purification with
caesium chloride equilibrium-density-gradient centrifuga-
tion these preparations' were viewed With an inverted
microscope to check the position of any bands present.
RIE 11831 had two clearly distinguishable bands lying
about a quarter of the way down the centrifuge tube while
MPRL 161 had one thick band lying in an equivalent
position (Fig. 5.10). There were no bands apparent in the
MPRL 558 preparation and there was only one very faint
band in the NCTC 11223 preparation. This was in the same
position as the upper band from RIE 11831.
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TABLE 5.6
Slide agglutination of formalinised C. difficile cells







NCTC 11223 + +
MPRL 161 +++ - + +
RIE 11831 +++ - + +
*: motility was assessed on a comparative basis after 24h
incubation of cells in CMB. +++ : very actively
motile; + : only sluggish motility
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^\\\\\\^
RIE 11831 MPRL 161
Fig. 5.10 Bands obtained following caesium chloride
equilibrium-density-gradient centrifugation
of crude flagellar preparations from RIE 11831 and MPRL
161. Bands 1 and 2 were collected separately; band 3 was
collected as two fractions a and b.
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The two bands from RIE 11831 were collected separately (1
and 2). The RI of both bands was checked. The upper one
had a RI of 1.3625; the lower one was 1. 3640 . These
values are equivalent to densities of 1.295g/cm3 and
1.310g/cm3 respectively. An upper and a lower fraction
were collected from the thick band present in MPRL 161
(3a and 3b); the NCTC 11223 and MPRL 558 preparations
were discarded. After removal of the CsCl2 present in the
samples (see section 2.20) each was applied to a
Formvar-coated copper grid, gold-palladium shadowed and
viewed by EM.
Flagella were clearly seen in three of the four fractions
(Table 5.7). There were many of the appendages present in
both fractions collected from MPRL 161 (see Fig. 5.11).
It was noted that they were not evenly spread over the
surface of the grid and in both samples they appeared
closely associated with large deposits of material. These
may well have been aggregations of flagella that had not
been dissociated during the resuspending process. There
appeared to be less flagella present in band 3b but this
may have been an artifact produced during preparation of
the grid. Band 1 from RIE 11831 gave the same sort of
picture but there were fewer of the appendages apparent.
Band 2 appeared to have no flagella present. There was
also a lack of any of the clumpy material seen with the
other fractions.
Protein assays of the preparations did not provide
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TABLE 5.7
Relative proportions of flagella seen in fractions














*: number of flagella present were graded +++ to + on a
purely comparative scale. no flagella present
Fig. 5.11 Flagella (magnified 27,000 times)





detectable results. However, after mixing each fraction
with an equal volume of double strength sample buffer and
boiling for 10 min, 50>il of this was loaded onto a gel
for SDS-PAGE and immunoblotting. Broad protein bands were
apparent in the Coomassie stain of fractions 1 and 2 from
RIE 11831 (Fig. 5.12). Much fainter bands were present in
samples 3a and 3b from MPRL 161. Each band was probed in
an immunoblot with antiserum raised against the
homologous bacterial strain. There was a strong antigenic
reaction with both fractions from each of the strains.
When tested against antiserum raised to the other strain
cross-reaction was demonstrated. Reaction with antisera
raised against MPRL 604, MPRL 683, MPRL 1123 and MPRL
1128 also gave a very weak positive immunoblot response.
However when the preparations were tested against
antiserum to NCTC 11223 there was no reaction at all.
Fig. 5.12 SDS-PAGE (a) and immunoblot (b) of flagella
from RIE 11831 and MPRL 161. Track 1 contains
an EDTA extract of each strain. Track 2 contains the
upper band or fraction from the CsCl2 gradient and track
3 the lower band or fraction.
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5.3. Discussion
5.3.1. The carbohydrate antigens of C. difficile
Previous work in this laboratory had shown that a phenol
extract of lyophilized supernate from broken cells of C.
difficile NCTC 11223 contained two antigens when studied
by CIE (Poxton and Cartmill, 1982). These antigens, which
appeared to be antigenically related, were proposed to
correspond to a) the LTA moiety, a type of which is found
in all Gram-positive organisms and b) a deacylated form
of this antigen which was found to cross-react with the
cell wall antigen (teichoic acid).
The LTA of most Gram-positive organisms has been reported
to be based on a poly-(glycerol phosphate) backbone. It
might be expected that such a molecule would not show a
ladder pattern such as was detected here when analysed by
PAGE. If the chain lengths were variable they would only
differ by a single substituted glycerol phosphate unit
which would probably not be resolved by PAGE. In C.
difficile the fatty acid antigen appears to be of a more
complex nature. It seems to be in a form more akin to the
smooth lipopolysaccharide of Gram-negative bacteria which
also produces a ladder pattern when examined by PAGE
(Tsai and Frasch, 1982). As such, it may be that the
molecule is composed of polysaccharide units, each
differing by one oligosaccharide repeating unit.
All immunoblots were performed with antiserum raised
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against C. difficile NCTC 11223. The four crude phenol
extracts examined all produced the same ladder pattern of
reactivity. It seems therefore, that this is a
cross-reactive antigen present in all the C. difficile
strains examined.
As far as I am aware this is the first report of the
analysis of a LTA (or its analogue) by PAGE. It has
however been speculated that a ladder pattern seen in
immunoblots of crude cell surface extracts of C.
botulinum might be due to such an LTA-type molecule
(Poxton, 1984). I do not know if this ladder pattern
would be produced by the LTA of many other Clostridia.
Silver-stained gels of the C. sordelli and C.
bifermentans extracts did not give this pattern although
there was antigenic cross-reactivity when the
carbohydrate was probed with the antiserum raised against
C. difficile NCTC 11223.
The identity of the second antigenic peak from the
Sepharose 6B column remains uncertain. This rather
heterogenous low-Mr material might be fragmented wall
antigen or deacylated membrane antigen. Purified wall
carbohydrate could not be detected by SDS-PAGE which may
indicate the second antigen was more likely to be
deacylated membrane carbohydrate. However, since native
wall antigen may be too large to enter the polyacrylamide
gel this may have accounted for the results observed.
The sodium hydroxide-extracted wall antigen obtained from
lay
three species of C. difficile all reacted with their
homologous antiserum. However none of them cross-reacted
with three of the sera tested (i.e. that raised against
MPRL 161, MPRL 683 or MPRL 1123). It was noted that the
extract of MPRL 161 required twice as much homologous
antiserum during CIE to provide a clear picture. It may
be that this strain, and the other two which did not
produce detectable antigenic responses, were not highly
immunogenic within the rabbits.
5.3.2. Studies on the cell wall proteins of C. difficile
Attention has been focussed on the cell proteins of C.
difficile as a result of some of the work being done to
develop methods for characterizing (or typing) different
strains of the organism. The immunochemical finger¬
printing method of Poxton et al. (1984) and the
radiolabelling employed by Tabaqchali et al. (1984) both
rely on the presence or absence of particular protein
bands in order to compare isolates.
Heard et al. (1986b) used immunoblotting to analyse
further the nine strains of C. difficile previously
characterized by 35s-methionine radiolabelling
(Tabaqchali et al., 1984). Antisera were raised against
each of these nine strains which were then used to probe
both the homologous strain and each of the other eight
heterologous strains. It was found that there were three
protein bands common to all of the strains when the serum
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was tested against whole cell extracts of each strain.
From the photographs in the paper I have calculated these
to have Mrs of about 70kDa (CBi), 58kDa (CB2) and 55kDa
(CB3 - see Appendix 4 for standard curve used). These
bands will be equivalent to the common antigenic bands of
high Mr detected during our epidemiological
investigations (Chapter 4). It was also reported that
when a specific antiserum was immunoblotted against
heterologous strains, the common bands were demonstrated
but the bands specific to the heterologous strains were
not.
From the studies done here I have demonstrated that each
of the five strains studied (shown to be different by
SDS-PAGE and immunoblotting of EDTA extracts) had between
one to three major proteins of different Mrs extracted. I
did think that these might correspond to one or other of
the patterns of radiolabelling described by Tabaqchali et
al. (1984). However on comparison of the M ^ values it
appears that only MPRL 1123 and MPRL 1128 had protein
bands that were detected by this autoradiography
technique. MPRL 1123 had a major band at 33.5kDa as well
as two fairly prominant bands calculated to have Mrs of
about 51.5 and 50kDa. From the figures in the Heard et.
al. (1986b) paper I have calculated that the two bands
detected in strain W have Mrs of 51 and 33kDa. This might
therefore be the same strain. Similarly, MPRL 1128 has a
major protein band at 37kDa and another prominent band at
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50kDa. Strain E, as defined by Tabaqchali et al. (1984),
has two autoradiograph bands which have Mrs of about 49.5
and 37kDa. The major protein bands isolated from NCTC
11223, MPRL 604 and MPRl~683 did not correspond to any of
the autoradiograph patterns described by this group. It
may be that this particular amino acid is not present in
these proteins or that it is present at only very low
levels. Equally, these proteins may not have been
synthesized over the period of labelling.
Minor proteins present in strains that had the same Mr
values to the major proteins of other strains could have
been assumed to be the same antigens. However few, if
ext.
any, cross-reactions were demonstr^bd between these
proteins. This observation further illustrates that
although immunoblotting with antiserum raised against one
strain of C. difficile can give a good indication of
whether strains are the same or different, it will not
fully characterize any strain unless it is entirely
homologous (see section 4.3.1) . This is a point also
noted by Heard et al. (1986b). Immunoblotting with one
antiserum cannot be used to characterize completely and
'type' an isolate.
Kawata et al. (1984) reported the presence of a regular
array in the OWL of C. difficile strains. This group
found that this regular array was composed of two main
proteins which could have Mrs of 45 to 47kDa and 32kDa (9
strains) or 42kDa and 38kDa (2 strains). Again, only one
192
of the strains from which a urea extract was made (NCTC
11223) had major proteins that corresponded to these Mrs
(46kDa and 32kDa).
The proteins extracted from NCTC 11223 were all very
acidic in nature. My initial aim in applying the urea
extract from this strain to a Chromatofocussing column
was to try and separate the three proteins with Mrs of
between 32kDa and 28.3kDa. Since they all focussed very
closely together after SDS-PAGE I had hoped they might
have sufficiently different pis to allow separation on
the basis of this parameter. However the results indicate
that separation of the molecules was not very successful.
The pH gradient of the column appears to have been
correctly formed as the graph of fraction collected
against pH of that fraction forms a straight line. 1 have
subsequently learned that it is difficult to separate
proteins of low pi by this system. It would perhaps have
been better to try and separate the proteins by
e.
isoelectric focussing. Unfortunately there were technical
problems with this technique that prevented the
acquisition of any useful results.
Results of the hydrophobicity assays done here indicate
that four of the five strains I was working with were
relatively hydrophilic in nature. Of the 12 C. difficile
isolates tested, only two (MPRL 604 and MPRL 678)
appeared to be hydrophobic in nature. The fact that these
two isolates, giving similar results, were shown to be
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the same strain by immunoblotting was a useful control on
the technique. Also, the S. aureus strain included gave a
decrease in absorbance of about 85% which is what has
been recorded for this organism in previous studies
(Rosenberg et al. , 1980).
Hydrophobicity is now generally considered to be a
preliminary step towards bacterial adhesion. Wood-Helie
et al. (1986) have previously reported that nine C.
difficile strains they examined were hydrophobic in
nature. This characteristic has been found to be common
to several enteric pathogens and it has been suggested
that it is an important prerequisite for colonization
(Wadstrom et al. , 1980). It is postulated that this
characteristic may allow constant access of bacterial
cells to the mucosa (overcoming electrostatic repulsion)
while also serving as a counterforce to peristalsis. This
group also suggested that the nonspecific attraction
resulting from hydrophobicity was probably followed by a
more specific adherence, both processes probably
contributing to the colonization of the bowel. It may
also provide a secondary reinforcement which counteracts
the competition of free mucus for the receptors on
epithelial cells (Freter, 1981).
Experiments employing hydrophobic interaction
chromatography have shown that surface proteins of
several pathogenic organims have a large number of
nonpolar amino acids which are responsible for their
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hydrophobic properties. Mutants lacking these proteins
did not bind to the gel surface. Included in this group
of organisms are E.coli which has colonization factor
antigens I, II and 111, K88 and K99, Salmonella species,
Campylobacter species and Yersinia enterocolitica
(Wadstrom et al., 1980).
The hydrophobicity values obtained for cells will very
much be influenced by the environment in which the cells
are cultured. The availability of nutrients is likely to
influence the character of the outermost cell envelope.
In the study by Wood-Helie et al. (1986) it was found
that all the species of Clostridia examined grown on
casamino acid (CAS) medium, showed some degree of
adherence to polystyrene, but when grown on CAS
containing clindamycin some species (i.e. C. perfringens,
C. bifermentans) subsequently failed to adhere.
Given that the cell wall proteins of NCTC 11223 were
highly charged when analysed by Chromatofocussing it
might be expected that the organism would appear
hydrophilic in nature. I did think that perhaps the
original culture of the organisms in PPY had influenced
the composition of the cell wall proteins since in the
study by Wood-Helie et al. (1986) organisms were grown on
solid media on which the environment may have been much
less acidic. I found the pH drop in an overnight PPY
culture to be from about pH 7.0 to pH 5.9. This was the
same for all cultures and would therefore not explain the
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difference in the hydrophobicity values obtained for MPRL
604 and MPRL 678. However, it was interesting to see that
culture of MPRL 604 on BA did decrease its apparent
hydrophobicity value by about a third.
The greater hydrophobicity detected with MPRL 604 and
MPRL 678 cannot be related directly to the virulence of
these organisms. One organism was isolated from a patient
with mild diarrhoea, the other from another with severe
symptoms. As discussed in section 5.1, many factors can
contribute to the disease symptoms occurring in
individuals; it is unrealistic to label any one surface
component or physiological aspect of a cell and say this
is the only factor involved in the production of
symptoms. Pathogenesis is now well known to be a
multifactorial process involving a variety of different
virulence factors (Smith, 1978). It may also be the case
that the immune response in these patients was different,
so influencing the severity of symptoms .
5.3.3. The flagella of C. difficile
The motility and chemotactic ability of flagella has been
shown to be associated with the virulence of
Gram-negative aerobes such as V. cholerae (Guentzel and
Berry, 1975; Yancy et al., 1978) and P. aeruginosa
(Craven and Montie, 1981; Montie et al. , 1982). The
flagella of these bacteria are known to play an important
role in inducing host protection against infection (Yancy
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et al.f 1979; Holder et al. , 1982). The role of flagella
in the virulence of anaerobic organisms does not appear
to have been studied very extensively. However studies on
one strain of Clostridium have been reported.
Investigations on the role of the flagella of C. chauvoei
in raising protective antibodies in mice have produced
conflicting results. Chandler and Gulasekharam (1974)
stated that the highly protective antigen of this
organism was not flagellar in origin. In contrast
Stevenson and Stronger (1979) reported that the flagella
did appear to induce a highly protective antibody
response .
The method used here for isolation of flagella from C.
difficile resulted in concentration of the appendages in
one or two closely associated bands after caesium
chloride density gradient centrifugation. Chandler and
Gulasekharam (1974) reported that one such dense band was
seen after this treatment of C. chauvoei. When the two
fractions collected from each strain were run on SDS-PAGE
it was apparent that each fraction contained protein of
the same Mr. When viewed by EM, following shadow casting,
the only material seen in each of the fractions was the
flagella. Immunoblotting of each extract against its
homologous antiserum showed that the appendages produced
an antigenic response within the rabbits. Antigenic cross
reaction was also demonstrated between the flagella
preparations from the two strains. A very weak response
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was also detected with antisera against another four
strains of C. difficile. No antigenic response was seen
when the protein was probed with antiserum against NCTC
11223. It is very probable that the flagella of this
strain do not elicit a very strong antigenic response.
This strain of the organism is only sluggishly motile and
there was only a very faint band apparent after the
caesium chloride centrifugation.
The chemical composition of the flagella in strictly
anaerobic bacteria has been little studied. However in
facultatively anaerobic or aerobic bacteria, with
peri tr ichj|©us or monotrichous flagella, the filament
protein (flagellin) is reported to be a multimer of a
single polypeptide with antigenicity and amino acid
composition differing from the proteins of the other
structural components (Dimmit and Simon, 1970; Kagawa et
ai., iy76j. From the results obtained here I would
suggest that the flagella extracted from both of the C.
difficile strains were composed of one single protein, as
demonstrated by their antigenic cross-reactivity. The
observed division of this protein within the caesium
chloride gradient (which was reproducible) may have
arisen as a result of the flagella forming aggregates.
However if such aggregates did exist they were not
separated during SDS-PAGE even after extensive boiling.




The occurrence of both common and unique antigens within
strains of C. difficile has been demonstrated. The
membrane carbohydrate antigen is of a novel nature,
different from that isolated from other Gram-positive
organisms such as staphylococci, streptococci,
lactobacilli and Bacillus species (Wicken and Knox,
1975). It has been shown that there is a variety of
proteins present in the cell walls of the organism.
Indeed, there is possibly a greater variety than has been
previously reported. It also appears that motile strains
of the organism contain flagella of a common nature as
demonstrated by their antigenic cross-reactivity. Further
work to elucidate the precise role and structure of
proteins in the cell walls and to determine whether any
of the antigens detected in these studies are important




During all these studies broths, diluents and agar plates
were pre-reduced before use on the bench.
5.4.1a Investigations into the association of C.
difficile with gut mucosa
The ileum was removed from a C3Hb mouse (or two, if
required) and was pushed onto a glass rod and tied at one
end. The gut was subsequently everted over the rod as
shown in Fig. 5.13, the contents being collected into 2ml
of Kre$-Ringer (KR) solution (see Appendix 1). The
everted ileum was rinsed with tissue culture medium (TCM
- RPMI 1640 - Gibco, Paisley, Renfrewshire), pH 7.3,
containing 20mM Hepes buffer; the pH of this was adjusted
with 1M HCl after addition of the Hepes. The gut was cut
into six pieces each 4.5cm in length. Studies showed that
this length of freshly excised and everted gut took up
between 0.0163ml and 0.0209ml of fluid (six pieces of gut
measured) with a mean value of 0.0192 (0.0015 standard
deviation).
Five of these pieces of gut were secured onto glass rods,
with threads tied a distance of 4cm apart. Each was
retained in TCM. The sixth piece was ground up with a
tissue grinder in 2ml of KR solution; 0.1ml of this was
spread onto a CCFA plate to provide a time zero negative
control. A similar volume of the gut contents solution





mucosal surface of ileum
serosal surface of ileum
Fig. 5.13 Eversion of mouse ileum over a glass rod.
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other five pieces of gut were individually introduced
into separate test-tubes containing 10ml of a 3h culture
of C. difficile MPRL 1121, adjusted to a concentration of
about 1 x 10*7 organisms/ml in TCM (after a total count
had been done) . This culture was derived from a 5%
inoculum of an overnight PPY culture into fresh p-r PPY.
One piece of ileum was dipped into this suspension
momentarily, only long enough to wet the entire surface
of the tissue (T0, about 2 sec). The other five pieces
were left in the suspension, on a shaker, for either 5,
10, 15, 30 or 60 minutes. After removal, each piece was
given four successive 10 sec washes, with gentle
agitation, in 25ml of KR solution (in Universal bottles)
and was finally cut from the glass rod and ground up with
2ml of KR solution. A sample (0.1ml) of each wash
solution and of the homogenized gut (plus any dilutions
made in KR solution) was spread onto a CCFA plate. These
were incubated for 48h before colony counts were done.
Tables 5.8a and 5.8b record the total number of organisms
present in each of these four wash solutions and on the
gut in two such experiments (A and B). These figures were
calculated as shown below:
For the washes: a x dilution factor x 10 x 25
For the homogenized gut: a x dilution factor x 10 x 2
where a is the total number of colonies per plate.























































































































































































































































































The total number of colonies per plate in both
experiments are noted in Appendix 3. The column marked
percentage association (Pa) is derived from the following
calculation:
Viable organisms on homogenized gut
Pa =
Viable organisms in wash 1 + wash 2 + wash 3 +
wash 4 + homogenized gut
This figure gives an indication as to the actual levels
of association of C. difficile with the ileal mucosa,
given the possible number of organisms that were in
contact with the gut at the time it was removed from the
C. difficile suspension. Tables 5.8a and 5.8b also
indicate the number of cells that would be expected in
each of the washes assuming that 0.0192ml of fluid was
transferred to each piece of gut from the original C.
difficile suspension * and from one wash to the next.
Viable counts were done on the C. difficile suspension
used during the course of Experiment B (two plates per
count). There were originally 1.43 x 10? viable cells/ml
at T0 but after 30 min this figure had fallen by 57.3%
(to 6.10 x 10®) and after 60 min it had fallen by 74.1%
(to 3.7 x 10®). The concentration of C. difficile at T0
in experiment A was 8.60 x 10® viable organisms/ml.
No C. difficile were recovered from either of the
negative control plates. It is clear that the total
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number of organisms being transferred from the C.
difficile suspension on the pieces of gut (washes 1, 2, 3
and 4 plus the homogenized gut figure), increased the
longer the tissue was left in contact with the organisms.
After 60 min the number of organisms transferred was 9.7
times that recovered at T0 in experiment A and 5.8 times
the T0 figure in experiment B. The majority of cells
transferred were removed in the first wash (63.6% in
experiment A and 79.9% in experiment B at T0, 44.7% and
55.6% respectively after 15 min and 46.7 and 50% after 60
min). At each time interval the subsequent washes had
decreasing numbers of cells in them (Fig. 5.14).
In both experiments the total number of organisms
recovered during the processing of the gut at T0 was
about 70% of the predicted carry over into the first
wash. This may indicate that the pieces of gut which were
kept moist prior to use were not in fact absorbing as much
fluid as was predicted by the measurements with freshly
excised tissue. It is also apparent that the subsequent
washes, 2 to 4, contained many more organisms than
predicted.
The number of organisms remaining associated with the gut
after the washes increased with time (Fig. 5.15). There
appears to be a linear increase in numbers over the first
30 min followed by a levelling off in the rate of
increase by 60 min. The Pa value is also seen to increase
with time and begin to level off after 30 min.
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Fig. 5.14 Graph of viable organisms recovered from each
wash after removal of ileal tissue from a C.
difficile suspension at the time specified (T0 to 60.
min). Figures are taken from Table 5.8a. A similar graph
was obtained with the results in Table 5.8b.
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• ♦homogenized jut (iieum) — viabl e count
o 0P3 va(ue
Fig. 5.15 Graph of viable organisms recovered with
increasing exposure of mouse ileum to c.
difficile. Also recorded is the ?a value for each time
interval. Figures are derived from Tables 5.3a (a) and
5.8b (S) .
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Two questions arose from these results. Firstly, was this
pattern of association of C. difficile with the gut
tissue unique to this organism and secondly, was the
association a competitive event? To try and answer these
questions the experimental procedure was repeated with a
Bacteroides fragilis strain. The results of this
experiment are described below.
5.4.1b Association of B. fragilis with gut mucosa; a
comparison with C. difficile
The B. fragilis strain used in this work (MPRL 1282) was
originally chosen as it had an unusual antibiotic
resistance profile which would have made detection on
selective agar easy. However, as it turned out the
organism was quite easily identified by colony appearance
on BA, as no organisms cultured from the ileum looked
similar to it.
The adhesion experiment was repeated exactly as described
previously for the C. difficile and the results obtained
are shown in Table 5.9. Viable counts done on the B.
fragilis suspension used indicated that at T0 there were
5.65 x 1()6 organisms/ml and that there was no significant
change in this count during the experiment. The predicted
recovery of cells from 0.0192ml of this suspension are
also included in Table 5.9.
The total number of cells transferred on the gut surface
increased with time but this increase (2.7 fold in the 60












































































































































min) was not as great as that observed with the C.
difficile. The actual number of organisms remaining
associated with the ileum after washing also increased
giving a similar curve to that of C. difficile (Fig.
5.16). However, the number of organisms recovered started
to level out after 15 rather than 30 min. The same effect
was found with the Pa values. These Pa values are all
lower than those calculated for C. difficile at the
corresponding times.
The number of B. fragilis recovered at any particular
time from the homogenized gut was always less than the
corresponding C. difficile figures, ranging from about 30
to 65%. However this was probably a consequence of the B.
fragilis viable count being only 38% (experiment B) to
66% (experiment A) of the C. difficile viable counts.
The B. fragilis cells available in suspension were much
more rapidly taken up by the surface of the gut at both
T0 and after 15 min - T15 (Table 5.10). However the
percentage increase in the actual number of organisms
recovered from the homogenized gut over time was of the
same order of magnitude as with the C. difficile (Table
5.11) .
Figure 5.17 shows the pattern of recovery of B. fragilis
from the washes was similar to that of C. difficile.
There was a greater percentage of the total cells
transferred lost in the first wash at T0 (93.9% compared
to 63.6% and 79.9% for C. difficile) . By 15 min the
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Fig. 5.16 Graph of viable organisms recovered with
increasing exposure of mouse ileum to B.
f ragilis. Also recorded is the Pa value for each time
interval. Figures are taken from Table 5.9.
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TABLE 5.10
Comparison of the total C. difficile and B. fragilis recovered as
a percentage of the viable count over the first 15 minutes of
adhesion experiments
Organism Experiment & Time Total cells recovered Pa*
Viable count Viable count




Tis 6.53% 27. 9%




Tl5 3.59% 26. 9%





?a (percentage association) values are included for comparison
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TABLE 5.11
Percentage increase in the number of organisms recovered
from homogenized gut with time
percentage increase in recovery of organisms*
Time
interval
B. fragilis C. difficile
Experiment A Experiment B
T0 - 15 min 2775% 1695% 1090%
T0 - 30 min 3525% 3105% 2417%
T0 - 60 min 3900% 4082% 3314%
Tx " T0




Tx is the homogenized gut
after 15, 30 or 60 min.
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Fig. 5.17 Graph of viable organisms recovered from each
wash after removal of ileal tissue from a B.
fragilis suspension at the time specified (T0 to 60 min).
Figures are taken from Table 5.9.
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percentage recovered in this first wash levelled out at
around 60%.
A further experiment was done to see whether prior
treatment of a piece of gut in a B. fragilis suspension
would result in a decrease in the association of C.
difficile with the ileal tissue. To try and get maximum
association of B. fragilis with the tissue the organism
was used at a higher concentration than the C. difficile
since a) it was much smaller than the C. difficile cells
and b) in the previous experiment fewer B. fragilis were
actually recovered from the gut than C. difficile.
Ileal tissue was placed in a suspension of B. fragilis
(viable count of 5.00 x 10^ organisms/ml) for 15 min and
then transferred, with no washing, to a suspension of C.
difficile at a concentration of 8.85 x 10^ organisms/ml
for a further 15 min. The number of B. fragilis and C.
difficile recovered from the gut after this are recorded
in Table 5.12. Results of control experiments, measuring
recovery of each organism from individual pieces of gut
at T0 and Ti5,are also included.
Taking the control experiments first it can be seen that
the C. difficile behaved in the same manner as observed
previously. The number of cells lost in the first wash at
T0 was 70.8% of the total recovered at this time and the
actual increase in recovery of organisms from the gut
over the 15 min was 1508%. The total number of organisms
TABLE5.12
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transferred on the pieces of gut increased by 4.8 fold.
The B. fragilis suspension behaved differently from the
previous experiment with this organism where 5.65 x 10^
organisms/ml were used. Now, with the cells at 88 times
this concentration, the actual increase in recovery of
the organisms from the gut over the 15 min was only 166%
compared with 2775% previously. As many more organisms
were recovered at both T0 and after 15 min in this
experiment this could indicate that more of the binding
sites were taken up by the B. fragilis at T0 and that the
potential for further uptake was reduced.
The results of the combined experiment show that the
presence of the B. fragilis on the gut has, compared to
the control T15 experiment, reduced both the total number
of C. difficile transferred (by 40%) and the number of
organisms finally recovered from the gut (by 48%).
In order to assess whether or not C. difficile would
associate with cells lacking mucus, attempts were made to
remove this layer from the everted gut. Attempts to
scrape the mucus off by purely physical means with a
scalpel were not successful. Subsequently, chemical
removal of the layer was attempted. This involved the
addition of the gut to 25mg/ml of N-acetyl-L-cysteine
(Sigma) in 0. 5M phosphate buffer, pH 7.0. This is a
mucolytic agent which was reported to be very effective
at removal of mucus from tissue (Professor G. Cooper,
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University of New South Wales, Australia - personal
communication). The pieces of gut were placed in this
solution on a magnetic stirrer for either 30 or 60 min at
37°C. Following this the gut was collected into
formalinized saline prior to preparation of
paraffin-embedded transverse tissue sections (see
sections 2.34 and 2.35) . When the stained sections were
viewed with the light microscope it was apparent that
although much of the mucus had been removed during this
treatment there was still a relatively large proportion
remaining in association with the cells. Results obtained
from experiments with this treated gut were inconsistent
and showed no clear pattern, most probably as a result of
uneven distribution of mucus on the pieces of gut.
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5.5. Discussion
Adhesion has been shown to increase the virulence of
Gram-negative toxigenic organisms such as V. cholerae
(Schrank and Verway, 1976) and E. coli (Jones and Rutter,
1972). In this work I wanted to assess the potential role
of adhesion in the pathogenesis of C. difficile-
associated disease since this is also a toxigenic
organism.
General confusion exists regarding whether or not C.
difficile adheres to the gut mucosa. Histological
examination of colonic biopsy material from cases of PMC
does not, in the vast majority of reports, show the
presence of bacterial cells within the characteristic
plaques. There is however one report (Borriello, 1979)
which does suggest that the organisms might adhere to
colonic tissue.
Barer (1984) reported apparent adhesion of C. difficile
to intestinal 407 cell monolayers. I would tend to
question the relevance of this study relying as it did,
upon the use of a cell line. It is well appreciated that
such cells have altered surface characteristics and they
are known to have atypical adherence properties.
Consequently, I would suggest that any results obtained
with such cells should be interpreted with caution. To
avoid these potential problems I wished to use an assay
system that would determine association of C. difficile
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with normal gut epithelium.
Ileal tissue was used for these studies as it was easy to
obtain and use rapidly. Colonic material would have
required considerable washing and would probably have
still been covered with many commensal organisms.
Comparatively few organisms were associated with the
ileal mucosa and those present could not be confused with
the C. difficile growing on CCFA and B. fragilis cultured
on BA. Finally, since the toxins produced by C. difficile
affect ileal as well as colonic cells (Mitchell et al. ,
1986) it seemed reasonable to use this tissue for the
studies. The C. difficile strain used (MPRL 1121) was
chosen as it was known to be pathogenic in animals (Dr.
S.P. Borriello - personal communication).
The results show that more viable cells from the C.
difficile suspension were removed on the surface of the
ileum the longer the tissue was left in contact with the
bacteria. Barer (1984) reported that it took at least 90
min before there was association of C. difficile with
cell monolayers. In comparison, the results here indicate
that there was very rapid association. This may well have
been facilitated by gut mucus which would not have been
present on the cell line.
In both the C. difficile experiments (A and B) the
figures for total recovery are very similar at each of
the time intervals. Fewer cells than expected were
recovered in wash 1 at T0 but, as mentioned previously,
222
this may have been due to less of the bacterial
suspension actually being taken up by the tissue than was
predicted. About 60 to 70% of the total cells recovered
at T0 were in wash 1; by 15 min this figure had fallen to
around 45 or 55% and was about 50% after 60 min. This
could indicate that the cells actually transferred on the
gut surface were sticking more thoroughly following
longer periods in the bacterial suspension.
The number of organisms remaining associated with the gut
after washing increased with time as did the Pa values.
The levelling off seen in these figures may have arisen
as a result of the ileal tissue shedding mucus and/or
cells during the washing steps. Pieces of the mucosa
could be seen, evenly dispersed throughout the wash
solutions, after 30 and 60 min and it is possible that
such loss of material was occurring at the earlier stages
in the experiments. It is certainly clear that many more
organisms were recovered in washes 2 to 4 than were
predicated at T0. It may therefore be that the figures
obtained for organisms remaining associated with the
homogenized gut are artificially low as a result of
pieces of the mucosa being shed during the wash process.
The decreasing rate of association may also indicate that
all the potential binding sites on the gut had been
utilized. An experiment with greater initial numbers of
cells would have shown whether this was the case if the
levelling off in association occurred more rapidly (see
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later discussion on B. fragilis) .
This levelling off in association of C. difficile with
the gut may also have been a result of the decreasing
viability of the cells. This being the case, the observed
increases in association are all the more significant. It
would have been preferable to do these experiments within
an anaerobic cabinet but a sufficiently large one was not
available.
The association of the B. fragilis with the gut tissue
showed some differences. To begin with, a greater
percentage of these cells were taken up on the surface of
the gut relative to the initial number of cells present
in suspension. However, compared to the C. difficile a
greater proportion of these cells were removed in the
first wash over the entire 60 min. This would indicate
that the cells actually picked up on the surface of the
gut were more easily removed than the C. difficile. The
lower Pa values calculated also suggest that of all the
cells transferred on the surface of the tissue, fewer
actually remained in association with it after washing.
It therefore appears that although more B. fragilis can
loosly associate with the gut, this organism does not
have the ability to 'stick' to the surface as thoroughly
as C. difficile.
The levelling off in Pa value and number of cells
recovered from the gut after 15 min cannot be attributed
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to decreasing viability of the B. fragilis culture. In
this experiment it is more likely to be due to a
saturation of available binding sites. This argument is
borne out by the fact that only 1.7 times as many B.
fragilis cells were recovered from the washed gut in the
later experiment employing 5.00 x 10® organisms/ml
compared to this one with only 5.65 x 10^ organisms/ml.
The final experiment done indicated that prior treatment
of the ileum with a high concentration of B. fragilis
cells could result in a decrease in subsequent recovery
of C. difficile from the gut. The fact that the Pa value
in the combined experiment was similar to the T15 control
Pa value indicates that those cells that did manage to
associate did so in the same manner as in the control
experiment. Since a greater proportion of cells were not
recovered in the washes this would suggest that the C.
difficile cells did not even loosly associate with those
sites on the tissue previously taken up by the B.
f rag"ilis. It may therefore be that although C. difficile
does have the ability to associate with the gut mucosa,
it cannot actually do this when the gut surface is
already covered with other organisms as in the situation
in vivo. It would have been interesting to see if
antibiotic treatment of organisms already associating
with the gut mucosa would have increased the eventual
recovery of C. difficile.
It is probable that the association observed between the
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gut and C. difficile or B. fragilis was facilitated by
the mucus layer, at least in the initial stages of
association. It would have been useful to compare the
results obtained with similar experiments done with
non-mucus covered cells. However it may be that the only
way to do this would be to use a cell line which, as
mentioned at the beginning of this discussion, may not be
worthwhile. Alternatively, chemical removal of the mucus
might be more successful if the gut was kept in
oxygenated conditions and left in an N-acetyl-L-cysteine
solution for longer before transferring it to anaerobic
conditions for the actual experiment. The use of a
fluorescent label against a C. difficile surface antigen
could be helpful in detecting precisely where the
organism associates with the tissue.
All the experiments done here were with the same strain
of C. difficile; it would be interesting to investigate
other strains for comparison. Further investigations into
the effect of normal gut commensals on association,
perhaps by use of mixed bacterial suspensions, might
provide greater insight into the potential for




"It is a riddle wrapped in a mystery inside an enigma"
Sir Winston S. Churchill
Many unanswered questions remain regarding C. difficile
and its role in the pathogenesis of bowel disease. When
initially isolated from patients with AA-PMC, it seemed
that it would be a simple task to correlate the
occurrence of this organism with the disease and that the
major virulence factor would be the easily detectable
cytotoxin. Clearly, the increasing research done since
then, has shown that things are far more complicated than
this. The organism has been found associated with several
other less severe bowel disorders and other factors have
emerged as potentially important in virulence.
The investigations undertaken in this thesis fell into
three main areas:
1) studies on cultural methods for the organism
2) epidemiological investigations
3) isolation and immunochemical investigation of surface
components.
Most of the cultural investigations undertaken centred
around attempts to isolate C. difficile from as high a
percentage of healthy individuals as possible. It is
apparent that the organism may be present at exceedingly
low levels in the healthy gut, making isolation without
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extensive enrichment improbable.
Based on these results we are no nearer providing a
definitive answer as to whether or not C. difficile is a
potential endogenous pathogen in all individuals. We can
say that it does exist at very low levels in a higher
percentage of individuals than previously reported in the
majority of investigations. It may be the case that only
certain people are colonized by the organism but the
factors which might determine this are not readily
apparent. Given appropriate conditions these organisms
may give rise to a pathogenic effect. In this study
tetracyclines and penicillins were not found to be among
these factors.
Enrichment culture is not routinely used here in the
diagnostic laboratories, for purely quantitative reasons.
If the organism is associated with symptoms it should be
present at high enough concentrations for direct
detection by plate culture. Occasional specimens used to
be enriched (where C. difficile infection was suspected
although the organism was not cultured on CCFA). However
now that use of 1/2 CCFA gives greater isolation rates
and as a result of my enrichment studies on normal
individuals, this is no longer considered worthwhile. Any
organisms recovered by enrichment in such a situation
could have been present at low levels before the patient
developed GI symptoms.
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Results of the epidemiological studies were again
inconclusive, although nontheless interesting. The MRU
investigation was the largest and provided a useful study
of the organism within an immunocompromised group. In
this instance it did look as if the broad spectrum oral
cephalosporins used in the treatment of many of the
infections in these patients may well have been
implicated in facilitating disease.
It would be interesting to study both patients and
isolates recovered from individuals with cystic fibrosis.
This would allow the study of organisms isolated in the
presence of antimicrobial agents that are not associated
with symptoms. It may be in such patients that the
altered physiological condition of the gut influences the
outcome of infection.
In conclusion it must be accepted from the evidence
currently available that disease can arise either as a
result of cross infection or be an endogenous entity. The
outcome will in all probability be dependent on a number
of other environmental and physiological factors.
The main work in this thesis concerned studying the
bacterial cell surface, assessing its potential
antigenicity and role in virulence. As discussed in
Chapter 5 no 'virulence factor' can be looked at in
isolation. For any organism to be pathogenic it requires
to have a variety of different factors that will permit
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it to a) invade b) associate c) elicit damage and d)
resist any immune response, consequently, many areas of
investigation are required in attempting to define what
makes a particular organism pathogenic.
Interesting points have been raised from the work done
here. There are clearly many potential antigens that
should be investigated further to assess their precise
functions. Is, for example, the novel LTA-type molecule
described involved in pathogenicity either as a direct
adhesin (as in streptococci) or by providing a
hydrophobic molecule within the cell surface? The
flagella could well be important in virulence as already
illustrated with other pathogenic organisms. Studies are
currently underway in this laboratory to assess whether
all motile strains of C. difficile might possess the same
flagellar antigen. It would be interesting to know if
different C. difficile strains all possess a regular
array and if so whether or not the variety of proteins
seen in the extracts prepared here is reflected in 'the
•'composition of this layer.
Work done on the toxins produced by C. difficile has
gained increasing importance over the period of this
project. Of all these molecules the enterotoxin (toxin A)
is emerging as potentially the factor most likely to
elicit the gross physical effects encountered in C.
difficile-associated pathogenicity.
I would like to conclude with a short summary of three
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papers recently published by Mitchell et al. (1987a,
1987b and 1987c) describing work this group have done to
try and elucidate the action of this toxin (and also
toxin B) on the gut mucosa.
6.1. An update on the possible mode(s) of action of C.
difficile toxin(s) on ileal and colonic tissue
It seems that the damage induced by toxin A is
histological rather than biochemical in nature. A
decrease in protein synthesis was observed in both rabbit
ileum and colon but this was associated with a loss of
protein synthesizing villus cells from the mucosa rather
than decreased protein synthetic ability. Also there was
no effect on membrane integrity/permeability in isolated
intestinal cells treated with the toxin.
The kinetics of the resulting tissue damage were very
different in the two tissues. A much longer incubation
period (4h) with toxin A. was reguired for fluid
accumulation to occur in the colon, compared with 45 min
in the ileum. Fluid secretion into the gut lumen was
induced only when toxin had gained access to deeper
tissues. It is speculated that this may be achieved by
several cycles of toxin uptake, with greater tissue
damage occurring after each one. Only after a given
amount of time would the accumulated damage finally
result in fluid secretion. Toxin A induced haemorrhage in
both ileal and colonic tissues. In ileum, the villus
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architecture was severely damaged and this eventually
gave rise to protein-rich bloody luminal fluid, as the
toxin gained access to the deeper tissues. In the colon,
although colonocytes were removed, the basement membrane
remained intact; this resulted in a tissue-localised
haemorrhage and a watery ultrafiltered luminal fluid low
in protein.
Returning to the role of toxin A in PMC, it was observed
that continuous membrane-like structures were seen
overlying intoxicated colonic tissue. Mitchell et al.
(1987c) speculate that the comparatively low volume of
watery diarrhoea associated with PMC could arise as a
result of limited foci of C. difficile infection within
which toxin A is synthesized and where it would be bound
or occluded and from which it would not disseminate
widely. Massive colonic involvement (sometimes seen at
autopsy) with little or no immediate pre-history of
diarrhoea could be due to the production (within many
close or near confluent foci) of very large quantities of
toxin A, the absorption of which would result in rapidly
lethal effects as observed in several test species when
toxin A is injected parenterally.
This work seems potentially to provide much insight into
the role of toxin A in disease. It was interesting to
note that although toxin B produced a much greater effect
on protein synthetic capabilities on tissue culture cells
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it produced no such effect when administered into the
intestinal lumen. This may well explain why for so long
researchers have been unable to agree upon the
correlation of cytopathic effect (produced mainly by
toxin B) with disease severity. The cytopathic effect
seen in vitro may be of little or no relevance in vivo.
It also underlines how one needs to be extremely cautious
in interpreting data obtained by use of cell lines.
One study by Aronnson et al. (1985b) which used an ELISA
technique to assess levels of toxin A in stools from
patients with AAD and AAC showed that 62 of 189 (33%) of
these patients had detectable toxin A (i.e. present at
5ng/ml or greater). Considering the likely role of this
toxin in causing tissue damage it might be expected that
it would be detected in a higher percentage of
individuals. Lyerly et al. (1983) detected toxin A in 17
of 29 (59%) of patients positive for C. difficile
cytotoxin in stools.
Several reasons can be put forward for these low levels
of toxin A detected in clinical specimens. Firstly, the
toxin may be there at levels below that possible to
detect with these ELISA techniques. Reduced sensitivity
may also be due to interfering factors like stool
proteases, which Viscidi et al. (1984) suggested may
degrade the solid phase proteins (i.e. antibody) coating
the ELISA plates.
In conclusion, it can be seen that there is still much
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worthwhile research to be done on C. difficile. It may in
fact be not very long before the mechanisms by which the
organism elicits its pathogenic effects are uncovered.
Once this is achieved it may then be simpler to assess
what factors are important in determining why some
individuals are more susceptible to developing C_^
difficile-associated disease than others.
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CCFA medium (George etal., 1979d)
40g proteose peptone no. 2 (Difco Laboratories,
Detroit, Michigan, USA)
lg NaCl
O.lg MgSC>4 (I used 0.2g MgSC>4. IH^O)
6g fructose (ICN Pharmaceuticals)-
20g agar
3ml 1% solution of neutral red in ethanol
Make up to 1000ml with distilled water.
Autoclave at 121°C and 151b/in2 for 15 min.
Once the above solution has cooled to 50°C add:
500>ig/ml of D-cycloserine
16yg/ml of.cefoxitin
5ml of egg yolk (Oxoid).
PPY medium (Deacon etal., 1978)
20g proteose peptone (Oxoid)
lOg yeast extract (Difco)
5g NaCl . „ . ,
oA^Jc tc pH
Make up to 1000ml with distilled water .and autoclave as
above. ^



















MgSC>4 . 7H2O 0 . 38g
Dissolve the above chemicals
up to 1090ml and autoclave.
in distilled water and make
Just prior to use, add filter steri
dissolved in a minimum quantity of









0.1% Sodium dodecyl sulphate (SDS)
Method:
Weigh out 6.057g Tris (hydroxymethy1) methylamine (BDH
Analar), 28.827g glycine (BDH chromatographically
homogeneous) and 2.Og SDS (BDH specially pure) into
separate containers.
Dissolve Tris and glycine in approximately 1000ml of
distilled water, adjust pH to 8.3 with 1M NaOH (BDH
Analar).
Add SDS. After it dissolves make up volume to 2000ml wi
distilled water. Store at room temperature.
Stacking gel buffer
0.2 5M Tris-HCl, pH6.8
0.2% SDS
Method:
Into separate containers, weigh out 15.143g Tris
(hydroxymethyl) methylamine (BDH Analar) and l.Og SDS
(BDH specially pure).
Dissolve the Tris in approximately 250ml of distilled
water; adjust to pH6.8 with 1M HCl (BDH Analar).
Add SDS and when it has dissolved make up to 500ml with
distilled water.
Store at room temperature.




Weigh out 90.855g Tris (hydroxymethyl) methylamine (BDH
APPENDIX 2 continued:
Analar and dissolve in approximately 500ml of distilled
water; adjust to pH8.8 with 1M HCl (BDH Analar).
Add 2.0g SDS (BDH specially pure), dissolve and make up
volume to 1000ml with distilled water. Filter through
Whatman No. 1 paper.
Store at room temperature.
Buffers for RIE, FRIE and CIE
Electrode buffer
Solution 1: barbital sodium 26.Og
barbital (barbitone) 4.24g
distilled water 2000ml
Solution 2: glycine 112.4g
Tris (not Analar grade) 90.4g
distilled water 2000ml
Method:
Mix equal volumes of solutions 1 and 2 (final molarity is
0 .18 7 M) .
Check that the pH is 8.8.
Store at 4°C
1% Agarose for immunoelectrophoresis




Mix ingredients and dissolve by boiling; stir
continuously. Add Triton X-100 (scintillation grade) to
give 1% v/v.
Dispense in 15 ml volumes for 1st dimension CIE and into
3ml volumes for RIE and 2nd dimension CIE.
APPENDIX 3
Viable counts obtained from three plates in an experiment
comparing recovery of C. difficile on CCFA and 1/2 CCFA
and from alcohol treated and untreated faecal samples
Figures are expressed as organisms per gramme of faeces.
Sample CCFA 1/2 CCFA
A 3.26 X 106 2.72 X 106
2.56 X 106 2.56 X 106
2.93 X 106 2.81 X 106
A* 4.80 X 106 5.76 X 106
5.28 X 106 6.08 X 106
5.60 X 106 7.04 X 106
B 2.72 X 107 2.78 X 107
2.72 X 107 2.94 X 107
2.61 X 107 2.94 X 107
B* 3.54 X 107 3 .65 X 107
3.20 X 107 3.49 X 107
3. 38 X 107
*: figures for alcohol treated samples
APPENDIX 3 continued:
Experiment A
Colony counts of C. difficile growing on CCFA after
48h incubation of plates in adhesion experiment
Time in C.d
suspension Wash 1 Wash 2 Wash 3 Wash 4
Homogenized
gut
101 UD UD UD 101 h-' O
2 sec 29 91 28 11 44 /
5 min 59 134 53 22 256 /
10 min 67 256 118 82 +++ 51
15 min 101 296 184 141 +++ 79
30 min 152 456 297 173 +++ 141




Colony counts of C. difficile growing on CCFA after
48h incubation of plates in adhesion experiment
Time in C.d
suspension Wash 1 Wash 2 Wash 3 Wash 4
Homogenized
gut
101 UD UD UD i—1OrH 102
2 sec 62 47 42 20 58 /
5 min 81 91 65 33 275 /
10 min 94 130 75 50 ++ + 44
15 min 114 170 123 68 ++ + 69
30 min •180 400 143 73 +++ 146
60 min 224 114 300 256 +++ 198
In both these tables (experiments A and B) the following
applies:
UD: undiluted
/: dilution not plated
+++: too many colonies to count
APPENDIX 3 continued:
Colony counts of B. fragilis growing on BA after
48h incubation of plates in adhesion experiment
Time in B.f
suspension Wash 1 Wash 2 Wash 3 Wash 4
Homogenized
gut
101 UD i—1o1—1 UD i—1o1—1 UD i—1O•—1 102 103
2 sec 124 44 / 13 / 12 16 / /
5 min 152 84 / 28 / 25 / / 14
10 min 174 147 / 54 / 51 / / 26
15 min 183 +++ 62 58 / 44 / / 46
30 min 197 386 / / 26 232 / / 58
60 min 212 +++ 48 232 / 199 / / 64
UD: undiluted
/: only figures used to calculate the viable count
are recorded.
+++: too many colonies to count.
APPENDIX 3 continued:
Colony counts obtained in experiment to assess the effect of prior treatment of
ileum with 3. fragilis on the association of C. difficile with ileal tissue
Organism Time Wash 1 Wash 2 Wash 3 Wash 4
Homogenized
gut
102 103 101 102 UD 101 UD 101 101 102
8. fragilis Tis
recovery
333 / 175 / / 132 / 110 / 56
3. fragilis To
control
190 / 98 / 197 / 113 / 301 /
3. fragilis T15
control
/ 36 / 33 / 136 / 88 / 80
10 1 UD UD UD 101 102
C. difficile Tis 91 121 81 35 385 /
recovery
C. difficile To 354
-
41 29 40 46 /
control
C. difficile Tis 120 346 193 93 74 /
control
UD: undiluted
/: only figures used to calculate the viable count are recorded.
I
Standard curve of molecular mass against
percentage mobility for proteins separated




20 40 60 8 0
percentage mobility
10 0
Standard curve of molecular mass against percentage
mobility for proteins separated by SDS-PAGE (Heard et al.
(1986b). Measurements were made from figures in this
paper.
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An Immunochemical Method for Fingerprinting
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The use of sodium dodecyl sulphate-polyacrylamide gel electrophoresis in association with electro-
phoretic transfer of proteins to nitrocellulose and subsequent probing with antisera appears useful as a
method for fingerprinting Clostridium difficile. Thorough testing of the stability of the antigenic nature of
isolates of the organism during subculture and antigen preparation has shown it to be remarkably stable
both in vitro and in vivo. Minor differences in the method of antigen extraction do not markedly alter the
immunoblot patterns produced. It has also been demonstrated that an individual may harbour more than
one strain of the organism at any one time. Results show the possible usefulness of this technique in
studying the epidemiology of diarrhoeal disease known to be associated with C. difficile. It is suggested
that for any serious study several colonies should be subcultured from the primary isolation plate.
Key words: Clostridium difficile - immunoblolting - fingerprinting
Introduction
Clostridium difficile is known to be associated with nearly all cases of antibiotic-
associated pseudomembranous colitis. The organism also appears to be involved to
some extent in a broad spectrum of other bowel conditions such as antibiotic-associ¬
ated diarrhoea, post-operative diarrhoea and chronic inflammatory bowel disease. It
has also been isolated from cases of sporadic non-antibiotic-associated diarrhoea
(British Medical Journal, 1981; Brettle et ah, 1982). Isolation of C. difficile from
healthy adults is uncommon although the organism can be cultured from a high
percentage of normal infants (George et ah, 1977; Stark et ah, 1982). The epidemiol¬
ogy of C. difficile-associated disease is poorly understood at present (Mulligan,
1984). There have been several reports indicating possible cross-infection between
patients from whom the organism has subsequently been isolated. However lack of a
reliable typing technique has hindered more detailed studies of these outbreaks. Sell
et ah (1983) suggested that the use of bacteriophage could prove useful in typing of
C. difficile while Tabaqchali et ah (1984) have used radiolabelling of growing cells as
a possible means of studying the epidemiology of the organism. Since then Delmee
0022-1759/85/$03.30 © 1985 Elsevier Science Publishers B.V. (Biomedical Division)
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et al. (1985) have shown that strains of the organism can be serogrouped into 6
different groups using a variety of antisera. Recently, in this laboratory the use of
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) in associ¬
ation with electrophoretic transfer of proteins to nitrocellulose and subsequent
probing with antisera has provided a useful method for fingerprinting the organism
(Poxton et al., 1984). Further studies have subsequently been performed to test the
reproducibility of results obtained with this technique. This paper provides a review
of the experimental work carried out and offers guidelines for the successful
application of the technique in the clinical situation.
Materials and Methods
Bacterial isolates
Isolation and identification of C. difficile was done as previously described
(Brettle et al„ 1982). Four strains of the organism, MPRL 558, 559, 589 and 720,
which had been isolated from patients attending the Renal Unit in the Royal
Infirmary of Edinburgh (RIE) during 1983 were used in this study. They were picked
from the primary isolation plates as single colonies, cultured overnight in cooked
meat broth (CMB) and lyophilised. MPRL 558 came from a severely ill patient;
MPRL 559 from a patient with no diarrhoea while MPRL 589 and MPRL 720 came
from 2 different patients with moderate diarrhoea.
Standard technique for culture and isolation of surface protein antigens
Lyophilised organisms were cultured in CMB for 17 h and 0.1 ml of this was
inoculated into 100 ml proteose peptone yeast extract broth (PPY) supplemented
with 0.04% (w/v) sodium carbonate and 0.075% (w/v) cysteine hydrochloride as
described by Poxton et al. (1984). After 17 h incubation anaerobically at 37°C the
cells were harvested (20,000 X g for 5 min at 4°C) and the washed pellet was
resuspended in phosphate-buffered saline, pH 7.4, containing 10 mM EDTA and
incubated at 45°C for 30 min. The supernatant, containing the antigens, was
collected after 2 cycles of centrifugation at 10,000 X g for 2.5 min and used
undialysed as antigen. The protein content of the preparation was measured by the
method of Lowry et al. (1951) using bovine serum albumin as standard.
Enrichment broth and selective agar
C. difficile was isolated from mouse faecal specimens using cycloserine-cefoxitin
egg yolk agar (CCFA) (George et al., 1979). Enrichment was achieved using CCF
broth which was CCFA without the egg yolk and agar.
SDS-PAGE
The buffer system of Laemmli (1970) with 10% slab gels as described by Poxton
and Brown (1979) was used. EDTA extracts containing 25 jag of protein in 50 jal of
sample buffer were run on gels in duplicate. One set of the separated proteins was




The method of Towbin et al. (1979) as described by Poxton et al. (1984) was
followed. This involved transfer of the SDS-PAGE-separated EDTA extracts to
nitrocellulose membrane in a Tris, glycine, methanol buffer pH 8.3 at 12 V and 40
mA for 18 h. After this the membrane was washed and probed with a rabbit
antiserum raised against UV-killed cells of C. difficile NCTC 11223. The method of
raising the antiserum was as described by Poxton and Byrne (1981).
Results
Work carried out with the standard technique for fingerprinting of C. difficile
isolates which was described earlier (Poxton et al., 1984) has raised questions as to
the reproducibility of the immunoblot patterns produced from one study to the next.
Minor variations occurred between blotting patterns produced from different clini¬
cal isolates. It was important to find out whether these differences were due to real
variations between strains or whether they arose simply because of differences in
growth conditions of particular strains or variation in antigen extraction. These
studies were therefore done to investigate the antigenic stability of isolates, both
during culture of the organism and subsequent antigen extraction.
Effect of variation in phase of growth at harvesting
In the standard technique the organisms were cultured for 16-17 h before
harvesting and antigen extraction. In order to find if culturing of the isolates for
differing periods would produce differences in the resulting immunoblot patterns
obtained, the following experiment was done. A 5% inoculum of MPRL 558 put into
PPY medium was incubated anaerobically at 37°C and 100 ml amounts were
harvested after 2, 4 and 8 h. Similarly a 1% inoculum was harvested after 16, 18, 20,
24 and 40 h. All other conditions remained the same throughout. It can be seen from
the resulting immunoblot patterns produced (Fig. la) that there was a great degree
of similarity in the banding patterns. There were minor variations, especially in the
higher molecular weight polypeptides, but these may in part be due to slight
variations in the amount of protein actually loaded onto the gel as seen in the
corresponding Coomassie blue stain (Fig. lb).
Variations in antigen extraction
Another likely source of variation between isolates could be differences in the
actual method of antigen preparation. To investigate this 3 of the renal isolates were
grown up in PPY for 17 h, harvested, washed and resuspended in EDTA buffer as
described previously. The EDTA suspensions were then divided into 4 equal aliquots
and each was subjected to one of the following treatments, (a) 'normal' antigen
extraction at 45°C for 30 min, (b) extraction at 50°C for 30 min, (c) extraction at
45°C for 2.5 h, (d) freeze-thawing (— 20°C to 37°C) 3 times over a period of 3 h and
then 45°C for 30 min. These 4 EDTA suspensions were then centrifuged as
described in Materials and Methods.
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a 12345678 b 12345678
Fig. 1. (a) Immunoblot patterns produced by EDTA extracts of C. difficile MPRL 558 obtained 2-40 h
after inoculation of PPY medium. Tracks 1-8 contained extracts obtained after 2, 4, 8, 16, 18. 20, 24 and
40 h respectively. Extracts were probed using antiserum raised to NCTC 11223. (b) Corresponding
SDS-PAGE profile stained with Coomassie blue.
When these various extracts were run on gels it was found that MPRL 558 and
559 produced very similar banding patterns by Coomassie blue staining but there
were consistent differences between the isolates in the patterns produced on im-
munoblotting (Fig. 2a and 2b). There was a much stronger reaction involving the
high molecular weight proteins in MPRL 559 than occurred with MPRL 558 and
this remained consistent despite the differing treatments of the extracts during
extraction. However, MPRL 589 behaved differently. It was found that the extracts
which had been heated for 2.5 h produced a blot pattern which was different from
the others in the mid-region of the track (Fig. 2c). Why this occurred is not clear.
With all 3 isolates the EDTA/freeze-thawed extracts had more protein bands
apparent on the Coomassie stained gel. However, the immunoblot patterns obtained
did not show up these additional bands indicating that they were probably intracell¬
ular proteins with which the antisera raised against whole UV-killed bacteria would
not react.
Variations on subculture of the organisms
Having found that no major variations in immunoblot patterns could be accounted
for by differences in culture or antigen preparation, further work was done to
investigate the stability of an individual isolate both in vitro and in vivo. MPRL 558
was used for both these areas of investigation. A CMB culture of the isolate was
passaged weekly into fresh pre-steamed CMB over the course of 7 weeks. An EDTA
extract of each of these broths was prepared in the standard way after each had been
incubated anaerobically at 37°C for 24 h. When these extracts were analysed by
SDS-PAGE and immunoblotting the patterns produced were identical.
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Fig. 2. SDS-PAGE and immunoblot patterns produced by (a) MPRL 558, (b) MPRL 559 and (c) MPRL
589 after various treatments during EDTA extraction. Track 1: extraction at 45°C for 30 min, track
2:50°C for 2.5 h. track 3:45°C for 2.5 h, track 4: freeze-thawed extract.
To study antigenic variation of the organism in vivo a spore suspension of MPRL
558 (100 ju.1 saline inoculated with 10 C. difficile colonies from a 72 h blood agar
plate) was given orally to a female BALB/c mouse which was known to be C.
difficile-negative. Faecal samples were collected weekly from the animal over a
period of 7 weeks. Each sample was inoculated into enrichment broth and the
organisms were recovered by plating of these broths onto CCFA. The isolates were
stored as CMB cultures and an EDTA extract of each isolate was prepared by the
standard method. Again it was found that there were only minor variations between
each of the isolates.
Another study was done with 3 strains where one colony from a CCFA plate was
streaked onto blood agar. Eight colonies were subsequently picked from this into
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Fig. 3. Analysis of EDTA extracts prepared from 8 different colonies picked from a CCFA primary
isolation plate, (a) SDS-PAGE, (b) immunoblot.
CMB and EDTA extracts prepared of each colony. When these extracts were
analysed it was found that the patterns produced were identical.
The only other possible source of variation during this work was in the composi¬
tion of the PPY medium used to culture the organisms. However, these studies were
done over a period of 4 months during which several different batches of media were
used and no variation in antigenic patterns was observed.
Different strains within one patient
It was now apparent that any one strain of C. difficile would remain antigenically
the same throughout any study. Further work was consequently done to see whether
an individual patient could harbour more than one strain of the organism at one
time. The original faecal sample from which MPRL 720 had been isolated was
spread onto CCFA. After incubation 8 different colonies were subcultured from this
plate. EDTA extracts were prepared from all of these isolates which were subse¬
quently analysed. It was found that from this primary isolation plate 2 different
banding patterns were produced by the isolates (Fig. 3). The pattern produced in
tracks 1, 2, 3, 6 and 7 was as expected for MPRL 720 (as indicated by other studies);
the pattern in the other tracks corresponding to that of another isolate cultured from
this patient 6 months previously. When this experiment was repeated with another 2
faecal samples one of these was also found to contain 2 different strains of C.
difficile.
Discussion
The immunochemical fingerprinting of C. difficile strains described here has been
used in this laboratory over the past 2 years to study various outbreaks of diarrhoea
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with which the organism was found to be associated. The first investigation involved
studying 28 strains of C. difficile sent from an outbreak in Sweden (Poxton et al.,
1984). With this technique it was possible to show the existence of a common strain
within one area of a hospital. The results of this study showed that this technique
could prove useful in tracing the epidemiology of C. difficile. Since then a further
study has been done involving renal patients attending the RIE who had differing
degrees of diarrhoea. In this particular group of 18 patients 13 different strains of
the organism appeared to be associated with their symptoms over a 9-month period
(Cumming et al., unpublished results). It was found however that in one or two
instances it was difficult to be absolutely certain whether or not 2 strains were the
same or different. For this reason it was felt necessary to investigate the stability of
the antigens that were being isolated and studied with this technique.
As we know from our previous studies, the Coomassie blue and immunoblot
patterns vary considerably from strain to strain although one or two major bands
and several minor bands are common to all strains. Some of the major bands in
Coomassie blue gels are antigenic while others are not, and this is also true for the
minor bands. In this study the variation in antigenicity of the bands can be seen by
comparing the patterns produced in Fig. 1 and 3. In Fig. 1 most of the major
Coomassie blue bands are also stained strongly in the immunoblot, while in Fig. 3
only one of the major Coomassie blue bands in tracks 1, 2, 3, 6 and 7 is strongly
immunogenic and most of the staining of the immunoblot is due to minor bands.
It is apparent from the studies done here that the antigenic nature of any
particular isolate of C. difficile will remain constant when analysed by this im-
munoblotting technique. The only major difference observed in an isolate was with
MPRL 589 when it was left to incubate for an extended period of time during
EDTA extraction of the antigens. It has been noticed that variations in the intensity
of banding seen on the Coomassie stain can lead to difficulty in interpreting the
immunoblotting patterns. Protein bands that are faint often do not show up on the
immunoblot. However, these minor problems do not detract from the usefulness of
this technique in the epidemiology of any outbreaks of diarrhoeal disease known to
be associated with C. difficile.
Recommendations for successful use of immunoblotting
(1) Pick several colonies (at least 10) from the primary isolation plate in case there
is more than one strain of C. difficile present in the patient.
(2) A standardised technique should be used for the culture and preparation of
the EDTA antigen extracts. Cells should be incubated for 30 min and at a
temperature of 45°C although minor variations in this do not appear to matter.
Since different strains may vary in their sensitivity to changes during antigen
extraction it is best to keep to a well-defined regimen. Freezing and thawing during
the EDTA extraction procedure releases more protein: this complicates the Coomas¬
sie blue pattern, adds nothing to the immunoblot and should be avoided.
(3) Only compare EDTA antigens run on the same gel. It is difficult to compare
one gel with another as it is impossible to reproduce running conditions accurately.
(4) When analysing the SDS-PAGE and immunoblot patterns produced by this
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technique minor variations should be overlooked if the general picture arising is of
similarity between the strains.
(5) Conclusions should be drawn using the information provided by both the gel
and the immunoblot since some patterns that appear similar on the blot can appear
quite different on the gel and vice versa. The advantage of doing an immunoblot as
well as a Coornassie blue-stained gel is that the blot is simpler and easier to read.
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1. SUMMARY
The membrane lipocarbohydrate antigen (lipo¬
teichoic acid analogue) of Clostridium difficile has
been purified by aqueous phenol extraction and
Sepharose 6B chromatography. After analysis by
polyacrylamide gel electrophoresis (PAGE) and
immunoblotting it has been shown to consist of a
series of components of differing Mr. It appears as
a regularly spaced ladder pattern similar to those
shown for the lipopolysaccharide (LPS) of many
Gram-negative bacteria.
2. INTRODUCTION
C. difficile is a Gram-positive, spore-forming,
anaerobic bacterium and is well recognised as
being the major cause of pseudomembranous and
antibiotic-associated colitis [1], The structure of
the cell-surface appears to be typically Gram-posi¬
tive: components analogous to wall and membrane
teichoic acids have been demonstrated [2] and a
regular surface array of protein subunits has been
recognised [3], The membrane teichoic acid ana¬
logue is not based on a poly-glycerol phosphate
backbone as in most other Gram-positive bacteria
so far investigated, but contains glucose, glucos¬
amine, phosphate and fatty acid in the molar
proportions of 2 :1 :1.6 : 0.04 [2],
In Gram-negative bacteria the LPS has been
investigated by PAGE. After silver staining, it has
been shown to be made up of a heterogeneous
population of differing Mr, adjacent bands vary¬
ing by one repeating unit of polysaccharide [4],
It might be expected that the appearance on
PAGE of lipoteichoic acid molecules based on the
typical poly-glycerol phosphate backbone would
not show the characteristic ladder pattern of LPS.
If the chain lengths were variable they would only
differ by a single substituted glycerol phosphate
unit, which might not be resolved on PAGE.
This present study uses PAGE and immuno¬
blotting to investigate the immunochemistry of the
atypical lipocarbohydrate of C. difficile. Antigeni-
cally related species are also compared.
3. MATERIALS AND METHODS
3.1. Culture of organisms and cell breakage
The strains used were C. difficile NCTC11223,
and 3 clinical isolates, RIE11831, MPRL161 and
MPRL597, C. sordellii NCTC8780 and C. bi-
^ fermentans NCTC506.
A 0.1% (v/v) inoculum of an overnight culture
0378-1097/86/S03.50 © 1986 Federation of European Microbiological Societies
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of bacteria in Robertsons' cooked meat broth was
added to 6 1 of pre-reduced proteose peptone yeast
extract medium containing 0.04% (w/v) sodium
carbonate and 0.075% (w/v) cysteine hydrochlo¬
ride [5] and incubated anaerobically at 37°C for
18 h in an anaerobic cabinet (Forma Scientific).
The bacteria were harvested (8500 X g for 10 min
at 4°C) and broken as described previously [2].
After removal of the cell walls at 45 000 X g for 20
min, the supernate, containing the membrane anti¬
gen, was lyophilized prior to further extraction.
3.2. Extraction of membrane antigen
The lyophilized supernate was defatted with
2 X 200 ml chloroform/methanol (2:1, v/v) over
24 h and extracted with cold 80% (w/w) phenol as
described by Coley et al. [6], The membrane
material (about 0.8 g) was suspended in distilled
water to about 10% (w/v), mixed with an equal
volume of 80% aqueous phenol (w/w) and stirred
at room temperature for 30 min. This was centri-
fuged at 2500 X g for 20 min at 4°C. The upper
aqueous layer, after dialysis, was mixed with an
equal volume to 0.2 M acetic acid/acetate buffer,
pH 5.0. containing 0.02 M MgCl,. Ribonuclease
and deoxyribonuclease (Sigma) were added and
the mixture incubated under toluene at 37°C over¬
night. Phenol/water extraction was repeated, the
upper aqueous layer dialysed and finally lyophi¬
lized. This was the crude membrane antigen.
Further purification of the MPRL161 sample
(13 mg in 500 p\ of distilled water) was carried out
by fractionating on a Sepharose 6B column (30 X 1
cm) by the method of Coley et al. [6].
3.3. Immunoelectrophoresis
Crossed immunoelectrophoresis (CIE) was per¬
formed by the procedure of Weeke [7] as described
by Poxton and Byrne [8] with antiserum raised to
MPRL161. Samples (10 p\) were applied at a
concentration of 10 mg/ml in distilled water.
Fused rocket immunoelectrophoresis (FRIE)
was done with antiserum raised to NCTC11223 as
described by Svendsen [9] with the same buffer
system as used for CIE. The pooled fractions were
desalted on a 10 ml Sephadex G25 column.
3.4. Preparation of antiserum
Antisera against UV-killed, whole, washed cells
of C. difficile NCTC11223 and MPRL161 were
prepared as described previously [8].
3.5. PAGE and immunoblotting
The buffer system of Laemmli [10] with 10%
slab gels as described by Poxton and Brown [11]
with and without SDS was used. Samples (50 jul)
containing 250 pg crude antigen or 25 pg purified
antigen were run on each track. Gels were stained
with silver [4] for 10-15 min. For immunoblotting
gels without SDS were used. Materials were trans¬
ferred to nitrocellulose membranes (0.2 jam pore,
Sartorius) and treated with antiserum raised against
NCTC11223 and anti-rabbit HRP conjugate, as
previously described [12], except that Tween 20
was omitted from the washing solutions.
4. RESULTS
Crude aqueous phenol-extracted membrane an¬
tigens from 4 strains of C. difficile and one strain
each of C. sordellii and C. bifermentans were
analysed by SDS-PAGE and stained with silver.
The results (Fig. 1) showed that the patterns pro¬
duced by the C. difficile strains all appeared as a
regularly spaced ladder pattern reminiscent of the
pattern produced by the LPS of Gram-negative
bacteria. The patterns produced by the other two
species were indistinct, and even when more
material was applied to the gel no ladder pattern
could be demonstrated. Immunoblots of the C.
difficile extracts with antiserum raised to C. dif¬
ficile MPRL11223 revealed patterns of faint anti¬
genic bands similar to those of the silver stain
(results not shown).
One of the crude antigens (from C. difficile
MPRL161) was analysed by CIE and produced a
pattern identical to that previously produced by
NCTC11223, i.e., two precipitin arcs showing par¬
tial identity [2]. After fractionation of the
MPRL161 crude phenol extract on a Sepharose 6B
column, two antigens were detected with FRIE,
one eluting in the void volume, the other with a
Kav of 0.71. This was similar to that previously
shown for NCTC11223 [2]. The fractions corre¬
sponding to the two antigens were pooled, de¬
salted and analysed further by PAGE and im-
Fig. 1. Silver-stained SDS-PAGE of crude aqueous-phenol
extracts of C. difficile. Lane 1, NCTC11223; lane 2, MPRL161;
lane 3, RIE118311; lane 4. MPRL597. Samples (50 \x 1) contain¬
ing 250 [ig crude antigen were applied to each lane.
munoblotting. Initial attempts to obtain good pho¬
tographs of immunoblots were hampered by the
apparent lack of sensitivity of the procedure. Sub¬
sequently, sodium dodecyl sulphate (SDS) was
omitted from the gels but retained in the sample
and electrode buffers. This resulted in greater
sensitivity of detection by immunoblotting, and
the silver-stained gel was extremely similar to the
SDS-containing gel, except that the bands ran
slower when SDS was omitted. The results of the
PAGE and corresponding immunoblot of the crude
membrane antigen and the two antigenic fractions
after Sepharose 6B treatment are shown in Fig. 2.
The material in fraction 1 gave an identical band¬
ing-pattern to that seen with the crude material. In
the silver stain there was nothing apparent in the
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Fig. 2. (a) Silver-stained PAGE (without SDS) of crude aque¬
ous-phenol extract of MPRL161 (lane 1) and the two antigenic
fractions detected by FRIE from the Sepharose 6B column
(lane 2 is first antigen and lane 3 the second). Lane 1 contained
250 /xg crude antigen, and lanes 2 and 3 25 /xg purified antigen,
(b) Corresponding immunoblot with antiserum raised against
NCTC11223.
sample corresponding to fraction 2. In the im¬
munoblot of fraction 2 an antigenic band was
detected just behind the gel front.
Immunoblotting with antiserum to NCTC11223
of the crude extracts of the four C. difficile strains
and the other two species was repeated, omitting
SDS. The patterns produced by C. difficile were
identical to those obtained with the silver stain.
There was distinct cross-reaction of the C. difficile
antiserum with the extracts from Clostridium
sordellii and Clostridium bifermentans, part of the
pattern in the mid-region of the C. sordellii and C.
bifermentans gels being series of fine lines which
appeared as a smear in the silver stain (not shown).
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5. DISCUSSION
Previous work has shown that a phenol extract
of lyophilized supernate from broken cells of C.
difficile NCTC11223 contained two antigens when
studied by CIE. These antigens, which appeared to
be antigenically related, were proposed to corre¬
spond to (a) the lipoteichoic acid moiety found in
all Gram positive organisms and (b) a deacylated
form of this antigen which cross-reacts with the
cell wall antigen (teichoic acid) [2], In this present
study the membrane carbohydrate has been shown
to be extremely similar in appearance to the LPS
of Gram-negative bacteria when examined by
PAGE, giving a ladder pattern; each rung ap¬
parently differing by one repeating unit of poly¬
saccharide. Relatively high concentrations of the
antigen were applied to the gels to ensure that the
silver-stained material developed rapidly, thus
avoiding problems with high background staining.
The identity of the second antigenic peak from the
Sepharose 6B column is uncertain. This rather
heterogeneous low-A/r material may be frag¬
mented wall antigen or deacylated membrane anti¬
gen.
As far as we are aware this is the first report of
the analysis of a lipoteichoic acid (or analogue) by
PAGE. It has however been speculated that a
ladder pattern seen in immunoblots of crude cell
surface extracts of Clostridium botulinum might be
due to such a molecule [13]. We do not know if
this ladder pattern is produced by the LTA ana¬
logues of other Clostridia or indeed of other
Gram-positive bacteria.
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Diarrhoea due to Clostridium difficile
associated with antibiotic treatment
in patients receiving dialysis: the role of
cross infection
Diarrhoea due to Clostridium difficile associated with treatment with
antibiotics has been described among patients receiving peritoneal dialysis,1
and cross infection is thought to be important.2 We describe an outbreak of
diarrhoea associated with C difficile in patients undergoing haemodiaiysis
and continuous ambulatory peritoneal dialysis in which a "fingerprinting"
technique of typing strains was used to investigate the possibility of person to
person spread.
Patients, methods, and results
The table gives details of 18 patients from whom C difficile was isolated on stool
culture. All developed diarrhoea while inpatients in the medical renal unit, Royal
Infirmary, Edinburgh, between July 1983 and April 1984. C difficile had been
isolated from only one patient with renal disease in the previous six months.
C difficile was cultured and identified as previously described3; strains
were identified by the fingerprinting method of Poxton et al, using SDS-
polyacrylamide gel electrophoresis of surface proteins extracted with edetic acid
followed by Coomassie blue staining and an immunoblot probe using rabbit
antiserum to cells ofC difficile NCTC 11223 killed with ultraviolet light.4 When C
difficile was isolated patients were given oral vancomycin (500 mg every six
hours) and other antibiotics were withdrawn if possible. Diarrhoea resolved in 12
patients. Four patients died during or shortly after treatment; all were severely
debilitated by pre-existing medical conditions. The fingerprinting technique
identified 13 different strains of C difficile. One strain occurred in five subjects
(cases 12, 13, 14, 15, and 18) and one strain in two (cases 7 and 11); the 11 other
strains occurred in only one patient each.
the major mechanisms by which organisms were acquired during this
outbreak. Among patients undergoing dialysis who have uraemia the
frequent use of broad spectrum antibiotics, defective immunity, abnormal
nutrition, and perhaps other changes in gut flora or mucosal defence
mechanisms might combine to permit acquisition of C difficile or to promote
its selective growth.5 After this outbreak we tried to give as narrow a range of
antibiotic treatment as possible and avoided oral antibiotics, particularly oral
cephalosporins; the incidence of isolation of C difficile and related clinical
disease returned to a low level.
We recommend early selective faecal culture for C difficile in any patients
undergoing dialysis who have diarrhoea. Our findings suggest that cross
infection with C difficile may occur in patients receiving dialysis, although it
is not always the major mechanism of acquisition of this organism. It would
be unwise to abandon standard measures against cross contamination, and it
should be appreciated that patients undergoing dialysis may be particularly
prone to infection with C difficile.
We thank the Scottish Home and Health Department and Upjohn Co for
financial support; R Brown, A B Harris, and G Fleming for technical help;
Professor J G Collee for advice and support; and Professor J S Robson, Dr Anne T
Lambie, and Dr R J Winney for advice and permission to report on patients
under their care.
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Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and
diarrhoea. J Med Microbiol 1984;17:317-24.
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pseudomembranous colitis. Lancet 1978p: 1063-6.
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Comment
Cross infection with C difficile in hospitals has been clearly shown
previously,4 and seemed likely in this series of cases among our patients
receiving dialysis; all had been inpatients in the medical renal unit, with
considerable overlap in their periods of stay in hospital, and the rate of
isolation of C difficile increased abrupdy over 10 months. Standard measures
to prevent spread of the organism were taken—namely, isolation when
feasible, use of gown and gloves when working with patients, and careful
attention to personal hygiene.
Isolation of patients was limited by lack of space and the specialised
nursing that dialysis requires. The five patients from whom the same strain
was isolated were probably cross infected; all were nursed in one of two
adjacent cubicles, the first four within one month. The isolation of 13
different strains of C difficile appears, however, to exclude cross infection as
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Details ofpatients from whom C difficile was isolated
Age
Case No (years) Sex Type of dialysis Type of infection Antimicrobials given
Month when
strain isolated Outcome
1 61 F CAPD Peritonitis None July 1983 Resolved
2 60 F CAPD Peritonitis Cephradine, flucloxacillin, tobramycin July 1983 Died
3 48 F Haemodiaiysis None None July 1983 Remained well
4 15 F CAPD Peritonitis Cephradine, tobramycin August 1983 Died
5 56 F Haemodiaiysis Wound Cefuroxime, metronidazole August 1983 Diarrhoea continued
6 59 F Haemodiaiysis Arteriovenous fistula Flucloxacillin, benzyl penicillin August 1983 Resolved
7 61 M CAPD Peritonitis Flucioxacillin, metronidazole, ticarcillin August 1983 Resolved
8 69 F CAPD Peritonitis Cephradine September 1983 Resolved
9 59 M Haemodiaiysis Mastoid Flucloxacillin, benzylpenicillin October 1983 Resolved
10 50 M Haemodiaiysis Pericolic abscess Cephradine, cefuroxime, metronidazole October 1983 Resolved
11 68 F CAPD Peritonitis Tobramycin November 1983 Resolved
12 71 F CRF None None January 1984 Resolved
13 73 M Haemodiaiysis (acute) Pneumonia Ampicillin, cefuroxime, erythromycin, metronidazole, January 1984 Resolved
gentamicin, benzylpenicillin
14 33 F Haemodiaiysis Urinary tract Co-trimoxazole February 1984 Resolved
15 63 F Haemodiaiysis (acute) Ischaemic bowel Cefuroxime, metronidazole, tobramycin February 1984 Died
16 64 F CAPD Peritonitis Flucloxacillin February 1984 Resolved
17 60 M CAPD Peritonitis Flucloxacillin March 1984 Resolved
18 66 F Haemodiaiysis Arteriovenous fistula Cephradine, cefuroxime, tobramycin March 1984 Died
CAPD=Continuous ambulatory peritoneal dialysis. CRF=End stage chronic renal failure.
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